CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ketamine
Accession: CHEBI:6121
browse the term
Definition: A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Synonyms: related_synonym: 2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone; 2-(methylamino)-2-(2-chlorophenyl)cyclohexanone; 2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone; Formula=C13H16ClNO; InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3; InChIKey=YQEZLKZALYSWHR-UHFFFAOYSA-N; NMDA; SMILES=CNC1(CCCCC1=O)c1ccccc1Cl; dl-ketamine; ketamina; ketaminum; special K
alt_id: CHEBI:138833
xref: CAS:100477-72-3; CAS:6740-88-1; DrugBank:DB01221; Drug_Central:1523; HMDB:HMDB0015352; KEGG:C07525; KEGG:D08098
xref_mesh: MESH:D007649
xref: PMID:3783598; Patent:BE634208; Patent:US3254124; Reaxys:2216965; VSDB:2978; Wikipedia:Ketamine
G
9530057J20Rik
RIKEN cDNA 9530057J20 gene
increases expression
ISO
Ketamine results in increased expression of POTEM mRNA
CTD
PMID:20080153
NCBI chr 8:20,478,979...20,510,931
Ensembl chr 8:20,478,993...20,501,314
G
Abca1
ATP-binding cassette, sub-family A member 1
increases expression
ISO
Ketamine results in increased expression of ABCA1 mRNA
CTD
PMID:20080153
NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
multiple interactions
EXP
ABCB1A protein affects the susceptibility to [Pentobarbital co-treated with Ketamine]
CTD
PMID:17959987
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcg1
ATP binding cassette subfamily G member 1
increases expression
ISO
Ketamine results in increased expression of ABCG1 mRNA
CTD
PMID:20080153
NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962
G
Abhd16a
abhydrolase domain containing 16A
increases expression
ISO
Ketamine results in increased expression of ABHD16A mRNA
CTD
PMID:20080153
NCBI chr17:35,308,210...35,321,963
Ensembl chr17:35,308,239...35,321,963
G
Abhd5
abhydrolase domain containing 5
decreases expression
ISO
Ketamine results in decreased expression of ABHD5 mRNA
CTD
PMID:20080153
NCBI chr 9:122,180,681...122,210,589
Ensembl chr 9:122,180,673...122,210,589
G
Acat2
acetyl-Coenzyme A acetyltransferase 2
decreases expression
ISO
Ketamine results in decreased expression of ACAT2 mRNA
CTD
PMID:20080153
NCBI chr17:13,161,929...13,179,612
Ensembl chr17:13,161,777...13,179,634
G
Acbd3
acyl-Coenzyme A binding domain containing 3
decreases expression
ISO
Ketamine results in decreased expression of ACBD3 mRNA
CTD
PMID:20080153
NCBI chr 1:180,553,608...180,581,769
Ensembl chr 1:180,553,608...180,581,769
G
Acbd5
acyl-Coenzyme A binding domain containing 5
decreases expression
ISO
Ketamine results in decreased expression of ACBD5 mRNA
CTD
PMID:20080153
NCBI chr 2:22,958,189...23,004,525
Ensembl chr 2:22,958,179...23,005,570
G
Ace
angiotensin I converting enzyme
increases expression
ISO
Ketamine results in increased expression of ACE mRNA
CTD
PMID:20080153
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Acp6
acid phosphatase 6, lysophosphatidic
decreases expression
ISO
Ketamine results in decreased expression of ACP6 mRNA
CTD
PMID:20080153
NCBI chr 3:97,066,070...97,083,892
Ensembl chr 3:97,066,093...97,084,615
G
Acr
acrosin prepropeptide
increases expression
ISO
Ketamine results in increased expression of ACR mRNA
CTD
PMID:20080153
NCBI chr15:89,452,549...89,458,790
Ensembl chr15:89,452,529...89,458,788
G
Acsbg1
acyl-CoA synthetase bubblegum family member 1
increases expression
ISO
Ketamine results in increased expression of ACSBG1 mRNA
CTD
PMID:20080153
NCBI chr 9:54,512,163...54,569,169
Ensembl chr 9:54,512,161...54,569,154
G
Acta2
actin alpha 2, smooth muscle, aorta
increases expression multiple interactions
ISO
Ketamine results in increased expression of ACTA2 mRNA; Ketamine results in increased expression of ACTA2 protein 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride inhibits the reaction [Ketamine results in increased expression of ACTA2 protein]
CTD
PMID:28331066
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
G
Actg2
actin, gamma 2, smooth muscle, enteric
decreases expression
ISO
Ketamine results in decreased expression of ACTG2 mRNA
CTD
PMID:20080153
NCBI chr 6:83,489,891...83,513,233
Ensembl chr 6:83,489,887...83,513,247
G
Acvr1c
activin A receptor, type IC
decreases expression
ISO
Ketamine results in decreased expression of ACVR1C mRNA
CTD
PMID:20080153
NCBI chr 2:58,157,465...58,247,909
Ensembl chr 2:58,157,465...58,247,907
G
Adap2
ArfGAP with dual PH domains 2
increases expression
ISO
Ketamine results in increased expression of ADAP2 mRNA
CTD
PMID:20080153
NCBI chr11:80,044,869...80,071,449
Ensembl chr11:80,044,931...80,069,784
G
Adck2
aarF domain containing kinase 2
decreases expression
ISO
Ketamine results in decreased expression of ADCK2 mRNA
CTD
PMID:20080153
NCBI chr 6:39,550,778...39,565,703
Ensembl chr 6:39,550,807...39,565,703
G
Adcy8
adenylate cyclase 8
decreases expression
ISO
Ketamine results in decreased expression of ADCY8 mRNA
CTD
PMID:20080153
NCBI chr15:64,570,884...64,794,145
Ensembl chr15:64,568,933...64,794,145
G
Adcy9
adenylate cyclase 9
increases expression
ISO
Ketamine results in increased expression of ADCY9 mRNA
CTD
PMID:20080153
NCBI chr16:4,102,750...4,255,094
Ensembl chr16:4,105,393...4,238,362
G
Adcyap1
adenylate cyclase activating polypeptide 1
decreases expression
ISO
Ketamine results in decreased expression of ADCYAP1 mRNA
CTD
PMID:20080153
NCBI chr17:93,506,448...93,513,967
Ensembl chr17:93,506,445...93,513,965
G
Add2
adducin 2
decreases expression
ISO
Ketamine results in decreased expression of ADD2 mRNA
CTD
PMID:20080153
NCBI chr 6:86,005,663...86,101,391
Ensembl chr 6:86,005,663...86,101,391
G
Adgrb2
adhesion G protein-coupled receptor B2
increases expression
ISO
Ketamine results in increased expression of ADGRB2 mRNA
CTD
PMID:20080153
NCBI chr 4:129,878,566...129,916,426
Ensembl chr 4:129,878,663...129,916,426
G
Afp
alpha fetoprotein
increases expression
ISO
Ketamine results in increased expression of AFP mRNA
CTD
PMID:20080153
NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766
G
Agt
angiotensinogen
decreases expression increases expression
ISO
Ketamine results in decreased expression of AGT protein Ketamine results in increased expression of AGT mRNA
CTD
PMID:6349867 PMID:20080153
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Agtrap
angiotensin II, type I receptor-associated protein
increases expression
ISO
Ketamine results in increased expression of AGTRAP mRNA
CTD
PMID:20080153
NCBI chr 4:148,161,518...148,172,521
Ensembl chr 4:148,161,518...148,172,488
G
Ahr
aryl-hydrocarbon receptor
decreases expression
ISO
Ketamine results in decreased expression of AHR mRNA
CTD
PMID:20080153
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Aif1
allograft inflammatory factor 1
decreases expression multiple interactions
ISO
Ketamine results in decreased expression of AIF1 mRNA Cannabidiol inhibits the reaction [Ketamine results in decreased expression of AIF1 mRNA]
CTD
PMID:31823199
NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
G
Akap9
A kinase anchor protein 9
decreases expression
ISO
Ketamine results in decreased expression of AKAP9 mRNA
CTD
PMID:20080153
NCBI chr 5:3,977,410...4,130,204
Ensembl chr 5:3,978,054...4,131,310
G
Alb
albumin
increases expression
ISO
Ketamine results in increased expression of ALB mRNA
CTD
PMID:20080153
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aldh18a1
aldehyde dehydrogenase 18 family, member A1
decreases expression
ISO
Ketamine results in decreased expression of ALDH18A1 mRNA
CTD
PMID:20080153
NCBI chr19:40,538,701...40,576,907
Ensembl chr19:40,538,701...40,576,907
G
Aldoc
aldolase C, fructose-bisphosphate
increases expression
ISO
Ketamine results in increased expression of ALDOC mRNA
CTD
PMID:20080153
NCBI chr11:78,213,899...78,218,607
Ensembl chr11:78,213,794...78,218,607
G
Alms1
ALMS1, centrosome and basal body associated
decreases expression
ISO
Ketamine results in decreased expression of ALMS1 mRNA
CTD
PMID:20080153
NCBI chr 6:85,564,482...85,698,973
Ensembl chr 6:85,564,513...85,679,735
G
Amigo2
adhesion molecule with Ig like domain 2
decreases expression
ISO
Ketamine results in decreased expression of AMIGO2 mRNA
CTD
PMID:20080153
NCBI chr15:97,141,955...97,145,168
Ensembl chr15:97,142,006...97,145,168
G
Anapc1
anaphase promoting complex subunit 1
increases expression
ISO
Ketamine results in increased expression of ANAPC1 mRNA
CTD
PMID:20080153
NCBI chr 2:128,452,003...128,529,558
Ensembl chr 2:128,452,024...128,529,311
G
Angptl4
angiopoietin-like 4
increases expression
ISO
Ketamine results in increased expression of ANGPTL4 mRNA
CTD
PMID:20080153
NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
G
Ankrd42
ankyrin repeat domain 42
decreases expression
ISO
Ketamine results in decreased expression of ANKRD42 mRNA
CTD
PMID:20080153
NCBI chr 7:92,230,922...92,286,348
Ensembl chr 7:92,230,931...92,286,350
G
Anxa11
annexin A11
increases expression
ISO
Ketamine results in increased expression of ANXA11 mRNA
CTD
PMID:20080153
NCBI chr14:25,842,575...25,887,228
Ensembl chr14:25,842,580...25,887,228
G
Anxa3
annexin A3
decreases expression
ISO
Ketamine results in decreased expression of ANXA3 mRNA
CTD
PMID:20080153
NCBI chr 5:96,941,257...96,993,825
Ensembl chr 5:96,941,198...96,993,825
G
Anxa4
annexin A4
increases expression
ISO
Ketamine results in increased expression of ANXA4 mRNA
CTD
PMID:20080153
NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566
G
Anxa5
annexin A5
decreases expression
ISO
Ketamine results in decreased expression of ANXA5 mRNA
CTD
PMID:20080153
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
G
Ap2m1
adaptor-related protein complex 2, mu 1 subunit
multiple interactions
EXP
Ketamine inhibits the reaction [NTRK2 protein binds to AP2M1 protein]
CTD
PMID:31631060
NCBI chr16:20,354,230...20,363,659
Ensembl chr16:20,354,228...20,363,659
G
Ap3m1
adaptor-related protein complex 3, mu 1 subunit
decreases expression
ISO
Ketamine results in decreased expression of AP3M1 mRNA
CTD
PMID:20080153
NCBI chr14:21,083,810...21,102,603
Ensembl chr14:21,081,510...21,102,576
G
Ap5m1
adaptor-related protein complex 5, mu 1 subunit
decreases expression
ISO
Ketamine results in decreased expression of AP5M1 mRNA
CTD
PMID:20080153
NCBI chr14:49,303,869...49,331,681
Ensembl chr14:49,303,554...49,331,691
G
Apex2
apurinic/apyrimidinic endonuclease 2
decreases expression
ISO
Ketamine results in decreased expression of APEX2 mRNA
CTD
PMID:20080153
NCBI chr X:149,286,625...149,371,175
Ensembl chr X:149,302,515...149,372,864
G
Aplf
aprataxin and PNKP like factor
decreases expression
ISO
Ketamine results in decreased expression of APLF mRNA
CTD
PMID:20080153
NCBI chr 6:87,605,407...87,649,244
Ensembl chr 6:87,605,406...87,649,175
G
Apmap
adipocyte plasma membrane associated protein
increases expression
ISO
Ketamine results in increased expression of APMAP mRNA
CTD
PMID:20080153
NCBI chr 2:150,425,000...150,450,487
Ensembl chr 2:150,425,000...150,450,487
G
Apoe
apolipoprotein E
decreases response to substance increases expression
ISO
APOE results in decreased susceptibility to Ketamine Ketamine results in increased expression of APOE mRNA
CTD
PMID:9778666 PMID:20080153
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
App
amyloid beta precursor protein
multiple interactions increases expression
ISO EXP
Ketamine results in decreased expression of and results in increased cleavage of APP protein; Monensin inhibits the reaction [Ketamine results in decreased expression of and results in increased cleavage of APP protein] [Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-40); [Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-42); Ketamine results in decreased expression of and results in increased cleavage of APP protein; Monensin inhibits the reaction [[Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-40)]; Monensin inhibits the reaction [[Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-42)] Ketamine results in increased expression of APP mRNA
CTD
PMID:35378374
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Appbp2
amyloid beta precursor protein binding protein 2
decreases expression
ISO
Ketamine results in decreased expression of APPBP2 mRNA
CTD
PMID:20080153
NCBI chr11:85,082,134...85,125,946
Ensembl chr11:85,078,088...85,125,956
G
Arfgef1
ADP ribosylation factor guanine nucleotide exchange factor 1
decreases expression
ISO
Ketamine results in decreased expression of ARFGEF1 mRNA
CTD
PMID:20080153
NCBI chr 1:10,207,732...10,303,306
Ensembl chr 1:10,207,796...10,302,895
G
Arhgap5
Rho GTPase activating protein 5
decreases expression
ISO
Ketamine results in decreased expression of ARHGAP5 mRNA
CTD
PMID:20080153
NCBI chr12:52,550,555...52,618,761
Ensembl chr12:52,550,755...52,618,758
G
Arih1
ariadne RBR E3 ubiquitin protein ligase 1
decreases expression
ISO
Ketamine results in decreased expression of ARIH1 mRNA
CTD
PMID:20080153
NCBI chr 9:59,295,837...59,395,469
Ensembl chr 9:59,295,541...59,393,901
G
Arl6
ADP-ribosylation factor-like 6
decreases expression
ISO
Ketamine results in decreased expression of ARL6 mRNA
CTD
PMID:20080153
NCBI chr16:59,433,312...59,459,772
Ensembl chr16:59,433,312...59,459,754
G
Arl6ip6
ADP-ribosylation factor-like 6 interacting protein 6
decreases expression
ISO
Ketamine results in decreased expression of ARL6IP6 mRNA
CTD
PMID:20080153
NCBI chr 2:53,082,096...53,109,233
Ensembl chr 2:53,081,738...53,109,232
G
Armc10
armadillo repeat containing 10
decreases expression
ISO
Ketamine results in decreased expression of ARMC10 mRNA
CTD
PMID:20080153
NCBI chr 5:21,851,004...21,867,697
Ensembl chr 5:21,850,811...21,867,692
G
Art3
ADP-ribosyltransferase 3
increases expression
ISO
Ketamine results in increased expression of ART3 mRNA
CTD
PMID:20080153
NCBI chr 5:92,479,659...92,562,487
Ensembl chr 5:92,479,686...92,562,487
G
Ascl1
achaete-scute family bHLH transcription factor 1
decreases expression
ISO
Ketamine results in decreased expression of ASCL1 mRNA
CTD
PMID:20080153
NCBI chr10:87,326,681...87,329,522
Ensembl chr10:87,326,681...87,329,522
G
Asic4
acid-sensing ion channel family member 4
increases expression
ISO
Ketamine results in increased expression of ASIC4 mRNA
CTD
PMID:20080153
NCBI chr 1:75,426,467...75,450,984
Ensembl chr 1:75,427,080...75,450,987
G
Aspdh
aspartate dehydrogenase domain containing
increases expression
ISO
Ketamine results in increased expression of ASPDH mRNA
CTD
PMID:20080153
NCBI chr 7:44,114,859...44,117,175
Ensembl chr 7:44,114,815...44,117,182
G
Atf4
activating transcription factor 4
increases expression
EXP
Ketamine results in increased expression of ATF4 mRNA
CTD
PMID:35728656
NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742
G
Atf6
activating transcription factor 6
increases expression
EXP
Ketamine results in increased expression of ATF6 mRNA
CTD
PMID:35728656
NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
G
Atg12
autophagy related 12
increases expression
ISO
Ketamine results in increased expression of ATG12 mRNA
CTD
PMID:20080153
NCBI chr18:46,865,484...46,874,683
Ensembl chr18:46,863,211...46,874,647
G
Atp13a4
ATPase type 13A4
increases expression
ISO
Ketamine results in increased expression of ATP13A4 mRNA
CTD
PMID:20080153
NCBI chr16:29,208,685...29,363,682
Ensembl chr16:29,214,671...29,363,682
G
Atp1a1
ATPase, Na+/K+ transporting, alpha 1 polypeptide
increases expression
ISO
Ketamine results in increased expression of ATP1A1 mRNA
CTD
PMID:20080153
NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000
G
Atp1a2
ATPase, Na+/K+ transporting, alpha 2 polypeptide
increases expression
ISO
Ketamine results in increased expression of ATP1A2 mRNA
CTD
PMID:20080153
NCBI chr 1:172,099,276...172,125,631
Ensembl chr 1:172,099,276...172,125,631
G
Atp1a3
ATPase, Na+/K+ transporting, alpha 3 polypeptide
increases expression
ISO
Ketamine results in increased expression of ATP1A3 mRNA
CTD
PMID:20080153
NCBI chr 7:24,677,592...24,705,338
Ensembl chr 7:24,677,592...24,705,383
G
Atp6v0a1
ATPase, H+ transporting, lysosomal V0 subunit A1
increases expression
ISO
Ketamine results in increased expression of ATP6V0A1 mRNA
CTD
PMID:20080153
NCBI chr11:100,899,262...100,954,545
Ensembl chr11:100,900,278...100,954,545
G
Atp6v1c2
ATPase, H+ transporting, lysosomal V1 subunit C2
increases expression
ISO
Ketamine results in increased expression of ATP6V1C2 mRNA
CTD
PMID:20080153
NCBI chr12:17,334,722...17,375,700
Ensembl chr12:17,334,722...17,379,360
G
Atp7a
ATPase, Cu++ transporting, alpha polypeptide
decreases expression
ISO
Ketamine results in decreased expression of ATP7A mRNA
CTD
PMID:20080153
NCBI chr X:105,070,830...105,171,766
Ensembl chr X:105,070,882...105,168,532
G
B230219D22Rik
RIKEN cDNA B230219D22 gene
decreases expression
ISO
Ketamine results in decreased expression of C17H5ORF24 mRNA
CTD
PMID:20080153
NCBI chr13:55,840,937...55,851,313
Ensembl chr13:55,840,937...55,851,313
G
B4gat1
beta-1,4-glucuronyltransferase 1
increases expression
ISO
Ketamine results in increased expression of B4GAT1 mRNA
CTD
PMID:20080153
NCBI chr19:5,088,854...5,091,162
Ensembl chr19:5,088,854...5,091,159 Ensembl chr19:5,088,854...5,091,159
G
Bace1
beta-site APP cleaving enzyme 1
increases expression multiple interactions
EXP ISO
Ketamine results in increased expression of BACE1 protein Ketamine results in increased expression of and affects the localization of BACE1 protein; Monensin inhibits the reaction [Ketamine results in increased expression of and affects the localization of BACE1 protein]
CTD
PMID:35378374
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
G
Bag3
BCL2-associated athanogene 3
increases expression
ISO
Ketamine results in increased expression of BAG3 mRNA
CTD
PMID:20080153
NCBI chr 7:128,125,307...128,148,705
Ensembl chr 7:128,125,340...128,148,705
G
Baiap2
brain-specific angiogenesis inhibitor 1-associated protein 2
increases expression
ISO
Ketamine results in increased expression of BAIAP2 mRNA
CTD
PMID:20080153
NCBI chr11:119,833,762...119,897,608
Ensembl chr11:119,833,589...119,897,608
G
Banp
BTG3 associated nuclear protein
decreases expression
ISO
Ketamine results in decreased expression of BANP mRNA
CTD
PMID:20080153
NCBI chr 8:122,674,711...122,755,999
Ensembl chr 8:122,676,489...122,755,997
G
Bax
BCL2-associated X protein
affects localization increases expression multiple interactions
ISO
Ketamine affects the localization of BAX protein Ketamine results in increased expression of BAX mRNA; Ketamine results in increased expression of BAX protein Curcumin inhibits the reaction [Ketamine results in increased expression of BAX mRNA]; Curcumin inhibits the reaction [Ketamine results in increased expression of BAX protein]; TRPV4 protein affects the reaction [Ketamine results in increased expression of BAX mRNA]; TRPV4 protein affects the reaction [Ketamine results in increased expression of BAX protein]
CTD
PMID:18456338 PMID:19001360 PMID:25937004 PMID:33536391 PMID:36305173
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bckdha
branched chain ketoacid dehydrogenase E1, alpha polypeptide
increases expression
ISO
Ketamine results in increased expression of BCKDHA mRNA
CTD
PMID:20080153
NCBI chr 7:25,329,371...25,358,178
Ensembl chr 7:25,329,371...25,358,406
G
Bcl2
B cell leukemia/lymphoma 2
multiple interactions decreases expression
ISO
Curcumin affects the reaction [Ketamine results in decreased expression of BCL2 protein]; Curcumin inhibits the reaction [Ketamine results in decreased expression of BCL2 mRNA]; TRPV4 protein affects the reaction [Ketamine results in decreased expression of BCL2 mRNA]; TRPV4 protein affects the reaction [Ketamine results in decreased expression of BCL2 protein] Ketamine results in decreased expression of BCL2 mRNA; Ketamine results in decreased expression of BCL2 protein LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in decreased expression of BCL2 protein]]; lipoxin A4 methyl ester inhibits the reaction [Ketamine results in decreased expression of BCL2 protein]
CTD
PMID:33536391 PMID:36305173 PMID:36907275
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bclaf3
Bclaf1 and Thrap3 family member 3
decreases expression
ISO
Ketamine results in decreased expression of BCLAF3 mRNA
CTD
PMID:20080153
NCBI chr X:158,315,639...158,376,077
Ensembl chr X:158,309,684...158,376,077
G
Bcorl1
BCL6 co-repressor-like 1
decreases expression
ISO
Ketamine results in decreased expression of BCORL1 mRNA
CTD
PMID:20080153
NCBI chr X:47,430,235...47,496,945
Ensembl chr X:47,430,235...47,496,926
G
Bcs1l
BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone
decreases expression
ISO
Ketamine results in decreased expression of BCS1L mRNA
CTD
PMID:20080153
NCBI chr 1:74,627,448...74,631,602
Ensembl chr 1:74,627,448...74,631,602
G
Bdkrb1
bradykinin receptor, beta 1
increases expression
EXP
Ketamine results in increased expression of BDKRB1 mRNA; Ketamine results in increased expression of BDKRB1 protein
CTD
PMID:27638051
NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
G
Bdnf
brain derived neurotrophic factor
multiple interactions increases expression
ISO EXP
Ketamine inhibits the reaction [Isoflurophate results in decreased expression of BDNF protein]; Ketamine inhibits the reaction [Pilocarpine results in increased expression of BDNF mRNA] Sirolimus inhibits the reaction [Ketamine results in increased expression of BDNF protein]
CTD
PMID:8635431 PMID:32592718 PMID:33022268
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Becn1
beclin 1, autophagy related
increases expression
EXP
Ketamine results in increased expression of BECN1 protein
CTD
PMID:34487425
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Bhlhe22
basic helix-loop-helix family, member e22
decreases expression
ISO
Ketamine results in decreased expression of BHLHE22 mRNA
CTD
PMID:20080153
NCBI chr 3:18,108,489...18,111,678
Ensembl chr 3:18,108,338...18,111,681
G
Bhlhe40
basic helix-loop-helix family, member e40
increases expression
ISO
Ketamine results in increased expression of BHLHE40 mRNA
CTD
PMID:20080153
NCBI chr 6:108,637,590...108,643,886
Ensembl chr 6:108,637,590...108,643,886
G
Bhlhe41
basic helix-loop-helix family, member e41
increases expression
ISO
Ketamine results in increased expression of BHLHE41 mRNA
CTD
PMID:20080153
NCBI chr 6:145,803,969...145,811,146
Ensembl chr 6:145,803,969...145,811,284
G
Bmi1
Bmi1 polycomb ring finger oncogene
decreases expression
ISO
Ketamine results in decreased expression of BMI1 mRNA
CTD
PMID:20080153
NCBI chr 2:18,681,953...18,691,440
Ensembl chr 2:18,681,829...18,691,440
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
decreases expression
ISO
Ketamine results in decreased expression of BNIP3 mRNA
CTD
PMID:20080153
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
Braf
Braf transforming gene
multiple interactions
EXP
Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of BRAF protein]
CTD
PMID:19540866
NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
G
Brinp2
bone morphogenic protein/retinoic acid inducible neural-specific 2
increases expression
ISO
Ketamine results in increased expression of BRINP2 mRNA
CTD
PMID:20080153
NCBI chr 1:158,072,835...158,185,096
Ensembl chr 1:158,072,839...158,183,896
G
Btg1
BTG anti-proliferation factor 1
decreases expression
ISO
Ketamine results in decreased expression of BTG1 mRNA
CTD
PMID:20080153
NCBI chr10:96,452,863...96,458,675
Ensembl chr10:96,452,868...96,458,671
G
Bub1b
BUB1B, mitotic checkpoint serine/threonine kinase
decreases expression
ISO
Ketamine results in decreased expression of BUB1B mRNA
CTD
PMID:20080153
NCBI chr 2:118,428,684...118,472,073
Ensembl chr 2:118,428,692...118,472,072
G
C1qa
complement component 1, q subcomponent, alpha polypeptide
increases expression
ISO
Ketamine results in increased expression of C1QA mRNA
CTD
PMID:20080153
NCBI chr 4:136,623,227...136,626,155
Ensembl chr 4:136,623,228...136,626,114
G
C1qb
complement component 1, q subcomponent, beta polypeptide
increases expression
ISO
Ketamine results in increased expression of C1QB mRNA
CTD
PMID:20080153
NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498
G
C1qc
complement component 1, q subcomponent, C chain
increases expression multiple interactions decreases expression
ISO
Ketamine results in increased expression of C1QC mRNA Cannabidiol inhibits the reaction [Ketamine results in decreased expression of C1QC mRNA]
CTD
PMID:20080153 PMID:31823199
NCBI chr 4:136,617,115...136,620,225
Ensembl chr 4:136,617,115...136,620,376
G
C2
complement C2
increases expression
ISO
Ketamine results in increased expression of C2 mRNA
CTD
PMID:20080153
NCBI chr17:35,081,578...35,101,076
Ensembl chr17:35,081,580...35,117,241
G
C2cd2l
C2 calcium-dependent domain containing 2-like
increases expression
ISO
Ketamine results in increased expression of C2CD2L mRNA
CTD
PMID:20080153
NCBI chr 9:44,220,534...44,231,579
Ensembl chr 9:44,220,534...44,231,582
G
C2cd4b
C2 calcium-dependent domain containing 4B
increases expression
ISO
Ketamine results in increased expression of C2CD4B mRNA
CTD
PMID:20080153
NCBI chr 9:67,623,506...67,668,215
Ensembl chr 9:67,666,719...67,668,212
G
Caap1
caspase activity and apoptosis inhibitor 1
decreases expression
ISO
Ketamine results in decreased expression of CAAP1 mRNA
CTD
PMID:20080153
NCBI chr 4:94,388,318...94,445,033
Ensembl chr 4:94,388,318...94,445,033
G
Cabcoco1
ciliary associated calcium binding coiled-coil 1
increases expression
ISO
Ketamine results in increased expression of CABCOCO1 mRNA
CTD
PMID:20080153
NCBI chr10:68,266,786...68,377,751
Ensembl chr10:68,266,783...68,377,726
G
Cabp7
calcium binding protein 7
increases expression
ISO
Ketamine results in increased expression of CABP7 mRNA
CTD
PMID:20080153
NCBI chr11:4,686,892...4,697,179
Ensembl chr11:4,686,892...4,696,778
G
Cacng2
calcium channel, voltage-dependent, gamma subunit 2
increases expression
ISO
Ketamine results in increased expression of CACNG2 mRNA
CTD
PMID:20080153
NCBI chr15:77,876,119...78,004,420
Ensembl chr15:77,875,948...78,004,228
G
Calb2
calbindin 2
increases expression
ISO
Ketamine results in increased expression of CALB2 mRNA
CTD
PMID:20080153
NCBI chr 8:110,869,158...110,894,844
Ensembl chr 8:110,864,134...110,894,842
G
Camkk1
calcium/calmodulin-dependent protein kinase kinase 1, alpha
increases expression
ISO
Ketamine results in increased expression of CAMKK1 mRNA
CTD
PMID:20080153
NCBI chr11:72,906,869...72,932,899
Ensembl chr11:72,909,834...72,932,899
G
Cand2
cullin associated and neddylation dissociated 2 (putative)
decreases expression
ISO
Ketamine results in decreased expression of CAND2 mRNA
CTD
PMID:20080153
NCBI chr 6:115,751,518...115,782,516
Ensembl chr 6:115,751,499...115,782,518
G
Cant1
calcium activated nucleotidase 1
increases expression
ISO
Ketamine results in increased expression of CANT1 mRNA
CTD
PMID:20080153
NCBI chr11:118,297,115...118,309,971
Ensembl chr11:118,297,115...118,309,912
G
Car4
carbonic anhydrase 4
increases expression
ISO
Ketamine results in increased expression of CAR4 mRNA
CTD
PMID:20080153
NCBI chr11:84,848,580...84,856,880
Ensembl chr11:84,848,612...84,856,870
G
Car7
carbonic anhydrase 7
increases expression
ISO
Ketamine results in increased expression of CAR7 mRNA
CTD
PMID:20080153
NCBI chr 8:105,261,326...105,276,979
Ensembl chr 8:105,261,321...105,276,975
G
Casp3
caspase 3
increases activity increases expression increases cleavage multiple interactions
ISO EXP
Ketamine results in increased activity of CASP3 protein Ketamine results in increased expression of CASP3 mRNA; Ketamine results in increased expression of CASP3 protein; Ketamine results in increased expression of CASP3 protein modified form Ketamine results in increased cleavage of CASP3 protein Curcumin inhibits the reaction [Ketamine results in increased expression of CASP3 mRNA]; Curcumin inhibits the reaction [Ketamine results in increased expression of CASP3 protein modified form]; Curcumin inhibits the reaction [Ketamine results in increased expression of CASP3 protein]; TRPV4 protein affects the reaction [Ketamine results in increased cleavage of CASP3 protein]; TRPV4 protein affects the reaction [Ketamine results in increased expression of CASP3 mRNA] LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased cleavage of CASP3 protein]]; lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased cleavage of CASP3 protein]
CTD
PMID:17920787 PMID:19001360 PMID:25937004 PMID:33536391 PMID:36305173 PMID:36907275 More...
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp6
caspase 6
increases activity
ISO
Ketamine results in increased activity of CASP6 protein
CTD
PMID:19001360
NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
G
Casp9
caspase 9
increases activity increases expression
ISO
Ketamine results in increased activity of CASP9 protein Ketamine results in increased expression of CASP9 mRNA
CTD
PMID:19001360 PMID:20080153
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cat
catalase
multiple interactions decreases activity
ISO
TRPV4 protein affects the reaction [Ketamine results in decreased activity of CAT protein]
CTD
PMID:33536391
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cbr3
carbonyl reductase 3
decreases expression
ISO
Ketamine results in decreased expression of CBR3 mRNA
CTD
PMID:20080153
NCBI chr16:93,480,107...93,487,879
Ensembl chr16:93,480,103...93,487,878
G
Cbx1
chromobox 1
decreases expression
ISO
Ketamine results in decreased expression of CBX1 mRNA
CTD
PMID:20080153
NCBI chr11:96,679,506...96,699,808
Ensembl chr11:96,679,953...96,699,466
G
Cbx7
chromobox 7
increases expression
ISO
Ketamine results in increased expression of CBX7 mRNA
CTD
PMID:20080153
NCBI chr15:79,800,005...79,855,344
Ensembl chr15:79,800,008...79,855,320
G
Ccdc115
coiled-coil domain containing 115
increases expression
ISO
Ketamine results in increased expression of CCDC115 mRNA
CTD
PMID:20080153
NCBI chr 1:34,475,751...34,478,753
Ensembl chr 1:34,475,751...34,478,753
G
Ccdc50
coiled-coil domain containing 50
decreases expression
ISO
Ketamine results in decreased expression of CCDC50 mRNA
CTD
PMID:20080153
NCBI chr16:27,205,815...27,270,968
Ensembl chr16:27,207,619...27,270,968
G
Ccdc85a
coiled-coil domain containing 85A
decreases expression
ISO
Ketamine results in decreased expression of CCDC85A mRNA
CTD
PMID:20080153
NCBI chr11:28,335,688...28,537,234
Ensembl chr11:28,335,685...28,534,324
G
Ccdc90b
coiled-coil domain containing 90B
decreases expression
ISO
Ketamine results in decreased expression of CCDC90B mRNA
CTD
PMID:20080153
NCBI chr 7:92,210,350...92,231,502
Ensembl chr 7:92,210,357...92,231,502
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
EXP
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein]
CTD
PMID:22245128
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccna2
cyclin A2
decreases expression
ISO
Ketamine results in decreased expression of CCNA2 mRNA
CTD
PMID:20080153
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
G
Ccnd1
cyclin D1
decreases expression
ISO
Ketamine results in decreased expression of CCND1 mRNA
CTD
PMID:20080153
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccndbp1
cyclin D-type binding-protein 1
decreases expression
ISO
Ketamine results in decreased expression of CCNDBP1 mRNA
CTD
PMID:20080153
NCBI chr 2:120,838,925...120,847,374
Ensembl chr 2:120,838,884...120,847,385
G
Ccpg1
cell cycle progression 1
increases expression
ISO
Ketamine results in increased expression of CCPG1 mRNA
CTD
PMID:20080153
NCBI chr 9:72,892,692...72,923,622
Ensembl chr 9:72,892,711...72,923,622
G
Ccr5
C-C motif chemokine receptor 5
increases expression
ISO
Ketamine results in increased expression of CCR5 mRNA
CTD
PMID:20080153
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Ccsap
centriole, cilia and spindle associated protein
increases expression
ISO
Ketamine results in increased expression of CCSAP mRNA
CTD
PMID:20080153
NCBI chr 8:124,566,712...124,586,948
Ensembl chr 8:124,567,570...124,586,948
G
Cd24a
CD24a antigen
decreases expression
ISO
Ketamine results in decreased expression of CD24 mRNA
CTD
PMID:20080153
NCBI chr10:43,454,433...43,460,261
Ensembl chr10:43,454,280...43,460,261
G
Cd38
CD38 antigen
increases expression
ISO
Ketamine results in increased expression of CD38 mRNA
CTD
PMID:20080153
NCBI chr 5:44,026,153...44,069,714
Ensembl chr 5:44,025,895...44,069,717
G
Cd83
CD83 antigen
increases expression
ISO
Ketamine results in increased expression of CD83 mRNA
CTD
PMID:20080153
NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608
G
Cdc42ep3
CDC42 effector protein 3
decreases expression
ISO
Ketamine results in decreased expression of CDC42EP3 mRNA
CTD
PMID:20080153
NCBI chr17:79,641,152...79,662,520
Ensembl chr17:79,641,156...79,662,520
G
Cdc6
cell division cycle 6
decreases expression
ISO
Ketamine results in decreased expression of CDC6 mRNA
CTD
PMID:20080153
NCBI chr11:98,798,627...98,814,768
Ensembl chr11:98,798,627...98,814,766
G
Cdca7
cell division cycle associated 7
decreases expression
ISO
Ketamine results in decreased expression of CDCA7 mRNA
CTD
PMID:20080153
NCBI chr 2:72,306,540...72,317,237
Ensembl chr 2:72,306,503...72,317,237
G
Cdh1
cadherin 1
decreases expression multiple interactions
ISO
Ketamine results in decreased expression of CDH1 mRNA; Ketamine results in decreased expression of CDH1 protein 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride inhibits the reaction [Ketamine results in decreased expression of CDH1 protein]
CTD
PMID:28331066
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
G
Cdh11
cadherin 11
decreases expression
ISO
Ketamine results in decreased expression of CDH11 mRNA
CTD
PMID:20080153
NCBI chr 8:103,358,727...103,512,125
Ensembl chr 8:103,358,727...103,512,274
G
Cdh7
cadherin 7, type 2
decreases expression
ISO
Ketamine results in decreased expression of CDH7 mRNA
CTD
PMID:20080153
NCBI chr 1:109,909,967...110,073,002
Ensembl chr 1:109,910,161...110,067,887
G
Cdk1
cyclin dependent kinase 1
decreases expression
ISO
Ketamine results in decreased expression of CDK1 mRNA
CTD
PMID:20080153
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
G
Cdk14
cyclin dependent kinase 14
decreases expression
ISO
Ketamine results in decreased expression of CDK14 mRNA
CTD
PMID:20080153
NCBI chr 5:4,853,384...5,430,650
Ensembl chr 5:4,853,391...5,470,312
G
Cdnf
cerebral dopamine neurotrophic factor
affects expression
EXP
Ketamine affects the expression of CDNF mRNA
CTD
PMID:35728656
NCBI chr 2:3,514,102...3,527,413
Ensembl chr 2:3,514,067...3,527,413
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
Ketamine results in increased expression of CEBPB mRNA
CTD
PMID:20080153
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cenpc1
centromere protein C1
decreases expression
ISO
Ketamine results in decreased expression of CENPC1 mRNA
CTD
PMID:20080153
NCBI chr 5:86,159,877...86,214,325
Ensembl chr 5:86,159,883...86,213,442
G
Cep70
centrosomal protein 70
decreases expression
ISO
Ketamine results in decreased expression of CEP70 mRNA
CTD
PMID:20080153
NCBI chr 9:99,065,640...99,205,569
Ensembl chr 9:99,125,420...99,182,457
G
Cfap126
cilia and flagella associated protein 126
increases expression
ISO
Ketamine results in increased expression of CFAP126 mRNA
CTD
PMID:20080153
NCBI chr 1:170,941,326...170,954,525
Ensembl chr 1:170,941,487...170,954,536
G
Cfap410
cilia and flagella associated protein 410
increases expression
ISO
Ketamine results in increased expression of CFAP410 mRNA
CTD
PMID:20080153
NCBI chr10:77,814,364...77,821,272
Ensembl chr10:77,814,358...77,822,739
G
Chi3l1
chitinase 3 like 1
increases expression
ISO
Ketamine results in increased expression of CHI3L1 mRNA
CTD
PMID:20080153
NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
G
Chordc1
cysteine and histidine rich domain containing 1
decreases expression
ISO
Ketamine results in decreased expression of CHORDC1 mRNA
CTD
PMID:20080153
NCBI chr 9:18,203,563...18,225,296
Ensembl chr 9:18,203,421...18,228,738
G
Chpf2
chondroitin polymerizing factor 2
increases expression
ISO
Ketamine results in increased expression of CHPF2 mRNA
CTD
PMID:20080153
NCBI chr 5:24,788,950...24,799,396
Ensembl chr 5:24,791,739...24,799,554
G
Chrm1
cholinergic receptor, muscarinic 1, CNS
multiple interactions
ISO
Ketamine inhibits the reaction [Scopolamine Derivatives binds to CHRM1 protein]
CTD
PMID:12456425
NCBI chr19:8,641,369...8,660,970
Ensembl chr19:8,641,153...8,660,951
G
Chrm2
cholinergic receptor, muscarinic 2, cardiac
multiple interactions
ISO
Ketamine inhibits the reaction [Scopolamine Derivatives binds to CHRM2 protein]
CTD
PMID:12456425
NCBI chr 6:36,364,928...36,505,573
Ensembl chr 6:36,365,019...36,505,349
G
Chrm3
cholinergic receptor, muscarinic 3, cardiac
multiple interactions
ISO
Ketamine inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]
CTD
PMID:12456425
NCBI chr13:9,925,522...10,411,131
Ensembl chr13:9,925,522...10,410,883
G
Ciao3
cytosolic iron-sulfur assembly component 3
increases expression
ISO
Ketamine results in increased expression of CIAO3 mRNA
CTD
PMID:20080153
NCBI chr17:25,992,750...26,002,306
Ensembl chr17:25,992,750...26,002,306
G
Cldn11
claudin 11
increases expression
ISO
Ketamine results in increased expression of CLDN11 mRNA
CTD
PMID:20080153
NCBI chr 3:31,204,069...31,218,475
Ensembl chr 3:31,204,069...31,218,473
G
Clec2l
C-type lectin domain family 2, member L
increases expression
ISO
Ketamine results in increased expression of CLEC2L mRNA
CTD
PMID:20080153
NCBI chr 6:38,640,004...38,657,800
Ensembl chr 6:38,640,002...38,657,800
G
Clec4a3
C-type lectin domain family 4, member a3
increases expression
ISO
Ketamine results in increased expression of CLEC4A3 mRNA
CTD
PMID:20080153
NCBI chr 6:122,929,474...122,946,837
Ensembl chr 6:122,929,474...122,946,834
G
Clk1
CDC-like kinase 1
decreases expression
ISO
Ketamine results in decreased expression of CLK1 mRNA
CTD
PMID:20080153
NCBI chr 1:58,451,147...58,463,247
Ensembl chr 1:58,449,348...58,463,225
G
Clmp
CXADR-like membrane protein
decreases expression
ISO
Ketamine results in decreased expression of CLMP mRNA
CTD
PMID:20080153
NCBI chr 9:40,596,975...40,696,849
Ensembl chr 9:40,597,258...40,696,615
G
Clu
clusterin
increases expression
ISO
Ketamine results in increased expression of CLU mRNA
CTD
PMID:20080153
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Cmtm5
CKLF-like MARVEL transmembrane domain containing 5
increases expression
ISO
Ketamine results in increased expression of CMTM5 mRNA
CTD
PMID:20080153
NCBI chr14:55,173,927...55,176,734
Ensembl chr14:55,173,718...55,176,731
G
Cmtm8
CKLF-like MARVEL transmembrane domain containing 8
increases expression
ISO
Ketamine results in increased expression of CMTM8 mRNA
CTD
PMID:20080153
NCBI chr 9:114,618,411...114,673,220
Ensembl chr 9:114,618,413...114,673,224
G
Cnksr3
Cnksr family member 3
increases expression
ISO
Ketamine results in increased expression of CNKSR3 mRNA
CTD
PMID:20080153
NCBI chr10:7,069,061...7,162,237
Ensembl chr10:7,069,063...7,162,237
G
Cnr1
cannabinoid receptor 1
decreases expression
ISO
Ketamine results in decreased expression of CNR1 mRNA
CTD
PMID:20080153
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Coa4
cytochrome c oxidase assembly factor 4
decreases expression
ISO
Ketamine results in decreased expression of COA4 mRNA
CTD
PMID:20080153
NCBI chr 7:100,186,307...100,189,579
Ensembl chr 7:100,186,278...100,189,576
G
Coa7
cytochrome c oxidase assembly factor 7
increases expression
ISO
Ketamine results in increased expression of COA7 mRNA
CTD
PMID:20080153
NCBI chr 4:108,185,349...108,197,915
Ensembl chr 4:108,185,337...108,198,741
G
Cog6
component of oligomeric golgi complex 6
decreases expression
ISO
Ketamine results in decreased expression of COG6 mRNA
CTD
PMID:20080153
NCBI chr 3:52,889,544...52,924,644
Ensembl chr 3:52,889,296...52,924,658
G
Col11a1
collagen, type XI, alpha 1
decreases expression
ISO
Ketamine results in decreased expression of COL11A1 mRNA
CTD
PMID:20080153
NCBI chr 3:113,823,933...114,014,405
Ensembl chr 3:113,824,189...114,014,367
G
Commd5
COMM domain containing 5
increases expression
ISO
Ketamine results in increased expression of COMMD5 mRNA
CTD
PMID:20080153
NCBI chr15:76,784,141...76,786,223
Ensembl chr15:76,784,110...76,785,505
G
Comt
catechol-O-methyltransferase
increases expression
ISO
Ketamine results in increased expression of COMT mRNA
CTD
PMID:20080153
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Coq8a
coenzyme Q8A
increases expression
ISO
Ketamine results in increased expression of COQ8A mRNA
CTD
PMID:20080153
NCBI chr 1:179,992,803...180,023,585
Ensembl chr 1:179,992,803...180,027,167
G
Cort
cortistatin
increases expression
ISO
Ketamine results in increased expression of CORT mRNA
CTD
PMID:20080153
NCBI chr 4:149,209,491...149,211,132
Ensembl chr 4:149,209,491...149,211,220
G
Cox6a2
cytochrome c oxidase subunit 6A2
increases expression
ISO
Ketamine results in increased expression of COX6A2 mRNA
CTD
PMID:20080153
NCBI chr 7:127,804,607...127,805,538
Ensembl chr 7:127,804,607...127,805,559
G
Cracdl
capping protein inhibiting regulator of actin like
increases expression
ISO
Ketamine results in increased expression of CRACDL mRNA
CTD
PMID:20080153
NCBI chr 1:37,650,758...37,758,905
Ensembl chr 1:37,650,758...37,759,166
G
Crcp
calcitonin gene-related peptide-receptor component protein
increases expression
ISO
Ketamine results in increased expression of CRCP mRNA
CTD
PMID:20080153
NCBI chr 5:130,058,147...130,089,628
Ensembl chr 5:130,058,131...130,089,630
G
Creg1
cellular repressor of E1A-stimulated genes 1
increases expression
ISO
Ketamine results in increased expression of CREG1 mRNA
CTD
PMID:20080153
NCBI chr 1:165,591,327...165,602,878
Ensembl chr 1:165,591,315...165,602,877
G
Creld2
cysteine-rich with EGF-like domains 2
decreases expression
ISO
Ketamine results in decreased expression of CRELD2 mRNA
CTD
PMID:20080153
NCBI chr15:88,703,849...88,710,884
Ensembl chr15:88,703,849...88,710,886
G
Crh
corticotropin releasing hormone
decreases expression
ISO
Ketamine results in decreased expression of CRH mRNA
CTD
PMID:20080153
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
G
Crls1
cardiolipin synthase 1
decreases expression
ISO
Ketamine results in decreased expression of CRLS1 mRNA
CTD
PMID:20080153
NCBI chr 2:132,688,557...132,708,706
Ensembl chr 2:132,688,586...132,708,705
G
Crtac1
cartilage acidic protein 1
increases expression
ISO
Ketamine results in increased expression of CRTAC1 mRNA
CTD
PMID:20080153
NCBI chr19:42,271,474...42,421,405
Ensembl chr19:42,256,726...42,420,224
G
Cryab
crystallin, alpha B
increases expression
ISO
Ketamine results in increased expression of CRYAB mRNA
CTD
PMID:20080153
NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936
G
Ctnnb1
catenin beta 1
multiple interactions increases expression
ISO
Chir 99021 promotes the reaction [Ketamine results in increased expression of CTNNB1 protein]
CTD
PMID:36334642
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Ctse
cathepsin E
increases expression
ISO
Ketamine results in increased expression of CTSE mRNA
CTD
PMID:20080153
NCBI chr 1:131,566,052...131,603,245
Ensembl chr 1:131,566,044...131,603,243
G
Ctsk
cathepsin K
increases expression
ISO
Ketamine results in increased expression of CTSK mRNA
CTD
PMID:20080153
NCBI chr 3:95,406,521...95,416,698
Ensembl chr 3:95,406,567...95,416,673
G
Ctss
cathepsin S
increases expression
ISO
Ketamine results in increased expression of CTSS mRNA
CTD
PMID:20080153
NCBI chr 3:95,434,097...95,463,716
Ensembl chr 3:95,434,097...95,463,714
G
Cttnbp2nl
CTTNBP2 N-terminal like
decreases expression
ISO
Ketamine results in decreased expression of CTTNBP2NL mRNA
CTD
PMID:20080153
NCBI chr 3:104,909,231...104,960,462
Ensembl chr 3:104,909,231...104,960,462
G
Cx3cl1
C-X3-C motif chemokine ligand 1
increases expression
ISO
Ketamine results in increased expression of CX3CL1 mRNA
CTD
PMID:20080153
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
EXP
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CXCL1 mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CXCL1 protein]
CTD
PMID:22245128
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cxxc4
CXXC finger 4
decreases expression
ISO
Ketamine results in decreased expression of CXXC4 mRNA
CTD
PMID:20080153
NCBI chr 3:133,938,927...133,967,924
Ensembl chr 3:133,942,245...133,967,922
G
Cyb5r3
cytochrome b5 reductase 3
increases expression
ISO
Ketamine results in increased expression of CYB5R3 mRNA
CTD
PMID:20080153
NCBI chr15:83,037,696...83,060,641
Ensembl chr15:83,037,695...83,056,793
G
Cyba
cytochrome b-245, alpha polypeptide
increases expression
EXP
Ketamine results in increased expression of CYBA
CTD
PMID:18063801
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
G
Cybb
cytochrome b-245, beta polypeptide
increases expression
EXP
Ketamine results in increased expression of CYBB
CTD
PMID:18063801
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
increases expression
ISO
Ketamine results in increased expression of CYP11A1 mRNA
CTD
PMID:20080153
NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
Ketamine results in increased expression of CYP1A1 protein
CTD
PMID:16076768
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression
ISO
Ketamine results in increased expression of CYP2E1 protein
CTD
PMID:16076768
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp46a1
cytochrome P450, family 46, subfamily a, polypeptide 1
increases expression
ISO
Ketamine results in increased expression of CYP46A1 mRNA
CTD
PMID:20080153
NCBI chr12:108,300,568...108,328,497
Ensembl chr12:108,300,640...108,328,493
G
Cyth4
cytohesin 4
decreases expression multiple interactions
ISO
Ketamine results in decreased expression of CYTH4 mRNA Cannabidiol inhibits the reaction [Ketamine results in decreased expression of CYTH4 mRNA]
CTD
PMID:31823199
NCBI chr15:78,481,247...78,506,219
Ensembl chr15:78,481,247...78,506,219
G
D130043K22Rik
RIKEN cDNA D130043K22 gene
decreases expression
ISO
Ketamine results in decreased expression of KIAA0319 mRNA
CTD
PMID:20080153
NCBI chr13:25,029,114...25,085,422
Ensembl chr13:25,029,118...25,085,253
G
Daglb
diacylglycerol lipase, beta
decreases expression
ISO
Ketamine results in decreased expression of DAGLB mRNA
CTD
PMID:20080153
NCBI chr 5:143,450,239...143,490,197
Ensembl chr 5:143,450,339...143,491,697
G
Dbndd1
dysbindin domain containing 1
decreases expression
ISO
Ketamine results in decreased expression of DBNDD1 mRNA
CTD
PMID:20080153
NCBI chr 8:124,231,744...124,245,535
Ensembl chr 8:124,231,457...124,242,202
G
Dcaf13
DDB1 and CUL4 associated factor 13
decreases expression
ISO
Ketamine results in decreased expression of DCAF13 mRNA
CTD
PMID:20080153
NCBI chr15:38,976,300...39,010,251
Ensembl chr15:38,976,260...39,010,251
G
Dctd
dCMP deaminase
decreases expression
ISO
Ketamine results in decreased expression of DCTD mRNA
CTD
PMID:20080153
NCBI chr 8:48,552,127...48,594,702
Ensembl chr 8:48,552,127...48,606,268
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
EXP ISO
Ketamine results in increased expression of DDIT3 mRNA Ketamine results in increased expression of DDIT3 protein LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased expression of DDIT3 protein]]; lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased expression of DDIT3 protein]
CTD
PMID:35728656 PMID:36907275
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Ddx31
DEAD/H box helicase 31
decreases expression
ISO
Ketamine results in decreased expression of DDX31 mRNA
CTD
PMID:20080153
NCBI chr 2:28,730,418...28,795,587
Ensembl chr 2:28,730,418...28,795,583
G
Defb1
defensin beta 1
decreases expression
ISO
Ketamine results in decreased expression of DEFB1 mRNA
CTD
PMID:20080153
NCBI chr 8:22,266,571...22,285,201
Ensembl chr 8:22,266,615...22,285,201
G
Dennd2b
DENN domain containing 2B
increases expression
ISO
Ketamine results in increased expression of DENND2B mRNA
CTD
PMID:20080153
NCBI chr 7:109,123,118...109,302,828
Ensembl chr 7:109,123,118...109,302,812
G
Dgat2
diacylglycerol O-acyltransferase 2
increases expression
ISO
Ketamine results in increased expression of DGAT2 mRNA
CTD
PMID:20080153
NCBI chr 7:98,802,870...98,831,920
Ensembl chr 7:98,802,865...98,831,926
G
Dhodh
dihydroorotate dehydrogenase
decreases expression
ISO
Ketamine results in decreased expression of DHODH mRNA
CTD
PMID:20080153
NCBI chr 8:110,319,876...110,335,330
Ensembl chr 8:110,317,975...110,335,305
G
Dhx36
DEAH-box helicase 36
decreases expression
ISO
Ketamine results in decreased expression of DHX36 mRNA
CTD
PMID:20080153
NCBI chr 3:62,375,436...62,414,464
Ensembl chr 3:62,375,434...62,414,425
G
Dipk1a
divergent protein kinase domain 1A
increases expression
ISO
Ketamine results in increased expression of DIPK1A mRNA
CTD
PMID:20080153
NCBI chr 5:108,055,908...108,134,943
Ensembl chr 5:108,055,919...108,134,951
G
Dlg4
discs large MAGUK scaffold protein 4
decreases expression increases expression multiple interactions
EXP
Ketamine results in decreased expression of DLG4 protein Ketamine results in increased expression of DLG4 protein Ketamine inhibits the reaction [Corticosterone results in decreased expression of DLG4 protein]; Sirolimus inhibits the reaction [Ketamine results in increased expression of DLG4 protein]
CTD
PMID:31470060 PMID:33022268 PMID:33872575
NCBI chr11:69,908,029...69,938,107
Ensembl chr11:69,907,768...69,938,348
G
Dlx5
distal-less homeobox 5
decreases expression
ISO
Ketamine results in decreased expression of DLX5 mRNA
CTD
PMID:20080153
NCBI chr 6:6,877,801...6,882,068
Ensembl chr 6:6,877,805...6,882,085
G
Dmac1
distal membrane arm assembly complex 1
decreases expression
ISO
Ketamine results in decreased expression of DMAC1 mRNA
CTD
PMID:20080153
NCBI chr 4:75,195,588...75,196,529
Ensembl chr 4:75,195,591...75,196,542
G
Dmrtc1a
DMRT-like family C1a
increases expression
ISO
Ketamine results in increased expression of DMRTC1A mRNA
CTD
PMID:20080153
NCBI chr X:101,946,822...101,953,753
Ensembl chr X:101,946,822...101,952,293
G
Dmtf1
cyclin D binding myb like transcription factor 1
decreases expression
ISO
Ketamine results in decreased expression of DMTF1 mRNA
CTD
PMID:20080153
NCBI chr 5:9,168,868...9,211,782
Ensembl chr 5:9,168,801...9,211,776
G
Dnajb14
DnaJ heat shock protein family (Hsp40) member B14
decreases expression
ISO
Ketamine results in decreased expression of DNAJB14 mRNA
CTD
PMID:20080153
NCBI chr 3:137,572,801...137,619,350
Ensembl chr 3:137,573,436...137,622,318
G
Dnajc15
DnaJ heat shock protein family (Hsp40) member C15
decreases expression
ISO
Ketamine results in decreased expression of DNAJC15 mRNA
CTD
PMID:20080153
NCBI chr14:78,063,657...78,112,357
Ensembl chr14:78,058,121...78,112,565
G
Dnm1
dynamin 1
increases expression
ISO
Ketamine results in increased expression of DNM1 mRNA
CTD
PMID:20080153
NCBI chr 2:32,198,483...32,243,361
Ensembl chr 2:32,198,483...32,243,350
G
Dnmt3b
DNA methyltransferase 3B
decreases expression
ISO
Ketamine results in decreased expression of DNMT3B mRNA
CTD
PMID:20080153
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
Dock11
dedicator of cytokinesis 11
decreases expression
ISO
Ketamine results in decreased expression of DOCK11 mRNA
CTD
PMID:20080153
NCBI chr X:35,150,924...35,340,223
Ensembl chr X:35,152,485...35,340,215
G
Dph5
diphthamide biosynthesis 5
decreases expression
ISO
Ketamine results in decreased expression of DPH5 mRNA
CTD
PMID:20080153
NCBI chr 3:115,681,785...115,728,010
Ensembl chr 3:115,681,486...115,728,010
G
Dpysl3
dihydropyrimidinase-like 3
decreases expression
ISO
Ketamine results in decreased expression of DPYSL3 mRNA
CTD
PMID:20080153
NCBI chr18:43,454,044...43,571,354
Ensembl chr18:43,454,049...43,571,351
G
Drd2
dopamine receptor D2
affects binding
ISO
Ketamine binds to Drd2 protein
RGD
PMID:15852061
RGD:1581406
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Dtx4
deltex 4, E3 ubiquitin ligase
decreases expression
ISO
Ketamine results in decreased expression of DTX4 mRNA
CTD
PMID:20080153
NCBI chr19:12,443,700...12,479,509
Ensembl chr19:12,443,702...12,478,818
G
Dusp11
dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)
decreases expression
ISO
Ketamine results in decreased expression of DUSP11 mRNA
CTD
PMID:20080153
NCBI chr 6:85,919,250...85,938,950
Ensembl chr 6:85,919,250...85,938,649
G
Dusp22
dual specificity phosphatase 22
increases expression
ISO
Ketamine results in increased expression of DUSP22 mRNA
CTD
PMID:20080153
NCBI chr13:30,844,042...30,895,215
Ensembl chr13:30,843,982...30,895,214
G
Dync2i2
dynein 2 intermediate chain 2
decreases expression
ISO
Ketamine results in decreased expression of DYNC2I2 mRNA
CTD
PMID:20080153
NCBI chr 2:29,921,563...29,938,891
Ensembl chr 2:29,921,558...29,938,893
G
Ears2
glutamyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
Ketamine results in decreased expression of EARS2 mRNA
CTD
PMID:20080153
NCBI chr 7:121,633,385...121,666,436
Ensembl chr 7:121,636,436...121,666,486
G
Ebp
EBP cholestenol delta-isomerase
decreases expression
ISO
Ketamine results in decreased expression of EBP mRNA
CTD
PMID:20080153
NCBI chr X:8,051,568...8,059,751
Ensembl chr X:8,051,568...8,059,751
G
Ebpl
emopamil binding protein-like
decreases expression
ISO
Ketamine results in decreased expression of EBPL mRNA
CTD
PMID:20080153
NCBI chr14:61,577,212...61,597,894
Ensembl chr14:61,569,191...61,597,888
G
Echs1
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial
increases expression
ISO
Ketamine results in increased expression of ECHS1 protein
CTD
PMID:18504422
NCBI chr 7:139,685,623...139,696,334
Ensembl chr 7:139,685,623...139,696,389
G
Ect2
ect2 oncogene
decreases expression
ISO
Ketamine results in decreased expression of ECT2 mRNA
CTD
PMID:20080153
NCBI chr 3:27,151,371...27,207,971
Ensembl chr 3:27,151,371...27,208,027
G
Edc3
enhancer of mRNA decapping 3
increases expression
ISO
Ketamine results in increased expression of EDC3 mRNA
CTD
PMID:20080153
NCBI chr 9:57,615,823...57,659,782
Ensembl chr 9:57,615,823...57,659,782
G
Eef2k
eukaryotic elongation factor-2 kinase
decreases expression
ISO
Ketamine results in decreased expression of EEF2K mRNA
CTD
PMID:20080153
NCBI chr 7:120,442,080...120,506,441
Ensembl chr 7:120,442,054...120,506,673
G
Efhb
EF hand domain family, member B
increases expression
ISO
Ketamine results in increased expression of EFHB mRNA
CTD
PMID:20080153
NCBI chr17:53,705,077...53,770,362
Ensembl chr17:53,705,917...53,770,349
G
Efna2
ephrin A2
decreases expression
ISO
Ketamine results in decreased expression of EFNA2 mRNA
CTD
PMID:20080153
NCBI chr10:80,015,316...80,025,844
Ensembl chr10:80,015,316...80,025,844
G
Egr4
early growth response 4
decreases expression
ISO
Ketamine results in decreased expression of EGR4 mRNA
CTD
PMID:20080153
NCBI chr 6:85,488,103...85,490,571
Ensembl chr 6:85,488,103...85,490,571
G
Eif1a
eukaryotic translation initiation factor 1A
decreases expression
ISO
Ketamine results in decreased expression of EIF1A mRNA
CTD
PMID:20080153
NCBI chr18:46,730,771...46,743,292
Ensembl chr18:46,730,768...46,749,523
G
Eif4e3
eukaryotic translation initiation factor 4E member 3
decreases expression
ISO
Ketamine results in decreased expression of EIF4E3 mRNA
CTD
PMID:20080153
NCBI chr 6:99,599,008...99,669,834
Ensembl chr 6:99,602,096...99,643,732
G
Eno2
enolase 2, gamma neuronal
decreases expression
ISO
Ketamine results in decreased expression of ENO2 protein
CTD
PMID:18504422
NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
increases expression
ISO
Ketamine results in increased expression of ENPP2 mRNA
CTD
PMID:20080153
NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288
G
Entrep1
endosomal transmembrane epsin interactor 1
increases expression
ISO
Ketamine results in increased expression of ENTREP1 mRNA
CTD
PMID:20080153
NCBI chr19:23,950,114...24,008,800
Ensembl chr19:23,950,114...24,008,383
G
Ephx4
epoxide hydrolase 4
increases expression
ISO
Ketamine results in increased expression of EPHX4 mRNA
CTD
PMID:20080153
NCBI chr 5:107,551,379...107,577,901
Ensembl chr 5:107,550,602...107,577,901
G
Erbb4
erb-b2 receptor tyrosine kinase 4
decreases expression
EXP
Ketamine results in decreased expression of ERBB4 mRNA
CTD
PMID:20000043
NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
G
Erich1
glutamate rich 1
decreases expression
ISO
Ketamine results in decreased expression of ERICH1 mRNA
CTD
PMID:20080153
NCBI chr 8:14,075,051...14,140,393
Ensembl chr 8:14,077,561...14,140,301
G
Ermp1
endoplasmic reticulum metallopeptidase 1
increases expression
ISO
Ketamine results in increased expression of ERMP1 mRNA
CTD
PMID:20080153
NCBI chr19:29,587,276...29,625,815
Ensembl chr19:29,585,614...29,625,815
G
Ezh1
enhancer of zeste 1 polycomb repressive complex 2 subunit
increases expression
ISO
Ketamine results in increased expression of EZH1 mRNA
CTD
PMID:20080153
NCBI chr11:101,081,941...101,117,268
Ensembl chr11:101,081,941...101,117,289
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression
ISO
Ketamine results in decreased expression of EZH2 mRNA
CTD
PMID:20080153
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
G
Fam110d
family with sequence similarity 110, member D
decreases expression
ISO
Ketamine results in decreased expression of FAM110D mRNA
CTD
PMID:20080153
NCBI chr 4:133,978,413...133,993,528
Ensembl chr 4:133,978,421...133,981,417
G
Fam120b
family with sequence similarity 120, member B
decreases expression
ISO
Ketamine results in decreased expression of FAM120B mRNA
CTD
PMID:20080153
NCBI chr17:15,616,464...15,653,843
Ensembl chr17:15,616,464...15,653,845
G
Fam136a
family with sequence similarity 136, member A
decreases expression
ISO
Ketamine results in decreased expression of FAM136A mRNA
CTD
PMID:20080153
NCBI chr 6:86,342,453...86,347,040
Ensembl chr 6:86,342,628...86,347,040
G
Fam180a
family with sequence similarity 180, member A
decreases expression
ISO
Ketamine results in decreased expression of FAM180A mRNA
CTD
PMID:20080153
NCBI chr 6:35,289,678...35,303,076
Ensembl chr 6:35,289,603...35,303,076
G
Fam210a
family with sequence similarity 210, member A
decreases expression
ISO
Ketamine results in decreased expression of FAM210A mRNA
CTD
PMID:20080153
NCBI chr18:68,393,248...68,433,404
Ensembl chr18:68,393,258...68,433,404
G
Fam98a
family with sequence similarity 98, member A
decreases expression
ISO
Ketamine results in decreased expression of FAM98A mRNA
CTD
PMID:20080153
NCBI chr17:75,844,080...75,858,941
Ensembl chr17:75,844,081...75,858,941
G
Fat3
FAT atypical cadherin 3
decreases expression
ISO
Ketamine results in decreased expression of FAT3 mRNA
CTD
PMID:20080153
NCBI chr 9:15,821,485...16,413,981
Ensembl chr 9:15,821,485...16,412,581
G
Fat4
FAT atypical cadherin 4
decreases expression
ISO
Ketamine results in decreased expression of FAT4 mRNA
CTD
PMID:20080153
NCBI chr 3:38,939,867...39,066,134
Ensembl chr 3:38,941,089...39,066,134
G
Faxc
failed axon connections homolog
increases expression
ISO
Ketamine results in increased expression of FAXC mRNA
CTD
PMID:20080153
NCBI chr 4:21,930,906...22,001,461
Ensembl chr 4:21,931,329...21,996,839
G
Fbl
fibrillarin
decreases expression
ISO
Ketamine results in decreased expression of FBL mRNA
CTD
PMID:20080153
NCBI chr 7:27,868,293...27,878,701
Ensembl chr 7:27,869,135...27,878,694
G
Fblim1
filamin binding LIM protein 1
decreases expression
ISO
Ketamine results in decreased expression of FBLIM1 mRNA
CTD
PMID:20080153
NCBI chr 4:141,303,373...141,333,351
Ensembl chr 4:141,303,373...141,333,407
G
Fbxl22
F-box and leucine-rich repeat protein 22
increases expression
ISO
Ketamine results in increased expression of FBXL22 mRNA
CTD
PMID:20080153
NCBI chr 9:66,415,738...66,425,752
Ensembl chr 9:66,415,657...66,421,891
G
Fbxo2
F-box protein 2
increases expression
ISO
Ketamine results in increased expression of FBXO2 mRNA
CTD
PMID:20080153
NCBI chr 4:148,244,605...148,250,874
Ensembl chr 4:148,245,078...148,250,881
G
Fbxo34
F-box protein 34
increases expression
ISO
Ketamine results in increased expression of FBXO34 mRNA
CTD
PMID:20080153
NCBI chr14:47,709,992...47,769,419
Ensembl chr14:47,687,878...47,769,419
G
Fbxo8
F-box protein 8
increases expression
ISO
Ketamine results in increased expression of FBXO8 mRNA
CTD
PMID:20080153
NCBI chr 8:57,004,189...57,046,974
Ensembl chr 8:57,004,125...57,046,974
G
Fdft1
farnesyl diphosphate farnesyl transferase 1
decreases expression
ISO
Ketamine results in decreased expression of FDFT1 mRNA
CTD
PMID:20080153
NCBI chr14:63,382,599...63,419,136
Ensembl chr14:63,382,599...63,417,027
G
Fem1b
fem 1 homolog b
increases expression
ISO
Ketamine results in increased expression of FEM1B mRNA
CTD
PMID:20080153
NCBI chr 9:62,699,106...62,718,930
Ensembl chr 9:62,699,103...62,719,216
G
Fgfr3
fibroblast growth factor receptor 3
increases expression
ISO
Ketamine results in increased expression of FGFR3 mRNA
CTD
PMID:20080153
NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412
G
Fgfrl1
fibroblast growth factor receptor-like 1
decreases expression
ISO
Ketamine results in decreased expression of FGFRL1 mRNA
CTD
PMID:20080153
NCBI chr 5:108,842,051...108,854,816
Ensembl chr 5:108,840,248...108,854,790
G
Fkbp15
FK506 binding protein 15
increases expression
ISO
Ketamine results in increased expression of FKBP15 mRNA
CTD
PMID:20080153
NCBI chr 4:62,218,579...62,278,828
Ensembl chr 4:62,218,579...62,278,785
G
Fn1
fibronectin 1
increases expression multiple interactions
ISO
Ketamine results in increased expression of FN1 mRNA; Ketamine results in increased expression of FN1 protein 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride inhibits the reaction [Ketamine results in increased expression of FN1 protein]
CTD
PMID:28331066
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
G
Fn3k
fructosamine 3 kinase
increases expression
ISO
Ketamine results in increased expression of FN3K mRNA
CTD
PMID:20080153
NCBI chr11:121,325,779...121,341,316
Ensembl chr11:121,325,739...121,341,317
G
Fos
FBJ osteosarcoma oncogene
multiple interactions
ISO
Ketamine inhibits the reaction [Formaldehyde results in increased expression of FOS protein]
CTD
PMID:17551412
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Foxo1
forkhead box O1
decreases expression
ISO
Ketamine results in decreased expression of FOXO1 mRNA
CTD
PMID:20080153
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
G
Frem3
Fras1 related extracellular matrix protein 3
increases expression
ISO
Ketamine results in increased expression of FREM3 mRNA
CTD
PMID:20080153
NCBI chr 8:81,337,668...81,422,186
Ensembl chr 8:81,337,709...81,421,985
G
Fubp1
far upstream element (FUSE) binding protein 1
decreases expression
ISO
Ketamine results in decreased expression of FUBP1 mRNA
CTD
PMID:20080153
NCBI chr 3:151,916,059...151,942,467
Ensembl chr 3:151,916,059...151,942,463
G
Fxyd7
FXYD domain-containing ion transport regulator 7
increases expression
ISO
Ketamine results in increased expression of FXYD7 mRNA
CTD
PMID:20080153
NCBI chr 7:30,741,940...30,750,879
Ensembl chr 7:30,741,938...30,750,892
G
G0s2
G0/G1 switch gene 2
decreases expression
ISO
Ketamine results in decreased expression of G0S2 mRNA
CTD
PMID:20080153
NCBI chr 1:192,954,468...192,955,496
Ensembl chr 1:192,954,469...192,955,525
G
Gabra5
gamma-aminobutyric acid type A receptor subunit alpha 5
increases expression
EXP
Ketamine results in increased expression of GABRA5 mRNA; Ketamine results in increased expression of GABRA5 protein
CTD
PMID:21712993
NCBI chr 7:57,057,417...57,240,808
Ensembl chr 7:57,057,420...57,159,807
G
Gabrb2
gamma-aminobutyric acid type A receptor subunit beta 2
decreases expression
ISO
Ketamine results in decreased expression of GABRB2 mRNA
CTD
PMID:20080153
NCBI chr11:42,310,342...42,523,418
Ensembl chr11:42,310,584...42,519,855
G
Gabrd
gamma-aminobutyric acid (GABA) A receptor, subunit delta
increases expression
ISO
Ketamine results in increased expression of GABRD mRNA
CTD
PMID:20080153
NCBI chr 4:155,469,437...155,482,528
Ensembl chr 4:155,469,437...155,482,569
G
Gabrg2
gamma-aminobutyric acid type A receptor, subunit gamma 2
decreases expression
ISO
Ketamine results in decreased expression of GABRG2 mRNA
CTD
PMID:20080153
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
G
Gad1
glutamate decarboxylase 1
multiple interactions decreases expression increases expression
EXP
acetovanillone inhibits the reaction [Ketamine results in decreased expression of GAD1 protein] Ketamine results in increased expression of GAD1 mRNA
CTD
PMID:18063801 PMID:23660488
NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
G
Galnt16
polypeptide N-acetylgalactosaminyltransferase 16
increases expression
ISO
Ketamine results in increased expression of GALNT16 mRNA
CTD
PMID:20080153
NCBI chr12:80,565,245...80,650,672
Ensembl chr12:80,565,051...80,677,746
G
Galr2
galanin receptor 2
decreases expression
ISO
Ketamine results in decreased expression of GALR2 mRNA
CTD
PMID:20080153
NCBI chr11:116,170,520...116,174,776
Ensembl chr11:116,171,765...116,174,764
G
Gapdhs
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic
increases expression
ISO
Ketamine results in increased expression of GAPDHS mRNA
CTD
PMID:20080153
NCBI chr 7:30,429,204...30,443,106
Ensembl chr 7:30,429,200...30,443,106
G
Garin5a
golgi associated RAB2 interactor 5A
increases expression
ISO
Ketamine results in increased expression of GARIN5A mRNA
CTD
PMID:20080153
NCBI chr 7:44,145,923...44,153,690
Ensembl chr 7:44,146,005...44,150,910
G
Gatad2b
GATA zinc finger domain containing 2B
decreases expression
ISO
Ketamine results in decreased expression of GATAD2B mRNA
CTD
PMID:20080153
NCBI chr 3:90,200,488...90,270,712
Ensembl chr 3:90,200,485...90,270,714
G
Gca
grancalcin
decreases expression
ISO
Ketamine results in decreased expression of GCA mRNA
CTD
PMID:20080153
NCBI chr 2:62,494,671...62,524,453
Ensembl chr 2:62,494,629...62,524,453
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression multiple interactions decreases expression
ISO
Ketamine results in increased expression of GCLC mRNA Curcumin inhibits the reaction [Ketamine results in decreased expression of GCLC mRNA]; Curcumin inhibits the reaction [Ketamine results in decreased expression of GCLC protein] Ketamine results in decreased expression of GCLC mRNA; Ketamine results in decreased expression of GCLC protein
CTD
PMID:20080153 PMID:36305173
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gdap1l1
ganglioside-induced differentiation-associated protein 1-like 1
increases expression
ISO
Ketamine results in increased expression of GDAP1L1 mRNA
CTD
PMID:20080153
NCBI chr 2:163,280,387...163,297,264
Ensembl chr 2:163,280,396...163,297,244
G
Gfap
glial fibrillary acidic protein
increases expression
ISO
Ketamine results in increased expression of GFAP mRNA
CTD
PMID:20080153
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
G
Gfod2
glucose-fructose oxidoreductase domain containing 2
decreases expression
ISO
Ketamine results in decreased expression of GFOD2 mRNA
CTD
PMID:20080153
NCBI chr 8:106,440,676...106,485,299
Ensembl chr 8:106,440,486...106,485,296
G
Gfpt2
glutamine fructose-6-phosphate transaminase 2
decreases expression
ISO
Ketamine results in decreased expression of GFPT2 mRNA
CTD
PMID:20080153
NCBI chr11:49,684,981...49,729,448
Ensembl chr11:49,685,005...49,729,440
G
Ggact
gamma-glutamylamine cyclotransferase
increases expression
ISO
Ketamine results in increased expression of GGACT mRNA
CTD
PMID:20080153
NCBI chr14:123,128,272...123,151,173
Ensembl chr14:123,053,635...123,151,169
G
Gjb6
gap junction protein, beta 6
increases expression
ISO
Ketamine results in increased expression of GJB6 mRNA
CTD
PMID:20080153
NCBI chr14:57,360,760...57,370,764
Ensembl chr14:57,360,760...57,371,068
G
Glul
glutamate-ammonia ligase
increases expression multiple interactions
ISO EXP
Ketamine results in increased expression of GLUL protein [Guanosine co-treated with Ketamine] results in increased activity of GLUL protein
CTD
PMID:18504422 PMID:36878458
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
G
Gpr22
G protein-coupled receptor 22
increases expression
ISO
Ketamine results in increased expression of GPR22 mRNA
CTD
PMID:20080153
NCBI chr12:31,756,866...31,763,882
Ensembl chr12:31,756,866...31,763,946
G
Gpr37l1
G protein-coupled receptor 37-like 1
increases expression
ISO
Ketamine results in increased expression of GPR37L1 mRNA
CTD
PMID:20080153
NCBI chr 1:135,087,988...135,095,419
Ensembl chr 1:135,087,972...135,095,419
G
Gpr84
G protein-coupled receptor 84
decreases expression multiple interactions
ISO
Ketamine results in decreased expression of GPR84 mRNA Cannabidiol inhibits the reaction [Ketamine results in decreased expression of GPR84 mRNA]
CTD
PMID:31823199
NCBI chr15:103,216,660...103,219,050
Ensembl chr15:103,216,662...103,219,039
G
Gpr85
G protein-coupled receptor 85
decreases expression
ISO
Ketamine results in decreased expression of GPR85 mRNA
CTD
PMID:20080153
NCBI chr 6:13,834,405...13,839,951
Ensembl chr 6:13,834,457...13,839,941
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
multiple interactions decreases expression
EXP ISO
Ketamine inhibits the reaction [Corticosterone results in decreased expression of GRIA1 protein]; MAPT protein affects the reaction [Ketamine results in decreased expression of GRIA1 protein] Ketamine promotes the reaction [Methamphetamine increases expression of Gria1 protein in hippocampus, striatum]
CTD RGD
PMID:31470060 PMID:33872575 PMID:37778205
RGD:405100237
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Gria2
glutamate receptor, ionotropic, AMPA2 (alpha 2)
decreases expression multiple interactions
EXP
Ketamine results in decreased expression of GRIA2 protein MAPT protein affects the reaction [Ketamine results in decreased expression of GRIA2 protein]
CTD
PMID:31470060
NCBI chr 3:80,588,757...80,711,534
Ensembl chr 3:80,588,757...80,710,142
G
Grik5
glutamate receptor, ionotropic, kainate 5 (gamma 2)
increases expression
ISO
Ketamine results in increased expression of GRIK5 mRNA
CTD
PMID:20080153
NCBI chr 7:24,709,274...24,775,421
Ensembl chr 7:24,709,274...24,771,771
G
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
increases expression
ISO
Ketamine results in increased expression of GRIN1 mRNA; Ketamine results in increased expression of GRIN1 protein
CTD
PMID:19126600 PMID:20080153 PMID:23065140
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
Grin2a
glutamate receptor, ionotropic, NMDA2A (epsilon 1)
affects response to substance increases expression
EXP ISO
GRIN2A protein affects the susceptibility to Ketamine Ketamine results in increased expression of GRIN2A mRNA
CTD
PMID:15731593 PMID:20080153
NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424
G
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
multiple interactions
ISO
Ketamine inhibits the reaction [remifentanil results in increased phosphorylation of GRIN2B protein]
CTD
PMID:20042082
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
G
Grin2c
glutamate receptor, ionotropic, NMDA2C (epsilon 3)
increases expression
ISO
Ketamine results in increased expression of GRIN2C mRNA
CTD
PMID:20080153
NCBI chr11:115,139,995...115,158,123
Ensembl chr11:115,139,995...115,158,069
G
Grm3
glutamate receptor, metabotropic 3
decreases expression
ISO
Ketamine results in decreased expression of GRM3 mRNA
CTD
PMID:20080153
NCBI chr 5:9,535,235...9,776,087
Ensembl chr 5:9,535,541...9,775,170
G
Gsk3b
glycogen synthase kinase 3 beta
decreases phosphorylation multiple interactions increases phosphorylation
ISO
Ketamine results in decreased phosphorylation of GSK3B protein Chir 99021 inhibits the reaction [Ketamine results in increased phosphorylation of GSK3B protein]
CTD
PMID:17952604 PMID:36334642
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Gsto2
glutathione S-transferase omega 2
increases expression
ISO
Ketamine results in increased expression of GSTO2 mRNA
CTD
PMID:20080153
NCBI chr19:47,853,879...47,874,747
Ensembl chr19:47,853,973...47,874,763
G
Gtf2h3
general transcription factor IIH, polypeptide 3
decreases expression
ISO
Ketamine results in decreased expression of GTF2H3 mRNA
CTD
PMID:20080153
NCBI chr 5:124,717,211...124,735,743
Ensembl chr 5:124,717,203...124,735,743
G
Gtf2ird1
general transcription factor II I repeat domain-containing 1
increases expression
ISO
Ketamine results in increased expression of GTF2IRD1 mRNA
CTD
PMID:20080153
NCBI chr 5:134,386,515...134,485,628
Ensembl chr 5:134,386,510...134,485,570
G
Gucy1b1
guanylate cyclase 1, soluble, beta 1
decreases expression
ISO
Ketamine results in decreased expression of GUCY1B1 mRNA
CTD
PMID:20080153
NCBI chr 3:81,939,311...81,982,018
Ensembl chr 3:81,939,313...81,981,996
G
Habp4
hyaluronic acid binding protein 4
increases expression
ISO
Ketamine results in increased expression of HABP4 mRNA
CTD
PMID:20080153
NCBI chr13:64,309,680...64,334,351
Ensembl chr13:64,309,638...64,334,351
G
Hacd3
3-hydroxyacyl-CoA dehydratase 3
decreases expression
ISO
Ketamine results in decreased expression of HACD3 mRNA
CTD
PMID:20080153
NCBI chr 9:64,894,265...64,929,014
Ensembl chr 9:64,894,265...64,928,975
G
Hap1
huntingtin-associated protein 1
increases expression
ISO
Ketamine results in increased expression of HAP1 mRNA
CTD
PMID:20080153
NCBI chr11:100,238,153...100,247,808
Ensembl chr11:100,238,153...100,246,954
G
Haus8
4HAUS augmin-like complex, subunit 8
decreases expression
ISO
Ketamine results in decreased expression of HAUS8 mRNA
CTD
PMID:20080153
NCBI chr 8:71,703,241...71,725,234
Ensembl chr 8:71,701,205...71,725,578
G
Havcr1
hepatitis A virus cellular receptor 1
multiple interactions
EXP
[Ketamine co-treated with Xylazine] results in increased secretion of HAVCR1 protein
CTD
PMID:30538007
NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405
G
Hbb-b1
hemoglobin, beta adult major chain
decreases expression
ISO
Ketamine results in decreased expression of HBB-B1 mRNA
CTD
PMID:20080153
G
Hecw1
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
decreases expression
ISO
Ketamine results in decreased expression of HECW1 mRNA
CTD
PMID:20080153
NCBI chr13:14,401,023...14,697,874
Ensembl chr13:14,401,023...14,697,813
G
Hes5
hes family bHLH transcription factor 5
decreases expression
ISO
Ketamine results in decreased expression of HES5 mRNA
CTD
PMID:20080153
NCBI chr 4:155,042,358...155,046,829
Ensembl chr 4:155,045,380...155,046,828
G
Hes6
hairy and enhancer of split 6
decreases expression
ISO
Ketamine results in decreased expression of HES6 mRNA
CTD
PMID:20080153
NCBI chr 1:91,339,204...91,342,901
Ensembl chr 1:91,339,205...91,341,760
G
Hibch
3-hydroxyisobutyryl-Coenzyme A hydrolase
decreases expression
ISO
Ketamine results in decreased expression of HIBCH mRNA
CTD
PMID:20080153
NCBI chr 1:52,884,197...52,960,145
Ensembl chr 1:52,884,088...52,960,145
G
Hmgcll1
3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase-like 1
decreases expression
ISO
Ketamine results in decreased expression of HMGCLL1 mRNA
CTD
PMID:20080153
NCBI chr 9:75,921,983...76,043,632
Ensembl chr 9:75,922,137...76,043,632
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
decreases expression
ISO
Ketamine results in decreased expression of HMGCR mRNA
CTD
PMID:20080153
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmgcs2
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2
increases expression
ISO
Ketamine results in increased expression of HMGCS2 mRNA
CTD
PMID:20080153
NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054
G
Hmgn1
high mobility group nucleosomal binding domain 1
decreases expression
ISO
Ketamine results in decreased expression of HMGN1 mRNA
CTD
PMID:20080153
NCBI chr16:95,922,788...95,928,925
Ensembl chr16:95,921,818...95,928,929
G
Hmgn3
high mobility group nucleosomal binding domain 3
increases expression
ISO
Ketamine results in increased expression of HMGN3 mRNA
CTD
PMID:20080153
NCBI chr 9:82,991,995...83,029,411
Ensembl chr 9:82,992,001...83,028,738
G
Hmox1
heme oxygenase 1
multiple interactions decreases expression
ISO
Curcumin inhibits the reaction [Ketamine results in decreased expression of HMOX1 mRNA]; Curcumin inhibits the reaction [Ketamine results in decreased expression of HMOX1 protein] Ketamine results in decreased expression of HMOX1 mRNA; Ketamine results in decreased expression of HMOX1 protein
CTD
PMID:36305173
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hmox2
heme oxygenase 2
increases expression
ISO
Ketamine results in increased expression of HMOX2 mRNA
CTD
PMID:20080153
NCBI chr16:4,544,225...4,584,606
Ensembl chr16:4,544,225...4,584,606
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
increases expression
ISO
Ketamine results in increased expression of HNRNPA2B1 protein
CTD
PMID:18504422
NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874
G
Hnrnph3
heterogeneous nuclear ribonucleoprotein H3
decreases expression
ISO
Ketamine results in decreased expression of HNRNPH3 mRNA
CTD
PMID:20080153
NCBI chr10:62,850,443...62,859,764
Ensembl chr10:62,850,443...62,859,996
G
Hopx
HOP homeobox
increases expression
ISO
Ketamine results in increased expression of HOPX mRNA
CTD
PMID:20080153
NCBI chr 5:77,234,831...77,262,970
Ensembl chr 5:77,234,835...77,262,968
G
Hpca
hippocalcin
increases expression
ISO
Ketamine results in increased expression of HPCA mRNA
CTD
PMID:20080153
NCBI chr 4:129,005,363...129,019,712
Ensembl chr 4:129,005,363...129,015,829
G
Hpdl
4-hydroxyphenylpyruvate dioxygenase-like
decreases expression
ISO
Ketamine results in decreased expression of HPDL mRNA
CTD
PMID:20080153
NCBI chr 4:116,677,104...116,678,705
Ensembl chr 4:116,677,101...116,678,904
G
Hpgd
hydroxyprostaglandin dehydrogenase 15 (NAD)
decreases expression
ISO
Ketamine results in decreased expression of HPGD mRNA
CTD
PMID:20080153
NCBI chr 8:56,747,587...56,774,081
Ensembl chr 8:56,747,620...56,774,078
G
Hras
Harvey rat sarcoma virus oncogene
multiple interactions
EXP
Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of HRAS protein]
CTD
PMID:19540866
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
G
Hrh3
histamine receptor H3
increases expression
ISO
Ketamine results in increased expression of HRH3 mRNA
CTD
PMID:20080153
NCBI chr 2:179,741,258...179,746,264
Ensembl chr 2:179,741,258...179,746,281
G
Hrk
harakiri, BCL2 interacting protein (contains only BH3 domain)
increases expression
ISO
Ketamine results in increased expression of HRK mRNA
CTD
PMID:20080153
NCBI chr 5:118,307,829...118,327,543
Ensembl chr 5:118,302,713...118,327,543
G
Hs3st5
heparan sulfate (glucosamine) 3-O-sulfotransferase 5
decreases expression
ISO
Ketamine results in decreased expression of HS3ST5 mRNA
CTD
PMID:20080153
NCBI chr10:36,382,794...36,710,393
Ensembl chr10:36,382,810...36,710,393
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
increases expression
ISO
Ketamine results in increased expression of HSD11B1 mRNA
CTD
PMID:20080153
NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383
G
Hsd17b4
hydroxysteroid (17-beta) dehydrogenase 4
decreases expression
ISO
Ketamine results in decreased expression of HSD17B4 mRNA
CTD
PMID:20080153
NCBI chr18:50,261,268...50,329,337
Ensembl chr18:50,261,268...50,329,336
G
Hspa2
heat shock protein 2
increases expression
ISO
Ketamine results in increased expression of HSPA2 mRNA
CTD
PMID:20080153
NCBI chr12:76,450,688...76,453,712
Ensembl chr12:76,450,950...76,453,712
G
Hspa5
heat shock protein 5
decreases expression affects expression increases expression multiple interactions
ISO EXP
Ketamine results in decreased expression of HSPA5 mRNA Ketamine affects the expression of HSPA5 mRNA Ketamine results in increased expression of HSPA5 protein LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased expression of HSPA5 protein]]; lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased expression of HSPA5 protein]
CTD
PMID:20080153 PMID:35728656 PMID:36907275
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Htra1
HtrA serine peptidase 1
increases expression
ISO
Ketamine results in increased expression of HTRA1 mRNA
CTD
PMID:20080153
NCBI chr 7:130,537,933...130,587,388
Ensembl chr 7:130,537,841...130,587,390
G
Icam1
intercellular adhesion molecule 1
multiple interactions
EXP
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of ICAM1 mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of ICAM1 protein]
CTD
PMID:22245128
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Icam5
intercellular adhesion molecule 5, telencephalin
increases expression
ISO
Ketamine results in increased expression of ICAM5 mRNA
CTD
PMID:20080153
NCBI chr 9:20,943,372...20,950,331
Ensembl chr 9:20,943,369...20,950,332
G
Idh1
isocitrate dehydrogenase 1 (NADP+), soluble
decreases expression
ISO
Ketamine results in decreased expression of IDH1 mRNA
CTD
PMID:20080153
NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659
G
Idi1
isopentenyl-diphosphate delta isomerase
decreases expression
ISO
Ketamine results in decreased expression of IDI1 mRNA
CTD
PMID:20080153
NCBI chr13:8,935,642...8,942,432
Ensembl chr13:8,935,537...8,942,487
G
Ifi27
interferon, alpha-inducible protein 27
increases expression
ISO
Ketamine results in increased expression of IFI27 mRNA
CTD
PMID:20080153
NCBI chr12:103,400,448...103,406,504
Ensembl chr12:103,400,470...103,406,498
G
Ifi27l2a
interferon, alpha-inducible protein 27 like 2A
increases expression
ISO
Ketamine results in increased expression of IFI27L1 mRNA
CTD
PMID:20080153
NCBI chr12:103,400,132...103,409,939
Ensembl chr12:103,408,426...103,409,939
G
Ifitm10
interferon induced transmembrane protein 10
increases expression
ISO
Ketamine results in increased expression of IFITM10 mRNA
CTD
PMID:20080153
NCBI chr 7:141,879,572...141,927,526
Ensembl chr 7:141,879,574...141,927,490
G
Ifngr1
interferon gamma receptor 1
increases expression
ISO
Ketamine results in increased expression of IFNGR1 mRNA
CTD
PMID:20080153
NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977
G
Ifngr2
interferon gamma receptor 2
increases expression
ISO
Ketamine results in increased expression of IFNGR2 mRNA
CTD
PMID:20080153
NCBI chr16:91,343,947...91,360,895
Ensembl chr16:91,343,960...91,362,511
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression
ISO
Ketamine results in increased expression of IGFBP1 mRNA
CTD
PMID:20080153
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
G
Igfbp3
insulin-like growth factor binding protein 3
increases expression
ISO
Ketamine results in increased expression of IGFBP3 mRNA
CTD
PMID:20080153
NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923
G
Igfbpl1
insulin-like growth factor binding protein-like 1
decreases expression
ISO
Ketamine results in decreased expression of IGFBPL1 mRNA
CTD
PMID:20080153
NCBI chr 4:45,809,507...45,826,827
Ensembl chr 4:45,809,468...45,826,923
G
Igsf9
immunoglobulin superfamily, member 9
decreases expression
ISO
Ketamine results in decreased expression of IGSF9 mRNA
CTD
PMID:20080153
NCBI chr 1:172,307,616...172,326,444
Ensembl chr 1:172,309,355...172,326,445
G
Ikbip
IKBKB interacting protein
decreases expression
ISO
Ketamine results in decreased expression of IKBIP mRNA
CTD
PMID:20080153
NCBI chr10:90,918,667...90,938,475
Ensembl chr10:90,918,802...90,938,469
G
Il12a
interleukin 12a
increases expression
ISO
Ketamine results in increased expression of IL12A mRNA
CTD
PMID:20080153
NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880
G
Il1b
interleukin 1 beta
increases expression multiple interactions increases secretion
ISO EXP
Ketamine results in increased expression of IL1B mRNA; Ketamine results in increased expression of IL1B protein Ozone inhibits the reaction [Ketamine results in increased expression of IL1B mRNA]; TRPV4 protein affects the reaction [Ketamine results in increased expression of IL1B protein] [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of IL1B mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of IL1B protein]; Ketamine inhibits the reaction [Acetaminophen results in increased expression of IL1B protein]; Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; TLR4 mutant form promotes the reaction [Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; TLR4 mutant form promotes the reaction [Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]] Ketamine results in increased secretion of IL1B protein
CTD
PMID:15207037 PMID:15207038 PMID:19540866 PMID:22245128 PMID:33536391 PMID:34487425 PMID:37491939 PMID:37515540 More...
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il6
interleukin 6
multiple interactions affects response to substance increases expression
ISO EXP
Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] IL6 affects the susceptibility to Ketamine Ketamine results in increased expression of IL6 mRNA; Ketamine results in increased expression of IL6 protein [Atropine co-treated with Ketamine] inhibits the reaction [Soman results in increased expression of IL6 mRNA]; [Atropine co-treated with Ketamine] inhibits the reaction [Soman results in increased expression of IL6 protein]; Ketamine inhibits the reaction [Acetaminophen results in increased expression of IL6 protein]; Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; mangiferin inhibits the reaction [Ketamine results in increased expression of IL6 protein] TRPV4 protein affects the reaction [Ketamine results in increased expression of IL6 protein]
CTD
PMID:15207037 PMID:15207038 PMID:15720977 PMID:19091984 PMID:19540866 PMID:22245128 PMID:23087136 PMID:33536391 PMID:34487425 PMID:37491939 More...
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Ina
internexin neuronal intermediate filament protein, alpha
increases expression
ISO
Ketamine results in increased expression of INA protein
CTD
PMID:18504422
NCBI chr19:47,003,120...47,013,766
Ensembl chr19:47,003,137...47,013,766
G
Ing2
inhibitor of growth family, member 2
increases expression
ISO
Ketamine results in increased expression of ING2 mRNA
CTD
PMID:20080153
NCBI chr 8:48,120,213...48,128,627
Ensembl chr 8:48,120,213...48,128,591
G
Inhba
inhibin beta-A
decreases expression
ISO
Ketamine results in decreased expression of INHBA mRNA
CTD
PMID:20080153
NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206
G
Ino80c
INO80 complex subunit C
increases expression
ISO
Ketamine results in increased expression of INO80C mRNA
CTD
PMID:20080153
NCBI chr18:24,237,818...24,254,876
Ensembl chr18:24,237,814...24,255,010
G
Inpp5d
inositol polyphosphate-5-phosphatase D
increases expression
ISO
Ketamine results in increased expression of INPP5D mRNA
CTD
PMID:20080153
NCBI chr 1:87,548,034...87,648,232
Ensembl chr 1:87,548,034...87,648,229
G
Inpp5f
inositol polyphosphate-5-phosphatase F
decreases expression
ISO
Ketamine results in decreased expression of INPP5F mRNA
CTD
PMID:20080153
NCBI chr 7:128,212,905...128,298,161
Ensembl chr 7:128,213,052...128,298,149
G
Ints3
integrator complex subunit 3
decreases expression
ISO
Ketamine results in decreased expression of INTS3 mRNA
CTD
PMID:20080153
NCBI chr 3:90,298,691...90,340,800
Ensembl chr 3:90,298,695...90,340,929
G
Isyna1
myo-inositol 1-phosphate synthase A1
decreases expression
ISO
Ketamine results in decreased expression of ISYNA1 mRNA
CTD
PMID:20080153
NCBI chr 8:71,047,131...71,049,940
Ensembl chr 8:71,047,023...71,049,940
G
Itih3
inter-alpha trypsin inhibitor, heavy chain 3
increases expression
ISO
Ketamine results in increased expression of ITIH3 mRNA
CTD
PMID:20080153
NCBI chr14:30,630,529...30,645,748
Ensembl chr14:30,630,529...30,645,717
G
Itm2c
integral membrane protein 2C
increases expression
ISO
Ketamine results in increased expression of ITM2C mRNA
CTD
PMID:20080153
NCBI chr 1:85,822,231...85,836,419
Ensembl chr 1:85,822,002...85,836,396
G
Itpka
inositol 1,4,5-trisphosphate 3-kinase A
increases expression
ISO
Ketamine results in increased expression of ITPKA mRNA
CTD
PMID:20080153
NCBI chr 2:119,572,818...119,581,734
Ensembl chr 2:119,572,818...119,581,744
G
Ivns1abp
influenza virus NS1A binding protein
decreases expression
ISO
Ketamine results in decreased expression of IVNS1ABP mRNA
CTD
PMID:20080153
NCBI chr 1:151,220,237...151,240,196
Ensembl chr 1:151,220,228...151,240,173
G
Jade3
jade family PHD finger 3
decreases expression
ISO
Ketamine results in decreased expression of JADE3 mRNA
CTD
PMID:20080153
NCBI chr X:20,291,611...20,386,178
Ensembl chr X:20,291,927...20,386,178
G
Jag2
jagged 2
decreases expression
ISO
Ketamine results in decreased expression of JAG2 mRNA
CTD
PMID:20080153
NCBI chr12:112,871,439...112,893,437
Ensembl chr12:112,871,439...112,893,396
G
Jak2
Janus kinase 2
decreases expression
ISO
Ketamine results in decreased expression of JAK2 mRNA
CTD
PMID:20080153
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Jmjd1c
jumonji domain containing 1C
decreases expression
ISO
Ketamine results in decreased expression of JMJD1C mRNA
CTD
PMID:20080153
NCBI chr10:66,932,189...67,092,105
Ensembl chr10:66,931,904...67,092,105
G
Jun
jun proto-oncogene
increases expression
ISO
Ketamine results in increased expression of JUN mRNA
CTD
PMID:20080153
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kazald1
Kazal-type serine peptidase inhibitor domain 1
increases expression
ISO
Ketamine results in increased expression of KAZALD1 mRNA
CTD
PMID:20080153
NCBI chr19:45,063,404...45,067,728
Ensembl chr19:45,063,680...45,067,728
G
Kazn
kazrin, periplakin interacting protein
increases expression
ISO
Ketamine results in increased expression of KAZN mRNA
CTD
PMID:20080153
NCBI chr 4:141,829,701...142,801,231
Ensembl chr 4:141,829,701...142,205,056
G
Kcnc2
potassium voltage gated channel, Shaw-related subfamily, member 2
decreases expression
ISO
Ketamine results in decreased expression of KCNC2 mRNA
CTD
PMID:20080153
NCBI chr10:112,105,803...112,302,209
Ensembl chr10:112,107,026...112,302,929
G
Kcng1
potassium voltage-gated channel, subfamily G, member 1
decreases expression
ISO
Ketamine results in decreased expression of KCNG1 mRNA
CTD
PMID:20080153
NCBI chr 2:168,102,037...168,123,453
Ensembl chr 2:168,102,037...168,123,656
G
Kcnip2
Kv channel-interacting protein 2
increases expression
ISO
Ketamine results in increased expression of KCNIP2 mRNA
CTD
PMID:20080153
NCBI chr19:45,780,785...45,804,948
Ensembl chr19:45,780,278...45,804,500
G
Kcnj14
potassium inwardly-rectifying channel, subfamily J, member 14
decreases expression
ISO
Ketamine results in decreased expression of KCNJ14 mRNA
CTD
PMID:20080153
NCBI chr 7:45,465,871...45,474,180
Ensembl chr 7:45,465,884...45,474,206
G
Kcns3
potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3
decreases expression
ISO
Ketamine results in decreased expression of KCNS3 mRNA
CTD
PMID:20080153
NCBI chr12:11,140,738...11,201,186
Ensembl chr12:11,140,203...11,201,057
G
Kif11
kinesin family member 11
decreases expression
ISO
Ketamine results in decreased expression of KIF11 mRNA
CTD
PMID:20080153
NCBI chr19:37,364,830...37,410,311
Ensembl chr19:37,364,851...37,410,307
G
Kif20a
kinesin family member 20A
decreases expression
ISO
Ketamine results in decreased expression of KIF20A mRNA
CTD
PMID:20080153
NCBI chr18:34,757,677...34,766,330
Ensembl chr18:34,757,666...34,766,330
G
Klf15
Kruppel-like transcription factor 15
increases expression
ISO
Ketamine results in increased expression of KLF15 mRNA
CTD
PMID:20080153
NCBI chr 6:90,437,785...90,468,785
Ensembl chr 6:90,439,558...90,452,220
G
Klf6
Kruppel-like transcription factor 6
decreases expression
ISO
Ketamine results in decreased expression of KLF6 mRNA
CTD
PMID:20080153
NCBI chr13:5,911,488...5,920,392
Ensembl chr13:5,911,481...5,920,393
G
Klf9
Kruppel-like transcription factor 9
increases expression
ISO
Ketamine results in increased expression of KLF9 mRNA
CTD
PMID:20080153
NCBI chr19:23,118,590...23,145,493
Ensembl chr19:23,118,590...23,145,498
G
Klhdc1
kelch domain containing 1
decreases expression
ISO
Ketamine results in decreased expression of KLHDC1 mRNA
CTD
PMID:20080153
NCBI chr12:69,274,529...69,331,420
Ensembl chr12:69,287,950...69,331,406
G
Klhdc9
kelch domain containing 9
increases expression
ISO
Ketamine results in increased expression of KLHDC9 mRNA
CTD
PMID:20080153
NCBI chr 1:171,186,017...171,188,366
Ensembl chr 1:171,186,014...171,188,366
G
Klhl24
kelch-like 24
decreases expression
ISO
Ketamine results in decreased expression of KLHL24 mRNA
CTD
PMID:20080153
NCBI chr16:19,916,286...19,947,976
Ensembl chr16:19,916,292...19,947,971
G
Klhl7
kelch-like 7
decreases expression
ISO
Ketamine results in decreased expression of KLHL7 mRNA
CTD
PMID:20080153
NCBI chr 5:24,305,563...24,368,363
Ensembl chr 5:24,305,603...24,365,790
G
Klhl8
kelch-like 8
decreases expression
ISO
Ketamine results in decreased expression of KLHL8 mRNA
CTD
PMID:20080153
NCBI chr 5:104,009,916...104,059,137
Ensembl chr 5:104,009,839...104,059,125
G
Klhl9
kelch-like 9
decreases expression
ISO
Ketamine results in decreased expression of KLHL9 mRNA
CTD
PMID:20080153
NCBI chr 4:88,636,529...88,640,745
Ensembl chr 4:88,636,529...88,640,702
G
Kmt5a
lysine methyltransferase 5A
decreases expression
ISO
Ketamine results in decreased expression of KMT5A mRNA
CTD
PMID:20080153
NCBI chr 5:124,577,980...124,600,371
Ensembl chr 5:124,577,993...124,600,371
G
Kng1
kininogen 1
multiple interactions
EXP
Ketamine inhibits the reaction [KNG1 protein results in increased expression of OCLN protein]
CTD
PMID:27638051
NCBI chr16:22,876,970...22,900,828
Ensembl chr16:22,876,615...22,900,828
G
Knstrn
kinetochore-localized astrin/SPAG5 binding
decreases expression
ISO
Ketamine results in decreased expression of KNSTRN mRNA
CTD
PMID:20080153
NCBI chr 2:118,644,470...118,667,691
Ensembl chr 2:118,644,484...118,684,438
G
Kpna2
karyopherin subunit alpha 2
decreases expression
ISO
Ketamine results in decreased expression of KPNA2 mRNA
CTD
PMID:20080153
NCBI chr11:106,879,455...106,890,351
Ensembl chr11:106,879,455...106,890,367
G
Kpnb1
karyopherin subunit beta 1
decreases expression
ISO
Ketamine results in decreased expression of KPNB1 mRNA
CTD
PMID:20080153
NCBI chr11:97,050,536...97,078,718
Ensembl chr11:97,050,540...97,078,707
G
Ktn1
kinectin 1
decreases expression
ISO
Ketamine results in decreased expression of KTN1 mRNA
CTD
PMID:20080153
NCBI chr14:47,886,551...47,974,021
Ensembl chr14:47,885,905...47,977,351
G
Lamb1
laminin B1
decreases expression
ISO
Ketamine results in decreased expression of LAMB1 mRNA
CTD
PMID:20080153
NCBI chr12:31,315,230...31,379,643
Ensembl chr12:31,315,233...31,379,643
G
Lamp5
lysosomal-associated membrane protein family, member 5
increases expression
ISO
Ketamine results in increased expression of LAMP5 mRNA
CTD
PMID:20080153
NCBI chr 2:135,893,945...135,911,837
Ensembl chr 2:135,894,159...135,911,837
G
Laptm4b
lysosomal-associated protein transmembrane 4B
increases expression
ISO
Ketamine results in increased expression of LAPTM4B mRNA
CTD
PMID:20080153
NCBI chr15:34,238,279...34,284,448
Ensembl chr15:34,238,174...34,284,448
G
Laptm5
lysosomal-associated protein transmembrane 5
increases expression
ISO
Ketamine results in increased expression of LAPTM5 mRNA
CTD
PMID:20080153
NCBI chr 4:130,640,627...130,663,459
Ensembl chr 4:130,640,436...130,663,452
G
Lbp
lipopolysaccharide binding protein
multiple interactions
ISO
Ketamine inhibits the reaction [Lipopolysaccharides binds to LBP protein]
CTD
PMID:19540866
NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772
G
Lcn2
lipocalin 2
multiple interactions
EXP
[Ketamine co-treated with Xylazine] results in decreased secretion of LCN2 protein
CTD
PMID:30538007
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Ldhb
lactate dehydrogenase B
decreases expression
ISO
Ketamine results in decreased expression of LDHB protein
CTD
PMID:18504422
NCBI chr 6:142,435,975...142,453,683
Ensembl chr 6:142,435,975...142,453,683
G
Leng8
leukocyte receptor cluster (LRC) member 8
decreases expression
ISO
Ketamine results in decreased expression of LENG8 mRNA
CTD
PMID:20080153
NCBI chr 7:4,140,014...4,151,176
Ensembl chr 7:4,140,038...4,151,176
G
Lep
leptin
multiple interactions decreases expression
ISO
LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in decreased expression of BCL2 protein]]; LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased cleavage of CASP3 protein]]; LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased expression of DDIT3 protein]]; LEP protein promotes the reaction [lipoxin A4 methyl ester inhibits the reaction [Ketamine results in increased expression of HSPA5 protein]]; lipoxin A4 methyl ester inhibits the reaction [Ketamine results in decreased expression of LEP protein]
CTD
PMID:36907275
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lepr
leptin receptor
multiple interactions decreases expression
ISO
lipoxin A4 methyl ester inhibits the reaction [Ketamine results in decreased expression of LEPR protein]
CTD
PMID:36907275
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
G
Lgals3bp
lectin, galactoside-binding, soluble, 3 binding protein
increases expression
ISO
Ketamine results in increased expression of LGALS3BP mRNA
CTD
PMID:20080153
NCBI chr11:118,283,573...118,292,787
Ensembl chr11:118,283,577...118,292,918
G
Lgi4
leucine-rich repeat LGI family, member 4
increases expression
ISO
Ketamine results in increased expression of LGI4 mRNA
CTD
PMID:20080153
NCBI chr 7:30,758,360...30,770,347
Ensembl chr 7:30,758,767...30,770,360
G
Lin7b
lin-7 homolog B, crumbs cell polarity complex component
increases expression
ISO
Ketamine results in increased expression of LIN7B mRNA
CTD
PMID:20080153
NCBI chr 7:45,017,315...45,019,988
Ensembl chr 7:45,017,315...45,020,007
G
Lix1l
Lix1-like
decreases expression
ISO
Ketamine results in decreased expression of LIX1L mRNA
CTD
PMID:20080153
NCBI chr 3:96,508,449...96,532,668
Ensembl chr 3:96,508,465...96,533,487
G
Lmbr1
limb region 1
increases expression
ISO
Ketamine results in increased expression of LMBR1 mRNA
CTD
PMID:20080153
NCBI chr 5:29,434,800...29,583,414
Ensembl chr 5:29,481,000...29,485,295 Ensembl chr 5:29,481,000...29,485,295
G
Lmcd1
LIM and cysteine-rich domains 1
increases expression
ISO
Ketamine results in increased expression of LMCD1 mRNA
CTD
PMID:20080153
NCBI chr 6:112,250,747...112,307,384
Ensembl chr 6:112,250,719...112,307,386
G
Lrpap1
low density lipoprotein receptor-related protein associated protein 1
increases expression
ISO
Ketamine results in increased expression of LRPAP1 mRNA
CTD
PMID:20080153
NCBI chr 5:35,248,834...35,263,043
Ensembl chr 5:35,248,845...35,263,110
G
Lrrc42
leucine rich repeat containing 42
decreases expression
ISO
Ketamine results in decreased expression of LRRC42 mRNA
CTD
PMID:20080153
NCBI chr 4:107,090,711...107,110,730
Ensembl chr 4:107,090,711...107,110,729
G
Lrrc55
leucine rich repeat containing 55
decreases expression
ISO
Ketamine results in decreased expression of LRRC55 mRNA
CTD
PMID:20080153
NCBI chr 2:85,018,411...85,029,110
Ensembl chr 2:84,992,678...85,027,541
G
Lsm10
U7 snRNP-specific Sm-like protein LSM10
decreases expression
ISO
Ketamine results in decreased expression of LSM10 mRNA
CTD
PMID:20080153
NCBI chr 4:125,990,350...125,992,375
Ensembl chr 4:125,990,416...125,992,377
G
Luc7l
Luc7-like
decreases expression
ISO
Ketamine results in decreased expression of LUC7L mRNA
CTD
PMID:20080153
NCBI chr17:26,471,874...26,504,484
Ensembl chr17:26,471,870...26,504,478
G
Lypd3
Ly6/Plaur domain containing 3
decreases expression
ISO
Ketamine results in decreased expression of LYPD3 mRNA
CTD
PMID:20080153
NCBI chr 7:24,335,995...24,340,543
Ensembl chr 7:24,335,975...24,340,543
G
Mal
myelin and lymphocyte protein, T cell differentiation protein
increases expression
ISO
Ketamine results in increased expression of MAL mRNA
CTD
PMID:20080153
NCBI chr 2:127,475,146...127,498,615
Ensembl chr 2:127,475,146...127,498,615
G
Man2b1
mannosidase 2, alpha B1
increases expression
ISO
Ketamine results in increased expression of MAN2B1 mRNA
CTD
PMID:20080153
NCBI chr 8:85,809,941...85,824,215
Ensembl chr 8:85,809,899...85,824,911
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
decreases expression
ISO EXP
Ketamine results in decreased expression of MANF mRNA
CTD
PMID:20080153 PMID:35728656
NCBI chr 9:106,765,952...106,769,137
Ensembl chr 9:106,715,511...106,769,178
G
Map1b
microtubule-associated protein 1B
decreases expression
ISO
Ketamine results in decreased expression of MAP1B mRNA
CTD
PMID:20080153
NCBI chr13:99,557,972...99,653,110
Ensembl chr13:99,557,954...99,653,048
G
Map2k1
mitogen-activated protein kinase kinase 1
multiple interactions
EXP
Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAP2K1 protein]
CTD
PMID:19540866
NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913
G
Map2k2
mitogen-activated protein kinase kinase 2
multiple interactions
EXP
Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of MAP2K2 protein]
CTD
PMID:19540866
NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809
G
Map6
microtubule-associated protein 6
increases expression
ISO
Ketamine results in increased expression of MAP6 mRNA
CTD
PMID:20080153
NCBI chr 7:98,916,270...98,986,344
Ensembl chr 7:98,916,654...98,986,344
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions
EXP
Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
CTD
PMID:19540866
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions
EXP
Ketamine inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]
CTD
PMID:19540866
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk7
mitogen-activated protein kinase 7
decreases expression
ISO
Ketamine results in decreased expression of MAPK7 mRNA
CTD
PMID:20080153
NCBI chr11:61,379,638...61,385,101
Ensembl chr11:61,379,638...61,385,232
G
Mapt
microtubule-associated protein tau
increases phosphorylation multiple interactions
EXP
Ketamine results in increased phosphorylation of MAPT protein MAPT protein affects the reaction [Ketamine results in decreased expression of GRIA1 protein]; MAPT protein affects the reaction [Ketamine results in decreased expression of GRIA2 protein]
CTD
PMID:20093173 PMID:31470060
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
G
Marf1
meiosis regulator and mRNA stability 1
decreases expression
ISO
Ketamine results in decreased expression of MARF1 mRNA
CTD
PMID:20080153
NCBI chr16:13,927,030...13,977,157
Ensembl chr16:13,927,037...13,981,215
G
Mas1
MAS1 oncogene
decreases expression
ISO
Ketamine results in decreased expression of MAS1 mRNA
CTD
PMID:20080153
NCBI chr17:13,056,981...13,087,037
Ensembl chr17:13,059,966...13,087,030
G
Matk
megakaryocyte-associated tyrosine kinase
increases expression
ISO
Ketamine results in increased expression of MATK mRNA
CTD
PMID:20080153
NCBI chr10:81,088,769...81,098,819
Ensembl chr10:81,088,769...81,099,199
G
Mavs
mitochondrial antiviral signaling protein
decreases expression
ISO
Ketamine results in decreased expression of MAVS mRNA
CTD
PMID:20080153
NCBI chr 2:131,075,445...131,089,945
Ensembl chr 2:131,075,983...131,089,945
G
Mbp
myelin basic protein
increases expression
ISO
Ketamine results in increased expression of MBP mRNA
CTD
PMID:20080153
NCBI chr18:82,492,883...82,603,762
Ensembl chr18:82,493,271...82,603,762
G
Mcm3
minichromosome maintenance complex component 3
decreases expression
ISO
Ketamine results in decreased expression of MCM3 mRNA
CTD
PMID:20080153
NCBI chr 1:20,873,188...20,890,536
Ensembl chr 1:20,873,192...20,890,536
G
Mcu
mitochondrial calcium uniporter
decreases expression
ISO
Ketamine results in decreased expression of MCU mRNA
CTD
PMID:20080153
NCBI chr10:59,282,806...59,453,231
Ensembl chr10:59,282,806...59,452,514
G
Mettl16
methyltransferase 16, N6-methyladenosine
decreases expression
ISO
Ketamine results in decreased expression of METTL16 mRNA
CTD
PMID:20080153
NCBI chr11:74,661,658...74,716,649
Ensembl chr11:74,661,656...74,719,351
G
Mettl25b
methyltransferase like 25B
increases expression
ISO
Ketamine results in increased expression of METTL25B mRNA
CTD
PMID:20080153
NCBI chr 3:87,829,908...87,838,337
Ensembl chr 3:87,829,908...87,838,024
G
Mettl3
methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit
decreases expression
ISO
Ketamine results in decreased expression of METTL3 mRNA
CTD
PMID:20080153
NCBI chr14:52,532,298...52,548,555
Ensembl chr14:52,532,298...52,542,585
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
ISO
Ketamine results in increased expression of MFSD2A mRNA
CTD
PMID:20080153
NCBI chr 4:122,840,643...122,855,844
Ensembl chr 4:122,840,643...122,854,981
G
Mgst2
microsomal glutathione S-transferase 2
increases expression
ISO
Ketamine results in increased expression of MGST2 mRNA
CTD
PMID:20080153
NCBI chr 3:51,544,179...51,590,096
Ensembl chr 3:51,567,781...51,590,098
G
Mib1
MIB E3 ubiquitin protein ligase 1
increases expression
ISO
Ketamine results in increased expression of MIB1 mRNA
CTD
PMID:20080153
NCBI chr18:10,725,523...10,822,969
Ensembl chr18:10,725,548...10,818,704
G
Mical1
microtubule associated monooxygenase, calponin and LIM domain containing 1
decreases expression
ISO
Ketamine results in decreased expression of MICAL1 mRNA
CTD
PMID:20080153
NCBI chr10:41,351,693...41,363,026
Ensembl chr10:41,352,310...41,363,028
G
Mif4gd
MIF4G domain containing
increases expression
ISO
Ketamine results in increased expression of MIF4GD mRNA
CTD
PMID:20080153
NCBI chr11:115,498,744...115,503,795
Ensembl chr11:115,498,744...115,503,795
G
Mis12
MIS12 kinetochore complex component
decreases expression
ISO
Ketamine results in decreased expression of MIS12 mRNA
CTD
PMID:20080153
NCBI chr11:70,910,394...70,918,197
Ensembl chr11:70,910,437...70,918,197
G
Mis18a
MIS18 kinetochore protein A
decreases expression
ISO
Ketamine results in decreased expression of MIS18A mRNA
CTD
PMID:20080153
NCBI chr16:90,516,200...90,524,259
Ensembl chr16:90,516,200...90,524,292
G
Mki67
antigen identified by monoclonal antibody Ki 67
increases expression
ISO
Ketamine results in increased expression of MKI67 protein
CTD
PMID:19919587
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Mkks
McKusick-Kaufman syndrome
decreases expression
ISO
Ketamine results in decreased expression of MKKS mRNA
CTD
PMID:20080153
NCBI chr 2:136,715,700...136,733,422
Ensembl chr 2:136,715,700...136,733,309
G
Mllt3
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3
decreases expression
ISO
Ketamine results in decreased expression of MLLT3 mRNA
CTD
PMID:20080153
NCBI chr 4:87,688,162...87,951,652
Ensembl chr 4:87,688,162...87,951,601
G
Mmd2
monocyte to macrophage differentiation-associated 2
increases expression
ISO
Ketamine results in increased expression of MMD2 mRNA
CTD
PMID:20080153
NCBI chr 5:142,549,229...142,594,886
Ensembl chr 5:142,548,113...142,594,555
G
Mmp14
matrix metallopeptidase 14 (membrane-inserted)
decreases expression
ISO
Ketamine results in decreased expression of MMP14 mRNA
CTD
PMID:20080153
NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821
G
Mog
myelin oligodendrocyte glycoprotein
increases expression
ISO
Ketamine results in increased expression of MOG mRNA
CTD
PMID:20080153
NCBI chr17:37,321,632...37,334,290
Ensembl chr17:37,321,635...37,334,290
G
Mon1a
MON1 homolog A, secretory traffciking associated
decreases expression
ISO
Ketamine results in decreased expression of MON1A mRNA
CTD
PMID:20080153
NCBI chr 9:107,765,282...107,780,338
Ensembl chr 9:107,765,350...107,780,338
G
Morn2
MORN repeat containing 2
increases expression
ISO
Ketamine results in increased expression of MORN2 mRNA
CTD
PMID:20080153
NCBI chr17:80,597,626...80,613,130
Ensembl chr17:80,597,632...80,604,905
G
Mras
muscle and microspikes RAS
increases expression
ISO
Ketamine results in increased expression of MRAS mRNA
CTD
PMID:20080153
NCBI chr 9:99,267,473...99,319,505
Ensembl chr 9:99,267,473...99,319,434
G
Mrpl18
mitochondrial ribosomal protein L18
decreases expression
ISO
Ketamine results in decreased expression of MRPL18 mRNA
CTD
PMID:20080153
NCBI chr17:13,130,232...13,136,674
Ensembl chr17:13,130,236...13,135,232
G
Mrpl50
mitochondrial ribosomal protein L50
decreases expression
ISO
Ketamine results in decreased expression of MRPL50 mRNA
CTD
PMID:20080153
NCBI chr 4:49,512,597...49,521,083
Ensembl chr 4:49,512,596...49,521,093
G
Mrps15
mitochondrial ribosomal protein S15
increases expression
ISO
Ketamine results in increased expression of MRPS15 mRNA
CTD
PMID:20080153
NCBI chr 4:125,940,721...125,949,329
Ensembl chr 4:125,940,718...125,949,325
G
Ms4a6c
membrane-spanning 4-domains, subfamily A, member 6C
increases expression
ISO
Ketamine results in increased expression of MS4A6A mRNA
CTD
PMID:20080153
NCBI chr19:11,446,718...11,464,433
Ensembl chr19:11,446,730...11,459,556
G
Msantd3
Myb/SANT-like DNA-binding domain containing 3
increases expression
ISO
Ketamine results in increased expression of MSANTD3 mRNA
CTD
PMID:20080153
NCBI chr 4:48,539,532...48,565,892
Ensembl chr 4:48,539,935...48,561,919
G
Msmo1
methylsterol monoxygenase 1
decreases expression
ISO
Ketamine results in decreased expression of MSMO1 mRNA
CTD
PMID:20080153
NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826
G
Mtcl3
MTCL family member 3
decreases expression
ISO
Ketamine results in decreased expression of MTCL3 mRNA
CTD
PMID:20080153
NCBI chr10:29,019,992...29,075,626
Ensembl chr10:29,019,835...29,075,626
G
Mterf2
mitochondrial transcription termination factor 2
decreases expression
ISO
Ketamine results in decreased expression of MTERF2 mRNA
CTD
PMID:20080153
NCBI chr10:84,951,092...84,963,982
Ensembl chr10:84,955,297...84,963,891
G
Mtg2
mitochondrial ribosome associated GTPase 2
decreases expression
ISO
Ketamine results in decreased expression of MTG2 mRNA
CTD
PMID:20080153
NCBI chr 2:179,712,366...179,727,695
Ensembl chr 2:179,712,381...179,727,695
G
Myc
myelocytomatosis oncogene
decreases expression
ISO
Ketamine results in decreased expression of MYC mRNA
CTD
PMID:20080153
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Mycn
v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived
decreases expression
ISO
Ketamine results in decreased expression of MYCN mRNA
CTD
PMID:20080153
NCBI chr12:12,986,094...12,991,837
Ensembl chr12:12,986,094...12,991,915
G
Myo19
myosin XIX
decreases expression
ISO
Ketamine results in decreased expression of MYO19 mRNA
CTD
PMID:20080153
NCBI chr11:84,770,996...84,802,052
Ensembl chr11:84,770,974...84,802,052
G
Naa35
N(alpha)-acetyltransferase 35, NatC auxiliary subunit
decreases expression
ISO
Ketamine results in decreased expression of MAK10 mRNA
CTD
PMID:20080153
NCBI chr13:59,733,147...59,782,612
Ensembl chr13:59,733,073...59,783,736
G
Nab1
Ngfi-A binding protein 1
decreases expression
ISO
Ketamine results in decreased expression of NAB1 mRNA
CTD
PMID:20080153
NCBI chr 1:52,494,146...52,539,553
Ensembl chr 1:52,496,453...52,539,838
G
Nabp1
nucleic acid binding protein 1
decreases expression
ISO
Ketamine results in decreased expression of NABP1 mRNA
CTD
PMID:20080153
NCBI chr 1:51,504,127...51,517,634
Ensembl chr 1:51,505,021...51,517,584
G
Nav3
neuron navigator 3
decreases expression
ISO
Ketamine results in decreased expression of NAV3 mRNA
CTD
PMID:20080153
NCBI chr10:109,517,121...110,292,148
Ensembl chr10:109,517,120...110,292,065
G
Ncdn
neurochondrin
increases expression
ISO
Ketamine results in increased expression of NCDN mRNA
CTD
PMID:20080153
NCBI chr 4:126,637,548...126,647,203
Ensembl chr 4:126,637,543...126,647,231
G
Nckap1l
NCK associated protein 1 like
decreases expression multiple interactions
ISO
Ketamine results in decreased expression of NCKAP1L mRNA Cannabidiol inhibits the reaction [Ketamine results in decreased expression of NCKAP1L mRNA]
CTD
PMID:31823199
NCBI chr15:103,362,219...103,411,288
Ensembl chr15:103,362,221...103,407,237
G
Ndrg2
N-myc downstream regulated gene 2
increases expression
ISO
Ketamine results in increased expression of NDRG2 mRNA
CTD
PMID:20080153
NCBI chr14:52,142,738...52,151,463
Ensembl chr14:52,142,728...52,151,615
G
Ndufs1
NADH:ubiquinone oxidoreductase core subunit S1
decreases expression
ISO
Ketamine results in decreased expression of NDUFS1 protein
CTD
PMID:18504422
NCBI chr 1:63,182,751...63,215,981
Ensembl chr 1:63,182,755...63,215,992
G
Nectin3
nectin cell adhesion molecule 3
decreases expression
ISO
Ketamine results in decreased expression of NECTIN3 mRNA
CTD
PMID:20080153
NCBI chr16:46,208,028...46,318,898
Ensembl chr16:46,208,069...46,318,888
G
Nefl
neurofilament, light polypeptide
decreases expression increases expression
ISO
Ketamine results in decreased expression of NEFL protein Ketamine results in increased expression of NEFL mRNA
CTD
PMID:18504422 PMID:20080153
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
G
Nes
nestin
decreases expression
ISO
Ketamine results in decreased expression of NES mRNA
CTD
PMID:20080153
NCBI chr 3:87,878,400...87,887,758
Ensembl chr 3:87,878,385...87,887,758
G
Neurod6
neurogenic differentiation 6
decreases expression
ISO
Ketamine results in decreased expression of NEUROD6 mRNA
CTD
PMID:20080153
NCBI chr 6:55,654,803...55,658,248
Ensembl chr 6:55,654,807...55,658,248
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
multiple interactions decreases expression
ISO
Curcumin inhibits the reaction [Ketamine results in decreased expression of NFE2L2 mRNA]; Curcumin inhibits the reaction [Ketamine results in decreased expression of NFE2L2 protein modified form]; Curcumin inhibits the reaction [Ketamine results in decreased expression of NFE2L2 protein] Ketamine results in decreased expression of NFE2L2 mRNA; Ketamine results in decreased expression of NFE2L2 protein; Ketamine results in decreased expression of NFE2L2 protein modified form
CTD
PMID:36305173
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfe2l3
nuclear factor, erythroid derived 2, like 3
decreases expression
ISO
Ketamine results in decreased expression of NFE2L3 mRNA
CTD
PMID:20080153
NCBI chr 6:51,409,649...51,435,752
Ensembl chr 6:51,409,650...51,435,748
G
Nfil3
nuclear factor, interleukin 3, regulated
decreases expression
ISO
Ketamine results in decreased expression of NFIL3 mRNA
CTD
PMID:20080153
NCBI chr13:53,121,245...53,136,914
Ensembl chr13:53,121,245...53,135,109
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
increases expression multiple interactions increases phosphorylation
ISO
Ketamine results in increased expression of NFKBIA mRNA TRPV4 protein affects the reaction [Ketamine results in increased phosphorylation of NFKBIA protein]
CTD
PMID:20080153 PMID:33536391
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Ngf
nerve growth factor
multiple interactions
ISO
Ketamine inhibits the reaction [Pilocarpine results in increased expression of NGF mRNA]
CTD
PMID:8635431
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Nif3l1
Ngg1 interacting factor 3-like 1 (S. pombe)
decreases expression
ISO
Ketamine results in decreased expression of NIF3L1 mRNA
CTD
PMID:20080153
NCBI chr 1:58,484,310...58,501,435
Ensembl chr 1:58,484,310...58,520,975
G
Nkiras1
NFKB inhibitor interacting Ras-like protein 1
increases expression
ISO
Ketamine results in increased expression of NKIRAS1 mRNA
CTD
PMID:20080153
NCBI chr14:4,185,693...4,198,560
Ensembl chr14:4,185,693...4,198,560
G
Nkx6-2
NK6 homeobox 2
increases expression
ISO
Ketamine results in increased expression of NKX6-2 mRNA
CTD
PMID:20080153
NCBI chr 7:139,159,292...139,162,726
Ensembl chr 7:139,159,292...139,162,713
G
Nln
neurolysin (metallopeptidase M3 family)
decreases expression
ISO
Ketamine results in decreased expression of NLN mRNA
CTD
PMID:20080153
NCBI chr13:104,159,558...104,246,170
Ensembl chr13:104,159,565...104,246,122
G
Nmb
neuromedin B
increases expression
ISO
Ketamine results in increased expression of NMB mRNA
CTD
PMID:20080153
NCBI chr 7:80,551,975...80,554,810
Ensembl chr 7:80,551,975...80,554,824
G
Nme6
NME/NM23 nucleoside diphosphate kinase 6
decreases expression
ISO
Ketamine results in decreased expression of NME6 mRNA
CTD
PMID:20080153
NCBI chr 9:109,661,830...109,672,042
Ensembl chr 9:109,661,817...109,672,184
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
Ketamine results in decreased expression of NNT mRNA
CTD
PMID:20080153
NCBI chr13:119,472,063...119,545,793
Ensembl chr13:119,471,984...119,545,533 Ensembl chr13:119,471,984...119,545,533
G
Nol4
nucleolar protein 4
decreases expression
ISO
Ketamine results in decreased expression of NOL4 mRNA
CTD
PMID:20080153
NCBI chr18:22,826,209...23,174,926
Ensembl chr18:22,826,238...23,174,710
G
Nova2
NOVA alternative splicing regulator 2
decreases expression
ISO
Ketamine results in decreased expression of NOVA2 mRNA
CTD
PMID:20080153
NCBI chr 7:18,659,319...18,699,244
Ensembl chr 7:18,659,813...18,699,244
G
Npm3
nucleoplasmin 3
decreases expression
ISO
Ketamine results in decreased expression of NPM3 mRNA
CTD
PMID:20080153
NCBI chr19:45,736,173...45,738,004
Ensembl chr19:45,736,173...45,738,030
G
Nppc
natriuretic peptide type C
decreases expression
ISO
Ketamine results in decreased expression of NPPC mRNA
CTD
PMID:20080153
NCBI chr 1:86,594,015...86,598,295
Ensembl chr 1:86,594,013...86,598,293
G
Npy
neuropeptide Y
increases response to substance
EXP
NPY protein results in increased susceptibility to Ketamine
CTD
PMID:11454027
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Npy1r
neuropeptide Y receptor Y1
decreases expression
ISO
Ketamine results in decreased expression of NPY1R mRNA
CTD
PMID:20080153
NCBI chr 8:67,149,595...67,159,452
Ensembl chr 8:67,149,844...67,159,444
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
multiple interactions decreases expression
ISO
Curcumin inhibits the reaction [Ketamine results in decreased expression of NQO1 mRNA]; Curcumin inhibits the reaction [Ketamine results in decreased expression of NQO1 protein] Ketamine results in decreased expression of NQO1 mRNA; Ketamine results in decreased expression of NQO1 protein
CTD
PMID:36305173
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
increases expression
ISO
Ketamine results in increased expression of NR1D1 mRNA
CTD
PMID:20080153
NCBI chr11:98,658,758...98,666,233
Ensembl chr11:98,658,758...98,666,159
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
decreases expression
ISO
Ketamine results in decreased expression of NR4A2 mRNA
CTD
PMID:20080153
NCBI chr 2:56,996,845...57,014,152
Ensembl chr 2:56,996,842...57,014,015
G
Nr4a3
nuclear receptor subfamily 4, group A, member 3
decreases expression
ISO
Ketamine results in decreased expression of NR4A3 mRNA
CTD
PMID:20080153
NCBI chr 4:48,045,098...48,086,446
Ensembl chr 4:48,045,153...48,086,447
G
Nradd
neurotrophin receptor associated death domain
decreases expression
ISO
Ketamine results in decreased expression of NRADD mRNA
CTD
PMID:20080153
NCBI chr 9:110,450,203...110,453,461
Ensembl chr 9:110,450,203...110,453,520
G
Nrde2
nrde-2 necessary for RNA interference, domain containing
increases expression
ISO
Ketamine results in increased expression of NRDE2 mRNA
CTD
PMID:20080153
NCBI chr12:100,091,709...100,126,981
Ensembl chr12:100,091,711...100,125,912
G
Nrep
neuronal regeneration related protein
decreases expression
ISO
Ketamine results in decreased expression of NREP mRNA
CTD
PMID:20080153
NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
G
Nrg1
neuregulin 1
decreases expression
EXP
Ketamine results in decreased expression of NRG1 mRNA
CTD
PMID:20000043
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Nrgn
neurogranin
increases expression
ISO
Ketamine results in increased expression of NRGN mRNA
CTD
PMID:20080153
NCBI chr 9:37,455,789...37,464,041
Ensembl chr 9:37,455,788...37,464,200
G
Nrip3
nuclear receptor interacting protein 3
decreases expression
ISO
Ketamine results in decreased expression of NRIP3 mRNA
CTD
PMID:20080153
NCBI chr 7:109,357,263...109,380,752
Ensembl chr 7:109,357,262...109,381,232
G
Nsf
N-ethylmaleimide sensitive fusion protein
increases expression
ISO
Ketamine results in increased expression of NSF mRNA
CTD
PMID:20080153
NCBI chr11:103,712,608...103,844,882
Ensembl chr11:103,712,608...103,844,882
G
Nsmce2
NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase
decreases expression
ISO
Ketamine results in decreased expression of NSMCE2 mRNA
CTD
PMID:20080153
NCBI chr15:59,246,047...59,473,538
Ensembl chr15:59,246,096...59,473,533
G
Nt5c2
5'-nucleotidase, cytosolic II
increases expression
ISO
Ketamine results in increased expression of NT5C2 mRNA
CTD
PMID:20080153
NCBI chr19:46,873,829...47,003,613
Ensembl chr19:46,871,756...47,003,592
G
Ntf3
neurotrophin 3
decreases expression
ISO
Ketamine results in decreased expression of NTF3 mRNA
CTD
PMID:20080153
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
G
Ntrk1
neurotrophic tyrosine kinase, receptor, type 1
increases expression
ISO
Ketamine results in increased expression of NTRK1 mRNA
CTD
PMID:20080153
NCBI chr 3:87,685,551...87,702,549
Ensembl chr 3:87,685,551...87,702,469
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
multiple interactions
ISO EXP
Ketamine inhibits the reaction [Pilocarpine results in increased expression of NTRK2 mRNA] Ketamine inhibits the reaction [NTRK2 protein binds to AP2M1 protein]
CTD
PMID:8635431 PMID:31631060
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Nudt6
nudix hydrolase 6
increases expression
ISO
Ketamine results in increased expression of NUDT6 mRNA
CTD
PMID:20080153
NCBI chr 3:37,459,126...37,474,391
Ensembl chr 3:37,459,059...37,474,360
G
Nup205
nucleoporin 205
decreases expression
ISO
Ketamine results in decreased expression of NUP205 mRNA
CTD
PMID:20080153
NCBI chr 6:35,154,551...35,224,534
Ensembl chr 6:35,154,356...35,224,531
G
Nup35
nucleoporin 35
decreases expression
ISO
Ketamine results in decreased expression of NUP35 mRNA
CTD
PMID:20080153
NCBI chr 2:80,469,156...80,490,415
Ensembl chr 2:80,447,580...80,489,250
G
Nup42
nucleoporin 42
increases expression
ISO
Ketamine results in increased expression of NUP42 mRNA
CTD
PMID:20080153
NCBI chr 5:24,369,961...24,389,011
Ensembl chr 5:24,369,961...24,389,011
G
Nup58
nucleoporin 58
decreases expression
ISO
Ketamine results in decreased expression of NUP58 mRNA
CTD
PMID:20080153
NCBI chr14:60,442,733...60,488,951
Ensembl chr14:60,422,061...60,488,880 Ensembl chr14:60,422,061...60,488,880
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
ISO
Ketamine results in decreased expression of NUSAP1 mRNA
CTD
PMID:20080153
NCBI chr 2:119,449,205...119,480,646
Ensembl chr 2:119,448,779...119,481,725
G
Ocln
occludin
multiple interactions
EXP
Ketamine inhibits the reaction [KNG1 protein results in increased expression of OCLN protein]
CTD
PMID:27638051
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
G
Oplah
5-oxoprolinase (ATP-hydrolysing)
increases expression
ISO
Ketamine results in increased expression of OPLAH mRNA
CTD
PMID:20080153
NCBI chr15:76,180,803...76,215,381
Ensembl chr15:76,180,801...76,212,215
G
Orc4
origin recognition complex, subunit 4
increases expression
ISO
Ketamine results in increased expression of ORC4 mRNA
CTD
PMID:20080153
NCBI chr 2:48,792,836...48,840,287
Ensembl chr 2:48,792,836...48,840,289
G
Ormdl3
ORM1-like 3 (S. cerevisiae)
increases expression
ISO
Ketamine results in increased expression of ORMDL3 mRNA
CTD
PMID:20080153
NCBI chr11:98,472,120...98,478,071
Ensembl chr11:98,472,082...98,478,194
G
Oxsr1
oxidative-stress responsive 1
decreases expression
ISO
Ketamine results in decreased expression of OXSR1 mRNA
CTD
PMID:20080153
NCBI chr 9:119,067,498...119,154,475
Ensembl chr 9:119,067,498...119,151,493
G
P2rx6
purinergic receptor P2X, ligand-gated ion channel, 6
increases expression
ISO
Ketamine results in increased expression of P2RX6 mRNA
CTD
PMID:20080153
NCBI chr16:17,379,749...17,389,879
Ensembl chr16:17,379,749...17,395,664
G
P4ha1
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha 1 polypeptide
decreases expression
ISO
Ketamine results in decreased expression of P4HA1 mRNA
CTD
PMID:20080153
NCBI chr10:59,159,019...59,209,126
Ensembl chr10:59,159,118...59,209,126
G
P4htm
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)
increases expression
ISO
Ketamine results in increased expression of P4HTM mRNA
CTD
PMID:20080153
NCBI chr 9:108,456,025...108,475,482
Ensembl chr 9:108,456,061...108,474,866
G
Pak5
p21 (RAC1) activated kinase 5
decreases expression
ISO
Ketamine results in decreased expression of PAK5 mRNA
CTD
PMID:20080153
NCBI chr 2:135,923,008...136,229,899
Ensembl chr 2:135,923,024...136,229,887
G
Pank1
pantothenate kinase 1
decreases expression
ISO
Ketamine results in decreased expression of PANK1 mRNA
CTD
PMID:20080153
NCBI chr19:34,784,335...34,862,420
Ensembl chr19:34,784,340...34,856,855
G
Papola
poly (A) polymerase alpha
decreases expression
ISO
Ketamine results in decreased expression of PAPOLA mRNA
CTD
PMID:20080153
NCBI chr12:105,750,926...105,805,208
Ensembl chr12:105,750,953...105,805,203
G
Pard6g
par-6 family cell polarity regulator gamma
decreases expression
ISO
Ketamine results in decreased expression of PARD6G mRNA
CTD
PMID:20080153
NCBI chr18:80,090,045...80,162,855
Ensembl chr18:80,090,105...80,162,854
G
Pbk
PDZ binding kinase
decreases expression
ISO
Ketamine results in decreased expression of PBK mRNA
CTD
PMID:20080153
NCBI chr14:66,043,337...66,055,271
Ensembl chr14:66,043,286...66,055,271
G
Pbx3
pre B cell leukemia homeobox 3
decreases expression
ISO
Ketamine results in decreased expression of PBX3 mRNA
CTD
PMID:20080153
NCBI chr 2:34,061,469...34,264,168
Ensembl chr 2:34,061,469...34,263,154
G
Pcgf6
polycomb group ring finger 6
decreases expression
ISO
Ketamine results in decreased expression of PCGF6 mRNA
CTD
PMID:20080153
NCBI chr19:47,022,056...47,039,379
Ensembl chr19:47,022,056...47,039,345
G
Pclaf
PCNA clamp associated factor
decreases expression
ISO
Ketamine results in decreased expression of PCLAF mRNA
CTD
PMID:20080153
NCBI chr 9:65,797,605...65,810,833
Ensembl chr 9:65,797,519...65,810,548
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
increases expression
ISO
Ketamine results in increased expression of PCSK2 mRNA
CTD
PMID:20080153
NCBI chr 2:143,388,053...143,658,204
Ensembl chr 2:143,388,076...143,658,205
G
Pde12
phosphodiesterase 12
increases expression
ISO
Ketamine results in increased expression of PDE12 mRNA
CTD
PMID:20080153
NCBI chr14:26,381,113...26,390,823
Ensembl chr14:26,381,113...26,391,038
G
Pdia2
protein disulfide isomerase associated 2
decreases expression
ISO
Ketamine results in decreased expression of PDIA2 mRNA
CTD
PMID:20080153
NCBI chr17:26,414,973...26,418,108
Ensembl chr17:26,414,973...26,418,061
G
Pdia4
protein disulfide isomerase associated 4
decreases expression
ISO
Ketamine results in decreased expression of PDIA4 mRNA
CTD
PMID:20080153
NCBI chr 6:47,773,075...47,790,446
Ensembl chr 6:47,773,075...47,790,364
G
Pdia5
protein disulfide isomerase associated 5
decreases expression
ISO
Ketamine results in decreased expression of PDIA5 mRNA
CTD
PMID:20080153
NCBI chr16:35,217,678...35,311,289
Ensembl chr16:35,217,682...35,311,243
G
Pdia6
protein disulfide isomerase associated 6
decreases expression
ISO
Ketamine results in decreased expression of PDIA6 mRNA
CTD
PMID:20080153
NCBI chr12:17,316,590...17,334,786
Ensembl chr12:17,316,546...17,334,771
G
Pdik1l
PDLIM1 interacting kinase 1 like
decreases expression
ISO
Ketamine results in decreased expression of PDIK1L mRNA
CTD
PMID:20080153
NCBI chr 4:134,002,313...134,015,157
Ensembl chr 4:134,002,313...134,015,206
G
Pdk2
pyruvate dehydrogenase kinase, isoenzyme 2
increases expression
ISO
Ketamine results in increased expression of PDK2 mRNA
CTD
PMID:20080153
NCBI chr11:94,917,084...94,932,197
Ensembl chr11:94,917,084...94,932,180
G
Pdlim7
PDZ and LIM domain 7
decreases expression
ISO
Ketamine results in decreased expression of PDLIM7 mRNA
CTD
PMID:20080153
NCBI chr13:55,645,300...55,661,281
Ensembl chr13:55,643,608...55,661,489
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
decreases expression
ISO
Ketamine results in decreased expression of PDP2 mRNA
CTD
PMID:20080153
NCBI chr 8:105,318,104...105,325,658
Ensembl chr 8:105,318,083...105,325,658
G
Pdrg1
p53 and DNA damage regulated 1
increases expression
ISO
Ketamine results in increased expression of PDRG1 mRNA
CTD
PMID:20080153
NCBI chr 2:152,850,810...152,857,939
Ensembl chr 2:152,850,810...152,857,347
G
Pef1
penta-EF hand domain containing 1
increases expression
ISO
Ketamine results in increased expression of PEF1 mRNA
CTD
PMID:20080153
NCBI chr 4:130,001,349...130,021,927
Ensembl chr 4:129,996,351...130,021,928
G
Per1
period circadian clock 1
increases expression
ISO
Ketamine results in increased expression of PER1 mRNA
CTD
PMID:20080153
NCBI chr11:68,985,934...69,000,791
Ensembl chr11:68,986,043...69,000,786
G
Pgpep1
pyroglutamyl-peptidase I
decreases expression
ISO
Ketamine results in decreased expression of PGPEP1 mRNA
CTD
PMID:20080153
NCBI chr 8:71,099,086...71,113,096
Ensembl chr 8:71,099,085...71,113,038
G
Phactr3
phosphatase and actin regulator 3
decreases expression
ISO
Ketamine results in decreased expression of PHACTR3 mRNA
CTD
PMID:20080153
NCBI chr 2:177,760,768...177,980,285
Ensembl chr 2:177,760,768...177,980,285
G
Phb1
prohibitin 1
increases expression
ISO
Ketamine results in increased expression of PHB1 protein
CTD
PMID:18504422
NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599
G
Phf13
PHD finger protein 13
decreases expression
ISO
Ketamine results in decreased expression of PHF13 mRNA
CTD
PMID:20080153
NCBI chr 4:152,074,088...152,080,636
Ensembl chr 4:152,074,090...152,080,715
G
Phf14
PHD finger protein 14
decreases expression
ISO
Ketamine results in decreased expression of PHF14 mRNA
CTD
PMID:20080153
NCBI chr 6:11,907,728...12,100,155
Ensembl chr 6:11,907,808...12,081,204
G
Phrf1
PHD and ring finger domains 1
decreases expression
ISO
Ketamine results in decreased expression of PHRF1 mRNA
CTD
PMID:20080153
NCBI chr 7:140,808,373...140,842,664
Ensembl chr 7:140,808,697...140,842,663
G
Phyhip
phytanoyl-CoA hydroxylase interacting protein
increases expression
ISO
Ketamine results in increased expression of PHYHIP mRNA
CTD
PMID:20080153
NCBI chr14:70,694,957...70,706,266
Ensembl chr14:70,694,916...70,706,272
G
Pibf1
progesterone immunomodulatory binding factor 1
decreases expression
ISO
Ketamine results in decreased expression of PIBF1 mRNA
CTD
PMID:20080153
NCBI chr14:99,336,892...99,492,335
Ensembl chr14:99,336,860...99,491,929
G
Pigl
phosphatidylinositol glycan anchor biosynthesis, class L
decreases expression
ISO
Ketamine results in decreased expression of PIGL mRNA
CTD
PMID:20080153
NCBI chr11:62,349,267...62,406,863
Ensembl chr11:62,349,286...62,405,243
G
Pik3ap1
phosphoinositide-3-kinase adaptor protein 1
decreases expression
ISO
Ketamine results in decreased expression of PIK3AP1 mRNA
CTD
PMID:20080153
NCBI chr19:41,260,980...41,373,541
Ensembl chr19:41,260,816...41,373,541
G
Pik3ip1
phosphoinositide-3-kinase interacting protein 1
increases expression
ISO
Ketamine results in increased expression of PIK3IP1 mRNA
CTD
PMID:20080153
NCBI chr11:3,280,731...3,292,971
Ensembl chr11:3,280,401...3,292,971
G
Pip4k2a
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha
decreases expression
ISO
Ketamine results in decreased expression of PIP4K2A mRNA
CTD
PMID:20080153
NCBI chr 2:18,847,066...19,003,101
Ensembl chr 2:18,847,066...19,002,937
G
Pkd1
polycystin 1, transient receptor potential channel interacting
increases expression
ISO
Ketamine results in increased expression of PKD1 mRNA
CTD
PMID:20080153
NCBI chr17:24,767,657...24,815,457
Ensembl chr17:24,768,808...24,815,482
G
Plaat3
phospholipase A and acyltransferase 3
increases expression
ISO
Ketamine results in increased expression of PLAAT3 mRNA
CTD
PMID:20080153
NCBI chr19:7,534,824...7,565,914
Ensembl chr19:7,534,824...7,565,910
G
Plat
plasminogen activator, tissue
increases expression
ISO
Ketamine results in increased expression of PLAT mRNA
CTD
PMID:20080153
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plcd4
phospholipase C, delta 4
increases expression
ISO
Ketamine results in increased expression of PLCD4 mRNA
CTD
PMID:20080153
NCBI chr 1:74,581,175...74,605,137
Ensembl chr 1:74,582,047...74,606,953
G
Plcl1
phospholipase C-like 1
decreases expression
ISO
Ketamine results in decreased expression of PLCL1 mRNA
CTD
PMID:20080153
NCBI chr 1:55,442,722...55,793,444
Ensembl chr 1:55,445,080...55,793,444
G
Plcxd3
phosphatidylinositol-specific phospholipase C, X domain containing 3
decreases expression
ISO
Ketamine results in decreased expression of PLCXD3 mRNA
CTD
PMID:20080153
NCBI chr15:4,404,973...4,605,067
Ensembl chr15:4,404,973...4,605,035
G
Pld4
phospholipase D family member 4
increases expression
ISO
Ketamine results in increased expression of PLD4 mRNA
CTD
PMID:20080153
NCBI chr12:112,727,089...112,735,420
Ensembl chr12:112,727,089...112,735,424
G
Plekhb1
pleckstrin homology domain containing, family B (evectins) member 1
increases expression
ISO
Ketamine results in increased expression of PLEKHB1 mRNA
CTD
PMID:20080153
NCBI chr 7:100,291,922...100,311,601
Ensembl chr 7:100,292,099...100,311,621
G
Plekhf2
pleckstrin homology domain containing, family F (with FYVE domain) member 2
decreases expression
ISO
Ketamine results in decreased expression of PLEKHF2 mRNA
CTD
PMID:20080153
NCBI chr 4:10,988,662...11,007,619
Ensembl chr 4:10,988,662...11,007,927
G
Plgrkt
plasminogen receptor, C-terminal lysine transmembrane protein
decreases expression
ISO
Ketamine results in decreased expression of PLGRKT mRNA
CTD
PMID:20080153
NCBI chr19:29,326,004...29,339,340
Ensembl chr19:29,325,999...29,344,790
G
Plp1
proteolipid protein (myelin) 1
increases expression
ISO
Ketamine results in increased expression of PLP1 mRNA
CTD
PMID:20080153
NCBI chr X:135,720,897...135,739,331
Ensembl chr X:135,723,420...135,740,482
G
Plppr1
phospholipid phosphatase related 1
decreases expression
ISO
Ketamine results in decreased expression of PLPPR1 mRNA
CTD
PMID:20080153
NCBI chr 4:49,054,986...49,340,261
Ensembl chr 4:49,059,273...49,340,259
G
Plvap
plasmalemma vesicle associated protein
increases expression
ISO
Ketamine results in increased expression of PLVAP mRNA
CTD
PMID:20080153
NCBI chr 8:71,950,397...71,964,446
Ensembl chr 8:71,950,409...71,964,396
G
Plxna2
plexin A2
decreases expression
ISO
Ketamine results in decreased expression of PLXNA2 mRNA
CTD
PMID:20080153
NCBI chr 1:194,302,020...194,499,177
Ensembl chr 1:194,300,526...194,499,177
G
Pmpca
peptidase (mitochondrial processing) alpha
increases expression
ISO
Ketamine results in increased expression of PMPCA mRNA
CTD
PMID:20080153
NCBI chr 2:26,275,554...26,287,134
Ensembl chr 2:26,279,351...26,287,134
G
Pnp2
purine-nucleoside phosphorylase 2
decreases expression
ISO
Ketamine results in decreased expression of PNP mRNA
CTD
PMID:20080153
NCBI chr14:51,193,598...51,202,206
Ensembl chr14:51,193,449...51,202,206
G
Pnpla2
patatin-like phospholipase domain containing 2
increases expression
ISO
Ketamine results in increased expression of PNPLA2 mRNA
CTD
PMID:20080153
NCBI chr 7:141,035,101...141,040,656
Ensembl chr 7:141,035,111...141,040,656
G
Pofut2
protein O-fucosyltransferase 2
decreases expression
ISO
Ketamine results in decreased expression of POFUT2 mRNA
CTD
PMID:20080153
NCBI chr10:77,095,056...77,105,420
Ensembl chr10:77,095,052...77,105,409
G
Pola1
polymerase (DNA directed), alpha 1
decreases expression
ISO
Ketamine results in decreased expression of POLA1 mRNA
CTD
PMID:20080153
NCBI chr X:92,348,372...92,675,993
Ensembl chr X:92,348,373...92,675,761
G
Pold1
polymerase (DNA directed), delta 1, catalytic subunit
decreases expression
ISO
Ketamine results in decreased expression of POLD1 mRNA
CTD
PMID:20080153
NCBI chr 7:44,182,168...44,198,239
Ensembl chr 7:44,182,170...44,198,273
G
Pole2
polymerase (DNA directed), epsilon 2 (p59 subunit)
decreases expression
ISO
Ketamine results in decreased expression of POLE2 mRNA
CTD
PMID:20080153
NCBI chr12:69,248,547...69,274,979
Ensembl chr12:69,248,547...69,274,969
G
Polg
polymerase (DNA directed), gamma
decreases expression
ISO
Ketamine results in decreased expression of POLG mRNA
CTD
PMID:20080153
NCBI chr 7:79,095,979...79,117,659
Ensembl chr 7:79,095,979...79,116,110
G
Polr2f
polymerase (RNA) II (DNA directed) polypeptide F
increases expression
ISO
Ketamine results in increased expression of POLR2F mRNA
CTD
PMID:20080153
NCBI chr15:79,025,525...79,035,974
Ensembl chr15:79,025,209...79,035,974
G
Polr3f
polymerase (RNA) III (DNA directed) polypeptide F
increases expression
ISO
Ketamine results in increased expression of POLR3F mRNA
CTD
PMID:20080153
NCBI chr 2:144,369,665...144,383,699
Ensembl chr 2:144,369,638...144,383,915
G
Polr3h
polymerase (RNA) III (DNA directed) polypeptide H
decreases expression
ISO
Ketamine results in decreased expression of POLR3H mRNA
CTD
PMID:20080153
NCBI chr15:81,799,231...81,813,824
Ensembl chr15:81,772,429...81,810,441
G
Pomt2
protein-O-mannosyltransferase 2
decreases expression
ISO
Ketamine results in decreased expression of POMT2 mRNA
CTD
PMID:20080153
NCBI chr12:87,153,635...87,194,742
Ensembl chr12:87,153,635...87,194,742
G
Pou3f2
POU domain, class 3, transcription factor 2
decreases expression
ISO
Ketamine results in decreased expression of POU3F2 mRNA
CTD
PMID:20080153
NCBI chr 4:22,482,095...22,488,366
Ensembl chr 4:22,482,780...22,488,366
G
Ppp1r14b
protein phosphatase 1, regulatory inhibitor subunit 14B
decreases expression
ISO
Ketamine results in decreased expression of PPP1R14B mRNA
CTD
PMID:20080153
NCBI chr19:6,952,416...6,954,692
Ensembl chr19:6,952,336...6,954,692
G
Ppp1r18
protein phosphatase 1, regulatory subunit 18
decreases expression
ISO
Ketamine results in decreased expression of PPP1R18 mRNA
CTD
PMID:20080153
NCBI chr17:36,176,483...36,186,488
Ensembl chr17:36,176,485...36,186,488
G
Ppp1r1b
protein phosphatase 1, regulatory inhibitor subunit 1B
increases expression
ISO
Ketamine results in increased expression of PPP1R1B mRNA
CTD
PMID:20080153
NCBI chr11:98,239,232...98,248,622
Ensembl chr11:98,239,230...98,248,622
G
Pprc1
peroxisome proliferative activated receptor, gamma, coactivator-related 1
decreases expression
ISO
Ketamine results in decreased expression of PPRC1 mRNA
CTD
PMID:20080153
NCBI chr19:46,044,955...46,061,348
Ensembl chr19:46,033,325...46,061,354
G
Prkag2
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
decreases expression
ISO
Ketamine results in decreased expression of PRKAG2 mRNA
CTD
PMID:20080153
NCBI chr 5:25,067,733...25,311,576
Ensembl chr 5:25,067,742...25,305,640
G
Prkcg
protein kinase C, gamma
increases expression
ISO
Ketamine results in increased expression of PRKCG mRNA
CTD
PMID:20080153
NCBI chr 7:3,352,038...3,379,615
Ensembl chr 7:3,337,704...3,379,615
G
Prmt2
protein arginine N-methyltransferase 2
decreases expression
ISO
Ketamine results in decreased expression of PRMT2 mRNA
CTD
PMID:20080153
NCBI chr10:76,043,060...76,073,699
Ensembl chr10:76,043,056...76,073,699
G
Prpf38b
PRP38 pre-mRNA processing factor 38 (yeast) domain containing B
decreases expression
ISO
Ketamine results in decreased expression of PRPF38B mRNA
CTD
PMID:20080153
NCBI chr 3:108,810,121...108,819,055
Ensembl chr 3:108,810,121...108,819,043
G
Prpf4b
pre-mRNA processing factor 4B
decreases expression
ISO
Ketamine results in decreased expression of PRPF4B mRNA
CTD
PMID:20080153
NCBI chr13:35,058,803...35,090,047
Ensembl chr13:35,059,285...35,090,047
G
Prr16
proline rich 16
decreases expression
ISO
Ketamine results in decreased expression of PRR16 mRNA
CTD
PMID:20080153
NCBI chr18:51,250,970...51,437,713
Ensembl chr18:51,250,805...51,553,116
G
Psap
prosaposin
increases expression
ISO
Ketamine results in increased expression of PSAP mRNA
CTD
PMID:20080153
NCBI chr10:60,113,436...60,138,379
Ensembl chr10:60,113,449...60,138,376
G
Ptchd1
patched domain containing 1
decreases expression
ISO
Ketamine results in decreased expression of PTCHD1 mRNA
CTD
PMID:20080153
NCBI chr X:154,352,732...154,407,185
Ensembl chr X:154,356,451...154,406,810
G
Ptk2
PTK2 protein tyrosine kinase 2
decreases expression
ISO
Ketamine results in decreased expression of PTK2 mRNA
CTD
PMID:20080153
NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
G
Ptprh
protein tyrosine phosphatase receptor type H
decreases expression
ISO
Ketamine results in decreased expression of PTPRH mRNA
CTD
PMID:20080153
NCBI chr 7:4,551,607...4,607,040
Ensembl chr 7:4,551,611...4,607,040
G
Ptprn
protein tyrosine phosphatase receptor type N
increases expression
ISO
Ketamine results in increased expression of PTPRN mRNA
CTD
PMID:20080153
NCBI chr 1:75,223,679...75,241,437
Ensembl chr 1:75,223,671...75,241,146
G
Ptpru
protein tyrosine phosphatase receptor type U
increases expression
ISO
Ketamine results in increased expression of PTPRU mRNA
CTD
PMID:20080153
NCBI chr 4:131,495,768...131,565,617
Ensembl chr 4:131,495,768...131,565,599
G
Pvalb
parvalbumin
multiple interactions decreases expression
EXP
acetovanillone inhibits the reaction [Ketamine results in decreased expression of PVALB protein]
CTD
PMID:18063801
NCBI chr15:78,075,312...78,090,600
Ensembl chr15:78,075,314...78,090,600
G
Pwwp3a
PWWP domain containing 3A, DNA repair factor
decreases expression
ISO
Ketamine results in decreased expression of PWWP3A mRNA
CTD
PMID:20080153
NCBI chr10:80,062,265...80,082,415
Ensembl chr10:80,062,268...80,079,737
G
Pygm
muscle glycogen phosphorylase
increases expression
ISO
Ketamine results in increased expression of PYGM mRNA
CTD
PMID:20080153
NCBI chr19:6,434,438...6,448,494
Ensembl chr19:6,434,429...6,448,489
G
Rab26
RAB26, member RAS oncogene family
increases expression
ISO
Ketamine results in increased expression of RAB26 mRNA
CTD
PMID:20080153
NCBI chr17:24,748,038...24,752,696
Ensembl chr17:24,746,215...24,753,184
G
Ramp1
receptor (calcitonin) activity modifying protein 1
increases expression
ISO
Ketamine results in increased expression of RAMP1 mRNA
CTD
PMID:20080153
NCBI chr 1:91,107,544...91,152,918
Ensembl chr 1:91,107,544...91,152,918
G
Rasa1
RAS p21 protein activator 1
decreases expression
ISO
Ketamine results in decreased expression of RASA1 mRNA
CTD
PMID:20080153
NCBI chr13:85,362,893...85,437,487
Ensembl chr13:85,362,899...85,437,249
G
Rasd2
RASD family, member 2
increases expression
ISO
Ketamine results in increased expression of RASD2 mRNA
CTD
PMID:20080153
NCBI chr 8:75,940,572...75,950,741
Ensembl chr 8:75,940,572...75,950,741
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
increases expression
ISO
Ketamine results in increased expression of RASGRF1 mRNA
CTD
PMID:20080153
NCBI chr 9:89,791,565...89,909,032
Ensembl chr 9:89,791,961...89,909,030
G
Rasl11a
RAS-like, family 11, member A
increases expression
ISO
Ketamine results in increased expression of RASL11A mRNA
CTD
PMID:20080153
NCBI chr 5:146,781,881...146,784,536
Ensembl chr 5:146,781,881...146,784,537
G
Rasl11b
RAS-like, family 11, member B
increases expression
ISO
Ketamine results in increased expression of RASL11B mRNA
CTD
PMID:20080153
NCBI chr 5:74,355,987...74,360,138
Ensembl chr 5:74,355,947...74,360,142
G
Rassf2
Ras association (RalGDS/AF-6) domain family member 2
decreases expression
ISO
Ketamine results in decreased expression of RASSF2 mRNA
CTD
PMID:20080153
NCBI chr 2:131,834,770...131,872,336
Ensembl chr 2:131,831,335...131,872,178
G
Rassf5
Ras association (RalGDS/AF-6) domain family member 5
increases expression
ISO
Ketamine results in increased expression of RASSF5 mRNA
CTD
PMID:20080153
NCBI chr 1:131,104,147...131,172,915
Ensembl chr 1:131,104,147...131,172,995
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
Ketamine results in decreased expression of RB1 mRNA
CTD
PMID:20080153
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
G
Rbbp6
retinoblastoma binding protein 6, ubiquitin ligase
increases expression
ISO
Ketamine results in increased expression of RBBP6 mRNA
CTD
PMID:20080153
NCBI chr 7:122,568,980...122,601,780
Ensembl chr 7:122,564,909...122,601,780
G
Rbbp8
retinoblastoma binding protein 8, endonuclease
decreases expression
ISO
Ketamine results in decreased expression of RBBP8 mRNA
CTD
PMID:20080153
NCBI chr18:11,766,333...11,876,264
Ensembl chr18:11,766,333...11,878,278
G
Rbm12b1
RNA binding motif protein 12 B1
decreases expression
ISO
Ketamine results in decreased expression of RBM12B mRNA
CTD
PMID:20080153
NCBI chr 4:12,138,957...12,148,922
Ensembl chr 4:12,140,264...12,146,731
G
Rbm4
RNA binding motif protein 4
decreases expression
ISO
Ketamine results in decreased expression of RBM4 mRNA
CTD
PMID:20080153
NCBI chr19:4,834,321...4,844,037
Ensembl chr19:4,834,321...4,843,929
G
Rbm4b
RNA binding motif protein 4B
decreases expression
ISO
Ketamine results in decreased expression of RBM4B mRNA
CTD
PMID:20080153
NCBI chr19:4,806,480...4,816,199
Ensembl chr19:4,806,525...4,817,093
G
Rbms1
RNA binding motif, single stranded interacting protein 1
decreases expression
ISO
Ketamine results in decreased expression of RBMS1 mRNA
CTD
PMID:20080153
NCBI chr 2:60,580,537...60,794,224
Ensembl chr 2:60,580,537...60,793,536
G
Recql
RecQ protein-like
decreases expression
ISO
Ketamine results in decreased expression of RECQL mRNA
CTD
PMID:20080153
NCBI chr 6:142,296,068...142,332,802
Ensembl chr 6:142,296,068...142,332,813
G
Reep5
receptor accessory protein 5
decreases expression
ISO
Ketamine results in decreased expression of REEP5 mRNA
CTD
PMID:20080153
NCBI chr18:34,477,938...34,508,044
Ensembl chr18:34,477,938...34,507,123
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
increases phosphorylation multiple interactions
ISO
Ketamine results in increased phosphorylation of RELA protein TRPV4 protein affects the reaction [Ketamine results in increased phosphorylation of RELA protein]
CTD
PMID:33536391
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Rem2
rad and gem related GTP binding protein 2
decreases expression
ISO
Ketamine results in decreased expression of REM2 mRNA
CTD
PMID:20080153
NCBI chr14:54,713,676...54,717,889
Ensembl chr14:54,713,557...54,717,888
G
Ren1
renin 1 structural
increases expression
ISO
Ketamine results in increased expression of REN protein
CTD
PMID:6349867
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
G
Resp18
regulated endocrine-specific protein 18
increases expression
ISO
Ketamine results in increased expression of RESP18 mRNA
CTD
PMID:20080153
NCBI chr 1:75,248,841...75,255,059
Ensembl chr 1:75,248,843...75,255,059
G
Rev1
REV1, DNA directed polymerase
increases expression
ISO
Ketamine results in increased expression of REV1 mRNA
CTD
PMID:20080153
NCBI chr 1:38,091,867...38,169,191
Ensembl chr 1:38,091,867...38,168,882
G
Rgs19
regulator of G-protein signaling 19
decreases expression
ISO
Ketamine results in decreased expression of RGS19 mRNA
CTD
PMID:20080153
NCBI chr 2:181,330,212...181,336,330
Ensembl chr 2:181,330,212...181,335,770
G
Rgs2
regulator of G-protein signaling 2
decreases expression
ISO
Ketamine results in decreased expression of RGS2 mRNA
CTD
PMID:20080153
NCBI chr 1:143,875,076...143,879,887
Ensembl chr 1:143,875,076...143,879,899
G
Rgs9
regulator of G-protein signaling 9
increases expression
ISO
Ketamine results in increased expression of RGS9 mRNA
CTD
PMID:20080153
NCBI chr11:109,116,174...109,189,013
Ensembl chr11:109,116,181...109,188,955
G
Rnase4
ribonuclease, RNase A family 4
increases expression
ISO
Ketamine results in increased expression of RNASE4 mRNA
CTD
PMID:20080153
NCBI chr14:51,328,534...51,343,608
Ensembl chr14:51,328,534...51,343,608
G
Rnd3
Rho family GTPase 3
decreases expression
ISO
Ketamine results in decreased expression of RND3 mRNA
CTD
PMID:20080153
NCBI chr 2:51,020,451...51,039,123
Ensembl chr 2:51,020,450...51,039,123
G
Rnf112
ring finger protein 112
increases expression
ISO
Ketamine results in increased expression of RNF112 mRNA
CTD
PMID:20080153
NCBI chr11:61,339,243...61,345,014
Ensembl chr11:61,339,268...61,344,957
G
Rnf138
ring finger protein 138
decreases expression
ISO
Ketamine results in decreased expression of RNF138 mRNA
CTD
PMID:20080153
NCBI chr18:21,134,202...21,161,281
Ensembl chr18:21,134,398...21,161,281
G
Rnf31
ring finger protein 31
increases expression
ISO
Ketamine results in increased expression of RNF31 mRNA
CTD
PMID:20080153
NCBI chr14:55,829,199...55,841,131
Ensembl chr14:55,829,165...55,841,150
G
Rnls
renalase, FAD-dependent amine oxidase
increases expression
ISO
Ketamine results in increased expression of RNLS mRNA
CTD
PMID:20080153
NCBI chr19:33,115,140...33,369,695
Ensembl chr19:33,115,147...33,369,665
G
Rora
RAR-related orphan receptor alpha
increases expression
ISO
Ketamine results in increased expression of RORA mRNA
CTD
PMID:20080153
NCBI chr 9:68,560,627...69,295,528
Ensembl chr 9:68,561,068...69,295,528
G
Rpf2
ribosome production factor 2 homolog
decreases expression
ISO
Ketamine results in decreased expression of RPF2 mRNA
CTD
PMID:20080153
NCBI chr10:40,099,242...40,123,035
Ensembl chr10:40,099,242...40,123,032
G
Rpusd3
RNA pseudouridylate synthase domain containing 3
increases expression
ISO
Ketamine results in increased expression of RPUSD3 mRNA
CTD
PMID:20080153
NCBI chr 6:113,392,280...113,396,309
Ensembl chr 6:113,392,280...113,396,301
G
Rras2
related RAS viral (r-ras) oncogene 2
decreases expression
ISO
Ketamine results in decreased expression of RRAS2 mRNA
CTD
PMID:20080153
NCBI chr 7:113,646,017...113,717,016
Ensembl chr 7:113,646,017...113,717,016
G
Rrm2
ribonucleotide reductase M2
decreases expression
ISO
Ketamine results in decreased expression of RRM2 mRNA
CTD
PMID:20080153
NCBI chr12:24,758,253...24,764,145
Ensembl chr12:24,758,240...24,764,145
G
Rrp1b
ribosomal RNA processing 1B
increases expression
ISO
Ketamine results in increased expression of RRP1B mRNA
CTD
PMID:20080153
NCBI chr17:32,255,087...32,281,839
Ensembl chr17:32,255,074...32,281,839
G
Rrp7a
ribosomal RNA processing 7 homolog A
decreases expression
ISO
Ketamine results in decreased expression of RRP7A mRNA
CTD
PMID:20080153
NCBI chr15:83,000,047...83,007,002
Ensembl chr15:82,997,634...83,007,002
G
Rtkn
rhotekin
increases expression
ISO
Ketamine results in increased expression of RTKN mRNA
CTD
PMID:20080153
NCBI chr 6:83,112,485...83,129,560
Ensembl chr 6:83,112,444...83,129,560
G
Rundc3a
RUN domain containing 3A
increases expression
ISO
Ketamine results in increased expression of RUNDC3A mRNA
CTD
PMID:20080153
NCBI chr11:102,284,219...102,293,381
Ensembl chr11:102,284,229...102,293,381
G
Rwdd2a
RWD domain containing 2A
increases expression
ISO
Ketamine results in increased expression of RWDD2A mRNA
CTD
PMID:20080153
NCBI chr 9:86,454,041...86,456,952
Ensembl chr 9:86,454,044...86,456,952
G
Rxfp1
relaxin/insulin-like family peptide receptor 1
decreases expression
ISO
Ketamine results in decreased expression of RXFP1 mRNA
CTD
PMID:20080153
NCBI chr 3:79,548,910...79,645,258
Ensembl chr 3:79,548,918...79,645,187
G
Rxrg
retinoid X receptor gamma
decreases expression
ISO
Ketamine results in decreased expression of RXRG mRNA
CTD
PMID:20080153
NCBI chr 1:167,425,902...167,467,191
Ensembl chr 1:167,425,953...167,467,192
G
S100a11
S100 calcium binding protein A11
decreases expression
ISO
Ketamine results in decreased expression of S100A11 mRNA
CTD
PMID:20080153
NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594
G
S100a4
S100 calcium binding protein A4
increases expression
ISO
Ketamine results in increased expression of S100A4 mRNA
CTD
PMID:20080153 PMID:28331066
NCBI chr 3:90,511,077...90,513,349
Ensembl chr 3:90,511,078...90,513,352
G
S100b
S100 protein, beta polypeptide, neural
increases expression
ISO
Ketamine results in increased expression of S100B mRNA
CTD
PMID:20080153
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
S1pr2
sphingosine-1-phosphate receptor 2
decreases expression
ISO
Ketamine results in decreased expression of S1PR2 mRNA
CTD
PMID:20080153
NCBI chr 9:20,877,248...20,888,089
Ensembl chr 9:20,873,657...20,888,077
G
Samd9l
sterile alpha motif domain containing 9-like
decreases expression
ISO
Ketamine results in decreased expression of SAMD9L mRNA
CTD
PMID:20080153
NCBI chr 6:3,372,257...3,399,458
Ensembl chr 6:3,372,257...3,399,572
G
Satb2
special AT-rich sequence binding protein 2
decreases expression
ISO
Ketamine results in decreased expression of SATB2 mRNA
CTD
PMID:20080153
NCBI chr 1:56,833,145...57,019,350
Ensembl chr 1:56,833,140...57,017,809
G
Scaper
S phase cyclin A-associated protein in the ER
decreases expression
ISO
Ketamine results in decreased expression of SCAPER mRNA
CTD
PMID:20080153
NCBI chr 9:55,457,163...55,845,505
Ensembl chr 9:55,457,163...55,845,403
G
Scara3
scavenger receptor class A, member 3
increases expression
ISO
Ketamine results in increased expression of SCARA3 mRNA
CTD
PMID:20080153
NCBI chr14:66,156,844...66,191,427
Ensembl chr14:66,156,843...66,191,384
G
Scarf2
scavenger receptor class F, member 2
increases expression
ISO
Ketamine results in increased expression of SCARF2 mRNA
CTD
PMID:20080153
NCBI chr16:17,615,146...17,626,158
Ensembl chr16:17,615,146...17,626,157
G
Scd1
stearoyl-Coenzyme A desaturase 1
increases expression
ISO
Ketamine results in increased expression of SCD1 mRNA
CTD
PMID:20080153
NCBI chr19:44,382,889...44,396,148
Ensembl chr19:44,382,894...44,396,318
G
Scn4b
sodium channel, type IV, beta
increases expression
ISO
Ketamine results in increased expression of SCN4B mRNA
CTD
PMID:20080153
NCBI chr 9:45,049,922...45,065,453
Ensembl chr 9:45,049,693...45,065,450
G
Sdc1
syndecan 1
decreases expression
ISO
Ketamine results in decreased expression of SDC1 mRNA
CTD
PMID:20080153
NCBI chr12:8,821,396...8,843,716
Ensembl chr12:8,821,323...8,843,715
G
Sdsl
serine dehydratase-like
increases expression
ISO
Ketamine results in increased expression of SDSL mRNA
CTD
PMID:20080153
NCBI chr 5:120,596,258...120,610,890
Ensembl chr 5:120,596,251...120,610,875
G
Senp7
SUMO1/sentrin specific peptidase 7
decreases expression
ISO
Ketamine results in decreased expression of SENP7 mRNA
CTD
PMID:20080153
NCBI chr16:55,869,306...56,010,394
Ensembl chr16:55,868,701...56,010,375
G
Septin4
septin 4
increases expression
ISO
Ketamine results in increased expression of SEPTIN4 mRNA
CTD
PMID:20080153
NCBI chr11:87,457,515...87,481,365
Ensembl chr11:87,457,479...87,481,365
G
Serpinb1a
serine (or cysteine) peptidase inhibitor, clade B, member 1a
increases expression
ISO
Ketamine results in increased expression of SERPINB1A mRNA
CTD
PMID:20080153
NCBI chr13:33,026,075...33,037,189
Ensembl chr13:33,026,075...33,035,168
G
Sesn1
sestrin 1
increases expression
ISO
Ketamine results in increased expression of SESN1 mRNA
CTD
PMID:20080153
NCBI chr10:41,686,570...41,784,432
Ensembl chr10:41,685,931...41,784,420
G
Setmar
SET domain without mariner transposase fusion
decreases expression
ISO
Ketamine results in decreased expression of SETMAR mRNA
CTD
PMID:20080153
NCBI chr 6:108,042,006...108,054,088
Ensembl chr 6:108,042,006...108,054,083
G
Sfpq
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated)
decreases expression
ISO
Ketamine results in decreased expression of SFPQ mRNA
CTD
PMID:20080153
NCBI chr 4:126,914,504...126,944,894
Ensembl chr 4:126,915,117...126,930,806
G
Sh2b2
SH2B adaptor protein 2
decreases expression
ISO
Ketamine results in decreased expression of SH2B2 mRNA
CTD
PMID:20080153
NCBI chr 5:136,247,003...136,275,446
Ensembl chr 5:136,247,001...136,275,410
G
Shoc2
Shoc2, leucine rich repeat scaffold protein
decreases expression
ISO
Ketamine results in decreased expression of SHOC2 mRNA
CTD
PMID:20080153
NCBI chr19:53,932,018...54,021,711
Ensembl chr19:53,932,737...54,021,564
G
Slain2
SLAIN motif family, member 2
decreases expression
ISO
Ketamine results in decreased expression of SLAIN2 mRNA
CTD
PMID:20080153
NCBI chr 5:73,071,705...73,136,184
Ensembl chr 5:73,071,647...73,136,172
G
Slc15a5
solute carrier family 15, member 5
decreases expression
ISO
Ketamine results in decreased expression of SLC15A5 mRNA
CTD
PMID:20080153
NCBI chr 6:137,960,584...138,056,914
Ensembl chr 6:137,960,584...138,056,914
G
Slc17a7
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7
increases expression
ISO
Ketamine results in increased expression of SLC17A7 mRNA
CTD
PMID:20080153
NCBI chr 7:44,813,345...44,825,563
Ensembl chr 7:44,813,373...44,825,566
G
Slc1a2
solute carrier family 1 (glial high affinity glutamate transporter), member 2
increases expression multiple interactions
ISO EXP
Ketamine results in increased expression of SLC1A2 mRNA [Guanosine co-treated with Ketamine] results in increased expression of SLC1A2 protein
CTD
PMID:20080153 PMID:36878458
NCBI chr 2:102,488,584...102,621,129
Ensembl chr 2:102,489,004...102,621,129
G
Slc20a2
solute carrier family 20, member 2
increases expression
ISO
Ketamine results in increased expression of SLC20A2 mRNA
CTD
PMID:20080153
NCBI chr 8:22,966,771...23,059,632
Ensembl chr 8:22,966,804...23,059,628
G
Slc25a1
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1
decreases expression
ISO
Ketamine results in decreased expression of SLC25A1 mRNA
CTD
PMID:20080153
NCBI chr16:17,743,075...17,746,083
Ensembl chr16:17,743,087...17,746,083
G
Slc26a6
solute carrier family 26, member 6
increases expression
ISO
Ketamine results in increased expression of SLC26A6 mRNA
CTD
PMID:20080153
NCBI chr 9:108,731,239...108,742,117
Ensembl chr 9:108,730,482...108,742,117
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
increases expression
ISO
Ketamine results in increased expression of SLC2A2 mRNA
CTD
PMID:20080153
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
G
Slc2a5
solute carrier family 2 (facilitated glucose transporter), member 5
increases expression
ISO
Ketamine results in increased expression of SLC2A5 mRNA
CTD
PMID:20080153
NCBI chr 4:150,203,801...150,228,625
Ensembl chr 4:150,203,740...150,228,626
G
Slc2a6
solute carrier family 2 (facilitated glucose transporter), member 6
decreases expression
ISO
Ketamine results in decreased expression of SLC2A6 mRNA
CTD
PMID:20080153
NCBI chr 2:26,911,375...26,918,011
Ensembl chr 2:26,911,375...26,918,010
G
Slc30a6
solute carrier family 30 (zinc transporter), member 6
decreases expression
ISO
Ketamine results in decreased expression of SLC30A6 mRNA
CTD
PMID:20080153
NCBI chr17:74,702,573...74,731,225
Ensembl chr17:74,702,603...74,731,216
G
Slc32a1
solute carrier family 32 (GABA vesicular transporter), member 1
increases expression
ISO
Ketamine results in increased expression of SLC32A1 mRNA
CTD
PMID:20080153
NCBI chr 2:158,449,158...158,457,667
Ensembl chr 2:158,452,687...158,457,668
G
Slc35e3
solute carrier family 35, member E3
decreases expression
ISO
Ketamine results in decreased expression of SLC35E3 mRNA
CTD
PMID:20080153
NCBI chr10:117,569,583...117,582,263
Ensembl chr10:117,569,584...117,582,270
G
Slc38a3
solute carrier family 38, member 3
increases expression
ISO
Ketamine results in increased expression of SLC38A3 mRNA
CTD
PMID:20080153
NCBI chr 9:107,528,353...107,546,167
Ensembl chr 9:107,527,833...107,546,729
G
Slc38a5
solute carrier family 38, member 5
decreases expression
ISO
Ketamine results in decreased expression of SLC38A5 mRNA
CTD
PMID:20080153
NCBI chr X:8,137,620...8,146,418
Ensembl chr X:8,137,372...8,146,418
G
Slc39a12
solute carrier family 39 (zinc transporter), member 12
increases expression
ISO
Ketamine results in increased expression of SLC39A12 mRNA
CTD
PMID:20080153
NCBI chr 2:14,345,476...14,499,787
Ensembl chr 2:14,393,127...14,499,788
G
Slc45a4
solute carrier family 45, member 4
increases expression
ISO
Ketamine results in increased expression of SLC45A4 mRNA
CTD
PMID:20080153
NCBI chr15:73,449,267...73,517,606
Ensembl chr15:73,449,273...73,517,611
G
Slc52a2
solute carrier protein 52, member 2
decreases expression
ISO
Ketamine results in decreased expression of SLC52A2 mRNA
CTD
PMID:20080153
NCBI chr15:76,422,994...76,432,078
Ensembl chr15:76,423,032...76,428,808
G
Slc5a3
solute carrier family 5 (inositol transporters), member 3
decreases expression
ISO
Ketamine results in decreased expression of SLC5A3 mRNA
CTD
PMID:20080153
NCBI chr16:91,855,210...91,884,361
Ensembl chr16:91,855,210...91,884,361
G
Slc6a2
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
multiple interactions decreases activity
EXP
[Ketamine co-treated with Xylenes] results in decreased activity of SLC6A2 protein Ketamine results in decreased activity of SLC6A2 protein
CTD
PMID:17934728
NCBI chr 8:93,687,100...93,728,295
Ensembl chr 8:93,686,707...93,728,295
G
Slc6a3
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3
multiple interactions
ISO
Ketamine inhibits the reaction [SLC6A3 protein results in increased uptake of Dopamine]
CTD
PMID:31009648
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
G
Slc7a10
solute carrier family 7 (cationic amino acid transporter, y+ system), member 10
increases expression
ISO
Ketamine results in increased expression of SLC7A10 mRNA
CTD
PMID:20080153
NCBI chr 7:34,885,520...34,900,539
Ensembl chr 7:34,885,810...34,900,539
G
Slc9a1
solute carrier family 9 (sodium/hydrogen exchanger), member 1
increases expression
ISO
Ketamine results in increased expression of SLC9A1 mRNA
CTD
PMID:20080153
NCBI chr 4:133,097,022...133,151,013
Ensembl chr 4:133,097,017...133,151,013
G
Slc9a6
solute carrier family 9 (sodium/hydrogen exchanger), member 6
decreases expression
ISO EXP
Ketamine results in decreased expression of SLC9A6 protein
CTD
PMID:35378374
NCBI chr X:55,654,921...55,709,590
Ensembl chr X:55,655,117...55,709,590
G
Slco1c1
solute carrier organic anion transporter family, member 1c1
decreases expression
ISO
Ketamine results in decreased expression of SLCO1C1 mRNA
CTD
PMID:20080153
NCBI chr 6:141,470,080...141,515,903
Ensembl chr 6:141,470,094...141,515,903
G
Slco5a1
solute carrier organic anion transporter family, member 5A1
decreases expression
ISO
Ketamine results in decreased expression of SLCO5A1 mRNA
CTD
PMID:20080153
NCBI chr 1:12,936,773...13,063,043
Ensembl chr 1:12,936,773...13,062,874
G
Sltm
SAFB-like, transcription modulator
decreases expression
ISO
Ketamine results in decreased expression of SLTM mRNA
CTD
PMID:20080153
NCBI chr 9:70,449,717...70,499,519
Ensembl chr 9:70,450,036...70,499,516
G
Smarca1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
decreases expression
ISO
Ketamine results in decreased expression of SMARCA1 mRNA
CTD
PMID:20080153
NCBI chr X:46,898,247...46,981,490
Ensembl chr X:46,898,245...46,981,851
G
Smc6
structural maintenance of chromosomes 6
decreases expression
ISO
Ketamine results in decreased expression of SMC6 mRNA
CTD
PMID:20080153
NCBI chr12:11,315,887...11,369,786
Ensembl chr12:11,315,887...11,369,786
G
Smoc2
SPARC related modular calcium binding 2
decreases expression
ISO
Ketamine results in decreased expression of SMOC2 mRNA
CTD
PMID:20080153
NCBI chr17:14,499,768...14,625,052
Ensembl chr17:14,499,768...14,625,052
G
Smox
spermine oxidase
increases expression
ISO
Ketamine results in increased expression of SMOX mRNA
CTD
PMID:20080153
NCBI chr 2:131,333,624...131,367,103
Ensembl chr 2:131,333,416...131,367,842
G
Snai1
snail family zinc finger 1
increases expression
ISO
Ketamine results in increased expression of SNAI1 mRNA
CTD
PMID:28331066
NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
G
Snai2
snail family zinc finger 2
increases expression
ISO
Ketamine results in increased expression of SNAI2 mRNA
CTD
PMID:28331066
NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249
G
Snapc3
small nuclear RNA activating complex, polypeptide 3
decreases expression
ISO
Ketamine results in decreased expression of SNAPC3 mRNA
CTD
PMID:20080153
NCBI chr 4:83,333,948...83,391,256
Ensembl chr 4:83,335,961...83,385,913
G
Snorc
secondary ossification center associated regulator of chondrocyte maturation
increases expression
ISO
Ketamine results in increased expression of SNORC mRNA
CTD
PMID:20080153
NCBI chr 1:87,397,734...87,403,204
Ensembl chr 1:87,397,993...87,403,204
G
Snta1
syntrophin, acidic 1
increases expression
ISO
Ketamine results in increased expression of SNTA1 mRNA
CTD
PMID:20080153
NCBI chr 2:154,218,234...154,250,004
Ensembl chr 2:154,218,233...154,250,019
G
Sntg2
syntrophin, gamma 2
decreases expression
ISO
Ketamine results in decreased expression of SNTG2 mRNA
CTD
PMID:20080153
NCBI chr12:30,224,481...30,423,424
Ensembl chr12:30,224,481...30,423,374
G
Snx16
sorting nexin 16
decreases expression
ISO
Ketamine results in decreased expression of SNX16 mRNA
CTD
PMID:20080153
NCBI chr 3:10,482,877...10,505,194
Ensembl chr 3:10,482,877...10,505,162
G
Socs3
suppressor of cytokine signaling 3
multiple interactions
EXP
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of SOCS3 mRNA]
CTD
PMID:22245128
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
G
Socs5
suppressor of cytokine signaling 5
decreases expression
ISO
Ketamine results in decreased expression of SOCS5 mRNA
CTD
PMID:20080153
NCBI chr17:87,414,707...87,445,153
Ensembl chr17:87,415,107...87,445,267
G
Sod3
superoxide dismutase 3, extracellular
increases expression
ISO
Ketamine results in increased expression of SOD3 mRNA
CTD
PMID:20080153
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
G
Sorcs1
sortilin-related VPS10 domain containing receptor 1
decreases expression
ISO
Ketamine results in decreased expression of SORCS1 mRNA
CTD
PMID:20080153
NCBI chr19:50,131,733...50,668,030
Ensembl chr19:50,131,737...50,667,084
G
Sox11
SRY (sex determining region Y)-box 11
decreases expression
ISO
Ketamine results in decreased expression of SOX11 mRNA
CTD
PMID:20080153
NCBI chr12:27,384,267...27,392,717
Ensembl chr12:27,384,263...27,392,573
G
Sox4
SRY (sex determining region Y)-box 4
decreases expression
ISO
Ketamine results in decreased expression of SOX4 mRNA
CTD
PMID:20080153
NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696
G
Spatc1
spermatogenesis and centriole associated 1
decreases expression
ISO
Ketamine results in decreased expression of SPATC1 mRNA
CTD
PMID:20080153
NCBI chr15:76,150,731...76,176,777
Ensembl chr15:76,152,289...76,176,772
G
Spdya
speedy/RINGO cell cycle regulator family, member A
increases expression
ISO
Ketamine results in increased expression of SPDYA mRNA
CTD
PMID:20080153
NCBI chr17:71,833,890...71,896,528
Ensembl chr17:71,859,056...71,896,528
G
Spsb1
splA/ryanodine receptor domain and SOCS box containing 1
increases expression
ISO
Ketamine results in increased expression of SPSB1 mRNA
CTD
PMID:20080153
NCBI chr 4:149,980,740...150,039,494
Ensembl chr 4:149,980,740...150,039,500
G
Sptbn4
spectrin beta, non-erythrocytic 4
increases expression
ISO
Ketamine results in increased expression of SPTBN4 mRNA
CTD
PMID:20080153
NCBI chr 7:27,055,808...27,147,128
Ensembl chr 7:27,055,808...27,147,111
G
Sqle
squalene epoxidase
decreases expression
ISO
Ketamine results in decreased expression of SQLE mRNA
CTD
PMID:20080153
NCBI chr15:59,186,941...59,203,042
Ensembl chr15:59,186,926...59,203,041
G
Sqstm1
sequestosome 1
increases expression
EXP
Ketamine results in increased expression of SQSTM1 mRNA; Ketamine results in increased expression of SQSTM1 protein
CTD
PMID:34487425
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression
ISO
Ketamine results in increased expression of SREBF1 mRNA
CTD
PMID:20080153
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
G
Srpk1
serine/arginine-rich protein specific kinase 1
decreases expression
ISO
Ketamine results in decreased expression of SRPK1 mRNA
CTD
PMID:20080153
NCBI chr17:28,806,622...28,841,795
Ensembl chr17:28,806,622...28,841,683
G
Srsf6
serine and arginine-rich splicing factor 6
decreases expression
ISO
Ketamine results in decreased expression of SFRS6 mRNA
CTD
PMID:20080153
NCBI chr 2:162,773,428...162,779,041
Ensembl chr 2:162,773,448...162,779,041
G
Ssr1
signal sequence receptor, alpha
increases expression
ISO
Ketamine results in increased expression of SSR1 mRNA
CTD
PMID:20080153
NCBI chr13:38,155,377...38,178,184
Ensembl chr13:38,150,581...38,178,193
G
Sstr1
somatostatin receptor 1
decreases expression
ISO
Ketamine results in decreased expression of SSTR1 mRNA
CTD
PMID:20080153
NCBI chr12:58,258,524...58,262,822
Ensembl chr12:58,258,558...58,260,673
G
Stim1
stromal interaction molecule 1
increases expression
ISO
Ketamine results in increased expression of STIM1 mRNA
CTD
PMID:20080153
NCBI chr 7:101,909,279...102,086,525
Ensembl chr 7:101,917,013...102,086,526
G
Sumf1
sulfatase modifying factor 1
increases expression
ISO
Ketamine results in increased expression of SUMF1 mRNA
CTD
PMID:20080153
NCBI chr 6:108,083,989...108,162,552
Ensembl chr 6:108,083,989...108,162,543
G
Suox
sulfite oxidase
decreases expression
ISO
Ketamine results in decreased expression of SUOX mRNA
CTD
PMID:20080153
NCBI chr10:128,505,756...128,509,787
Ensembl chr10:128,505,763...128,509,942
G
Syn1
synapsin I
multiple interactions increases expression
EXP
Ketamine inhibits the reaction [Corticosterone results in decreased expression of SYN1 protein]; Sirolimus inhibits the reaction [Ketamine results in increased expression of SYN1 protein]
CTD
PMID:33022268 PMID:33872575
NCBI chr X:20,726,750...20,787,157
Ensembl chr X:20,726,750...20,787,243
G
Syt12
synaptotagmin XII
increases expression
ISO
Ketamine results in increased expression of SYT12 mRNA
CTD
PMID:20080153
NCBI chr19:4,495,936...4,527,171
Ensembl chr19:4,495,936...4,527,475
G
Sytl2
synaptotagmin-like 2
increases expression
ISO
Ketamine results in increased expression of SYTL2 mRNA
CTD
PMID:20080153
NCBI chr 7:89,951,421...90,059,927
Ensembl chr 7:89,951,460...90,059,927
G
Tac2
tachykinin 2
increases expression
ISO
Ketamine results in increased expression of TAC2 mRNA
CTD
PMID:20080153
NCBI chr10:127,560,347...127,567,637
Ensembl chr10:127,560,347...127,567,637
G
Tacstd2
tumor-associated calcium signal transducer 2
decreases expression
ISO
Ketamine results in decreased expression of TACSTD2 mRNA
CTD
PMID:20080153
NCBI chr 6:67,511,043...67,512,806
Ensembl chr 6:67,511,046...67,512,780
G
Tafa1
TAFA chemokine like family member 1
decreases expression
ISO
Ketamine results in decreased expression of TAFA1 mRNA
CTD
PMID:20080153
NCBI chr 6:96,090,135...96,634,169
Ensembl chr 6:96,090,135...96,634,159
G
Tagln3
transgelin 3
increases expression
ISO
Ketamine results in increased expression of TAGLN3 protein
CTD
PMID:18504422
NCBI chr16:45,531,591...45,545,271
Ensembl chr16:45,531,593...45,544,971
G
Tax1bp3
Tax1 (human T cell leukemia virus type I) binding protein 3
decreases expression
ISO
Ketamine results in decreased expression of TAX1BP3 mRNA
CTD
PMID:20080153
NCBI chr11:73,067,909...73,072,872
Ensembl chr11:73,067,909...73,073,988
G
Tbc1d10b
TBC1 domain family, member 10b
decreases expression
ISO
Ketamine results in decreased expression of TBC1D10B mRNA
CTD
PMID:20080153
NCBI chr 7:126,796,631...126,807,640
Ensembl chr 7:126,796,631...126,807,640
G
Tbccd1
TBCC domain containing 1
decreases expression
ISO
Ketamine results in decreased expression of TBCCD1 mRNA
CTD
PMID:20080153
NCBI chr16:22,631,964...22,676,441
Ensembl chr16:22,631,964...22,676,419
G
Tef
thyrotroph embryonic factor
increases expression
ISO
Ketamine results in increased expression of TEF mRNA
CTD
PMID:20080153
NCBI chr15:81,686,874...81,711,064
Ensembl chr15:81,686,622...81,711,064
G
Tekt2
tektin 2
increases expression
ISO
Ketamine results in increased expression of TEKT2 mRNA
CTD
PMID:20080153
NCBI chr 4:126,215,914...126,219,481
Ensembl chr 4:126,215,914...126,219,481
G
Tes
testin LIM domain protein
decreases expression
ISO
Ketamine results in decreased expression of TES mRNA
CTD
PMID:20080153
NCBI chr 6:17,065,148...17,105,824
Ensembl chr 6:17,065,148...17,105,827
G
Tesc
tescalcin
increases expression
ISO
Ketamine results in increased expression of TESC mRNA
CTD
PMID:20080153
NCBI chr 5:118,165,808...118,199,943
Ensembl chr 5:118,165,808...118,199,943
G
Tfap2d
transcription factor AP-2, delta
decreases expression
ISO
Ketamine results in decreased expression of TFAP2D mRNA
CTD
PMID:20080153
NCBI chr 1:19,173,246...19,244,172
Ensembl chr 1:19,173,246...19,236,570
G
Tfe3
transcription factor E3
increases expression
ISO
Ketamine results in increased expression of TFE3 mRNA
CTD
PMID:20080153
NCBI chr X:7,628,769...7,641,441
Ensembl chr X:7,628,799...7,641,441
G
Tgfb1
transforming growth factor, beta 1
increases expression increases secretion
ISO
Ketamine results in increased expression of TGFB1 mRNA Ketamine results in increased expression of TGFB1 protein Ketamine results in increased secretion of TGFB1 protein
CTD
PMID:28331066
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfbr1
transforming growth factor, beta receptor I
increases expression
ISO
Ketamine results in increased expression of TGFBR1 mRNA
CTD
PMID:28331066
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Tgfbr2
transforming growth factor, beta receptor II
increases expression
ISO
Ketamine results in increased expression of TGFBR2 mRNA
CTD
PMID:28331066
NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
G
Thnsl2
threonine synthase-like 2 (bacterial)
increases expression
ISO
Ketamine results in increased expression of THNSL2 mRNA
CTD
PMID:20080153
NCBI chr 6:71,105,150...71,121,364
Ensembl chr 6:71,105,150...71,121,423
G
Thrsp
thyroid hormone responsive
increases expression
ISO
Ketamine results in increased expression of THRSP mRNA
CTD
PMID:20080153
NCBI chr 7:97,062,140...97,066,757
Ensembl chr 7:97,062,145...97,066,937
G
Thumpd3
THUMP domain containing 3
decreases expression
ISO
Ketamine results in decreased expression of THUMPD3 mRNA
CTD
PMID:20080153
NCBI chr 6:113,023,292...113,045,239
Ensembl chr 6:113,023,186...113,045,234
G
Thy1
thymus cell antigen 1, theta
increases expression
ISO
Ketamine results in increased expression of THY1 mRNA
CTD
PMID:20080153
NCBI chr 9:43,954,681...43,959,876
Ensembl chr 9:43,954,681...43,959,876
G
Tia1
cytotoxic granule-associated RNA binding protein 1
decreases expression
ISO
Ketamine results in decreased expression of TIA1 mRNA
CTD
PMID:20080153
NCBI chr 6:86,381,001...86,410,387
Ensembl chr 6:86,381,201...86,410,387
G
Tifa
TRAF-interacting protein with forkhead-associated domain
increases expression
ISO
Ketamine results in increased expression of TIFA mRNA
CTD
PMID:20080153
NCBI chr 3:127,582,524...127,592,043
Ensembl chr 3:127,583,454...127,625,813
G
Tigd2
tigger transposable element derived 2
increases expression
ISO
Ketamine results in increased expression of TIGD2 mRNA
CTD
PMID:20080153
NCBI chr 6:59,185,855...59,189,018
Ensembl chr 6:59,185,855...59,189,018
G
Tlcd3a
TLC domain containing 3A
decreases expression
ISO
Ketamine results in decreased expression of TLCD3A mRNA
CTD
PMID:20080153
NCBI chr11:76,070,497...76,100,243
Ensembl chr11:76,070,497...76,105,653
G
Tlr4
toll-like receptor 4
multiple interactions
EXP
TLR4 mutant form promotes the reaction [Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; TLR4 mutant form promotes the reaction [Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]
CTD
PMID:19540866
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tmeff1
transmembrane protein with EGF-like and two follistatin-like domains 1
decreases expression
ISO
Ketamine results in decreased expression of TMEFF1 mRNA
CTD
PMID:20080153
NCBI chr 4:48,585,064...48,663,136
Ensembl chr 4:48,585,174...48,663,131
G
Tmeff2
transmembrane protein with EGF-like and two follistatin-like domains 2
decreases expression
ISO
Ketamine results in decreased expression of TMEFF2 mRNA
CTD
PMID:20080153
NCBI chr 1:50,951,946...51,226,429
Ensembl chr 1:50,939,806...51,226,429
G
Tmem140
transmembrane protein 140
increases expression
ISO
Ketamine results in increased expression of TMEM140 mRNA
CTD
PMID:20080153
NCBI chr 6:34,840,081...34,851,881
Ensembl chr 6:34,840,081...34,851,881
G
Tmem200a
transmembrane protein 200A
decreases expression
ISO
Ketamine results in decreased expression of TMEM200A mRNA
CTD
PMID:20080153
NCBI chr10:25,867,080...25,955,713
Ensembl chr10:25,788,229...25,954,950
G
Tmem222
transmembrane protein 222
increases expression
ISO
Ketamine results in increased expression of TMEM222 mRNA
CTD
PMID:20080153
NCBI chr 4:132,993,356...133,005,101
Ensembl chr 4:132,993,356...133,005,103
G
Tmem248
transmembrane protein 248
increases expression
ISO
Ketamine results in increased expression of TMEM248 mRNA
CTD
PMID:20080153
NCBI chr 5:130,248,585...130,272,606
Ensembl chr 5:130,245,922...130,272,606
G
Tmem74
transmembrane protein 74
decreases expression
ISO
Ketamine results in decreased expression of TMEM74 mRNA
CTD
PMID:20080153
NCBI chr15:43,726,741...43,733,462
Ensembl chr15:43,728,042...43,733,432
G
Tmem74b
transmembrane protein 74B
decreases expression
ISO
Ketamine results in decreased expression of TMEM74B mRNA
CTD
PMID:20080153
NCBI chr 2:151,543,294...151,558,665
Ensembl chr 2:151,543,928...151,554,077
G
Tmpo
thymopoietin
decreases expression
ISO
Ketamine results in decreased expression of TMPO mRNA
CTD
PMID:20080153
NCBI chr10:90,983,433...91,017,614
Ensembl chr10:90,983,433...91,017,177
G
Tmtc4
transmembrane and tetratricopeptide repeat containing 4
decreases expression
ISO
Ketamine results in decreased expression of TMTC4 mRNA
CTD
PMID:20080153
NCBI chr14:123,156,383...123,220,697
Ensembl chr14:123,156,383...123,221,447
G
Tnf
tumor necrosis factor
multiple interactions decreases expression affects expression increases expression
ISO EXP
Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] Ketamine results in decreased expression of TNF mRNA Ozone inhibits the reaction [Ketamine results in decreased expression of TNF mRNA]; TRPV4 protein affects the reaction [Ketamine results in increased expression of TNF protein] [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of TNF mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of TNF protein]; Ketamine inhibits the reaction [Acetaminophen results in increased expression of TNF protein]; Ketamine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] Ketamine co-treated with xylazine inhibits the reaction [lipopolysaccharide increases expression of Tnf protein in serum and mucosa of stomach]
CTD RGD
PMID:15207037 PMID:15207038 PMID:15720977 PMID:19540866 PMID:22245128 PMID:33536391 PMID:37491939 PMID:12813371 More...
RGD:14995427
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfaip1
tumor necrosis factor, alpha-induced protein 1 (endothelial)
decreases expression
ISO
Ketamine results in decreased expression of TNFAIP1 mRNA
CTD
PMID:20080153
NCBI chr11:78,413,676...78,427,122
Ensembl chr11:78,413,676...78,427,158
G
Tnfrsf11b
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
decreases expression
ISO
Ketamine results in decreased expression of TNFRSF11B mRNA
CTD
PMID:20080153
NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880
G
Tnnc2
troponin C2, fast
increases expression
ISO
Ketamine results in increased expression of TNNC2 mRNA
CTD
PMID:20080153
NCBI chr 2:164,619,081...164,621,654
Ensembl chr 2:164,619,081...164,621,887
G
Tnnt1
troponin T1, skeletal, slow
increases expression
EXP
Ketamine results in increased expression of TNNT1 mRNA
CTD
PMID:19162068
NCBI chr 7:4,507,568...4,518,974
Ensembl chr 7:4,507,569...4,519,381
G
Tnpo1
transportin 1
decreases expression
ISO
Ketamine results in decreased expression of TNPO1 mRNA
CTD
PMID:20080153
NCBI chr13:98,975,527...99,062,851
Ensembl chr13:98,975,527...99,062,892
G
Tns3
tensin 3
increases expression
ISO
Ketamine results in increased expression of TNS3 mRNA
CTD
PMID:20080153
NCBI chr11:8,381,652...8,614,758
Ensembl chr11:8,381,652...8,614,681
G
Tpm1
tropomyosin 1, alpha
increases expression
ISO
Ketamine results in increased expression of TPM1 mRNA
CTD
PMID:20080153
NCBI chr 9:66,929,872...66,956,954
Ensembl chr 9:66,929,872...66,956,688
G
Tpm4
tropomyosin 4
decreases expression
ISO
Ketamine results in decreased expression of TPM4 mRNA
CTD
PMID:20080153
NCBI chr 8:72,889,132...72,906,986
Ensembl chr 8:72,884,018...72,906,986
G
Tra2a
transformer 2 alpha
decreases expression
ISO
Ketamine results in decreased expression of TRA2A mRNA
CTD
PMID:20080153
NCBI chr 6:49,220,855...49,241,182
Ensembl chr 6:49,220,858...49,240,967
G
Traip
TRAF-interacting protein
increases expression
ISO
Ketamine results in increased expression of TRAIP mRNA
CTD
PMID:20080153
NCBI chr 9:107,828,158...107,849,469
Ensembl chr 9:107,827,335...107,849,469
G
Trem2
triggering receptor expressed on myeloid cells 2
increases expression
ISO
Ketamine results in increased expression of TREM2 mRNA
CTD
PMID:20080153
NCBI chr17:48,653,429...48,659,304
Ensembl chr17:48,653,429...48,661,175
G
Trf
transferrin
increases expression
ISO
Ketamine results in increased expression of TF mRNA
CTD
PMID:20080153
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
G
Trh
thyrotropin releasing hormone
increases expression
ISO
Ketamine results in increased expression of TRH mRNA
CTD
PMID:20080153
NCBI chr 6:92,219,042...92,221,631
Ensembl chr 6:92,219,042...92,221,631
G
Trim13
tripartite motif-containing 13
decreases expression
ISO
Ketamine results in decreased expression of TRIM13 mRNA
CTD
PMID:20080153
NCBI chr14:61,835,675...61,847,736
Ensembl chr14:61,835,696...61,843,395
G
Trim36
tripartite motif-containing 36
decreases expression
ISO
Ketamine results in decreased expression of TRIM36 mRNA
CTD
PMID:20080153
NCBI chr18:46,298,367...46,345,674
Ensembl chr18:46,298,367...46,345,674
G
Trim39
tripartite motif-containing 39
decreases expression
ISO
Ketamine results in decreased expression of TRIM39 mRNA
CTD
PMID:20080153
NCBI chr17:36,569,764...36,582,896
Ensembl chr17:36,569,765...36,583,139
G
Trim54
tripartite motif-containing 54
increases expression
ISO
Ketamine results in increased expression of TRIM54 mRNA
CTD
PMID:20080153
NCBI chr 5:31,273,956...31,294,970
Ensembl chr 5:31,274,056...31,294,974
G
Trp53
transformation related protein 53
increases expression
ISO
Ketamine results in increased expression of TP53 protein
CTD
PMID:19919587
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trpc3
transient receptor potential cation channel, subfamily C, member 3
multiple interactions decreases expression
ISO
Chir 99021 promotes the reaction [Ketamine results in decreased expression of TRPC3 protein] Ketamine results in decreased expression of TRPC3 mRNA; Ketamine results in decreased expression of TRPC3 protein
CTD
PMID:36334642
NCBI chr 3:36,674,626...36,744,276
Ensembl chr 3:36,674,631...36,744,316
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
decreases expression
ISO
Ketamine results in decreased expression of TRPV2 mRNA
CTD
PMID:20080153
NCBI chr11:62,465,312...62,491,131
Ensembl chr11:62,465,312...62,491,341
G
Trpv4
transient receptor potential cation channel, subfamily V, member 4
increases expression multiple interactions
ISO
Ketamine results in increased expression of TRPV4 mRNA; Ketamine results in increased expression of TRPV4 protein TRPV4 protein affects the reaction [Ketamine results in decreased activity of CAT protein]; TRPV4 protein affects the reaction [Ketamine results in decreased expression of BCL2 mRNA]; TRPV4 protein affects the reaction [Ketamine results in decreased expression of BCL2 protein]; TRPV4 protein affects the reaction [Ketamine results in increased cleavage of CASP3 protein]; TRPV4 protein affects the reaction [Ketamine results in increased expression of BAX mRNA]; TRPV4 protein affects the reaction [Ketamine results in increased expression of BAX protein]; TRPV4 protein affects the reaction [Ketamine results in increased expression of CASP3 mRNA]; TRPV4 protein affects the reaction [Ketamine results in increased expression of IL1B protein]; TRPV4 protein affects the reaction [Ketamine results in increased expression of IL6 protein]; TRPV4 protein affects the reaction [Ketamine results in increased expression of TNF protein]; TRPV4 protein affects the reaction [Ketamine results in increased phosphorylation of NFKBIA protein]; TRPV4 protein affects the reaction [Ketamine results in increased phosphorylation of RELA protein]
CTD
PMID:33536391
NCBI chr 5:114,760,213...114,796,497
Ensembl chr 5:114,760,213...114,796,482
G
Tsen2
tRNA splicing endonuclease subunit 2
decreases expression
ISO
Ketamine results in decreased expression of TSEN2 mRNA
CTD
PMID:20080153
NCBI chr 6:115,521,652...115,555,297
Ensembl chr 6:115,521,625...115,555,589
G
Tspan14
tetraspanin 14
decreases expression
ISO
Ketamine results in decreased expression of TSPAN14 mRNA
CTD
PMID:20080153
NCBI chr14:40,628,384...40,688,835
Ensembl chr14:40,628,402...40,688,764
G
Tspan33
tetraspanin 33
increases expression
ISO
Ketamine results in increased expression of TSPAN33 mRNA
CTD
PMID:20080153
NCBI chr 6:29,694,213...29,718,557
Ensembl chr 6:29,694,221...29,718,558
G
Tspo
translocator protein
multiple interactions
ISO
[Ketamine co-treated with Midazolam co-treated with Valproic Acid] inhibits the reaction [[Sarin co-treated with [Atropine co-treated with trimethylene-bis(4-hydroxyiminomethylpyridinium)]] results in increased expression of TSPO protein]
CTD
PMID:33823148
NCBI chr15:83,447,774...83,458,404
Ensembl chr15:83,447,793...83,458,404
G
Ttc14
tetratricopeptide repeat domain 14
decreases expression
ISO
Ketamine results in decreased expression of TTC14 mRNA
CTD
PMID:20080153
NCBI chr 3:33,853,923...33,869,009
Ensembl chr 3:33,853,981...33,869,009
G
Ttc21b
tetratricopeptide repeat domain 21B
decreases expression
ISO
Ketamine results in decreased expression of TTC21B mRNA
CTD
PMID:20080153
NCBI chr 2:66,014,131...66,087,144
Ensembl chr 2:66,014,671...66,086,961
G
Ttll1
tubulin tyrosine ligase-like 1
decreases expression
ISO
Ketamine results in decreased expression of TTLL1 mRNA
CTD
PMID:20080153
NCBI chr15:83,367,258...83,402,675
Ensembl chr15:83,367,970...83,395,094
G
Ttll7
tubulin tyrosine ligase-like family, member 7
decreases expression
ISO
Ketamine results in decreased expression of TTLL7 mRNA
CTD
PMID:20080153
NCBI chr 3:146,557,312...146,690,156
Ensembl chr 3:146,558,122...146,689,764
G
Tuba1c
tubulin, alpha 1C
decreases expression
ISO
Ketamine results in decreased expression of TUBA1C protein
CTD
PMID:18504422
NCBI chr15:98,927,772...98,935,986
Ensembl chr15:98,927,772...98,935,991
G
Tuba4a
tubulin, alpha 4A
increases expression
ISO
Ketamine results in increased expression of TUBA4A mRNA
CTD
PMID:20080153
NCBI chr 1:75,190,867...75,197,905
Ensembl chr 1:75,190,872...75,196,509
G
Twist1
twist basic helix-loop-helix transcription factor 1
increases expression
ISO
Ketamine results in increased expression of TWIST1 mRNA
CTD
PMID:28331066
NCBI chr12:34,007,670...34,009,830
Ensembl chr12:34,007,670...34,009,828
G
Txndc17
thioredoxin domain containing 17
decreases expression
ISO
Ketamine results in decreased expression of TXNDC17 mRNA
CTD
PMID:20080153
NCBI chr11:72,098,380...72,101,313
Ensembl chr11:72,098,373...72,100,841
G
Txnip
thioredoxin interacting protein
increases expression
ISO
Ketamine results in increased expression of TXNIP mRNA
CTD
PMID:20080153
NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
G
Tyms
thymidylate synthase
decreases expression
ISO
Ketamine results in decreased expression of TYMS mRNA
CTD
PMID:20080153
NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
G
U2surp
U2 snRNP-associated SURP domain containing
decreases expression
ISO
Ketamine results in decreased expression of U2SURP mRNA
CTD
PMID:20080153
NCBI chr 9:95,338,947...95,394,049
Ensembl chr 9:95,338,951...95,394,049
G
Uap1
UDP-N-acetylglucosamine pyrophosphorylase 1
decreases expression
ISO
Ketamine results in decreased expression of UAP1 mRNA
CTD
PMID:20080153
NCBI chr 1:169,967,473...170,002,358
Ensembl chr 1:169,969,507...170,002,526
G
Ubap1
ubiquitin-associated protein 1
decreases expression
ISO
Ketamine results in decreased expression of UBAP1 mRNA
CTD
PMID:20080153
NCBI chr 4:41,348,996...41,389,766
Ensembl chr 4:41,348,996...41,390,525
G
Ubap2
ubiquitin-associated protein 2
decreases expression
ISO
Ketamine results in decreased expression of UBAP2 mRNA
CTD
PMID:20080153
NCBI chr 4:41,194,313...41,276,016
Ensembl chr 4:41,194,313...41,275,144
G
Ube2b
ubiquitin-conjugating enzyme E2B
increases expression
ISO
Ketamine results in increased expression of UBE2B mRNA
CTD
PMID:20080153
NCBI chr11:51,875,965...51,894,972
Ensembl chr11:51,876,324...51,891,589
G
Ubqln1
ubiquilin 1
decreases expression
ISO
Ketamine results in decreased expression of UBQLN1 mRNA
CTD
PMID:20080153
NCBI chr13:58,323,970...58,363,467
Ensembl chr13:58,323,970...58,363,467
G
Ugdh
UDP-glucose dehydrogenase
decreases expression
ISO
Ketamine results in decreased expression of UGDH mRNA
CTD
PMID:20080153
NCBI chr 5:65,570,550...65,593,185
Ensembl chr 5:65,570,564...65,593,292
G
Unc5c
unc-5 netrin receptor C
decreases expression
ISO
Ketamine results in decreased expression of UNC5C mRNA
CTD
PMID:20080153
NCBI chr 3:141,171,360...141,540,685
Ensembl chr 3:141,170,977...141,540,685
G
Usp2
ubiquitin specific peptidase 2
increases expression
ISO
Ketamine results in increased expression of USP2 mRNA
CTD
PMID:20080153
NCBI chr 9:43,978,318...44,006,924
Ensembl chr 9:43,978,318...44,006,924
G
Usp43
ubiquitin specific peptidase 43
decreases expression
ISO
Ketamine results in decreased expression of USP43 mRNA
CTD
PMID:20080153
NCBI chr11:67,745,349...67,812,979
Ensembl chr11:67,745,349...67,812,979
G
Utp6
UTP6 small subunit processome component
decreases expression
ISO
Ketamine results in decreased expression of UTP6 mRNA
CTD
PMID:20080153
NCBI chr11:79,824,782...79,853,213
Ensembl chr11:79,823,147...79,853,216
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
EXP
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of VCAM1 mRNA]
CTD
PMID:22245128
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vcan
versican
decreases expression
ISO
Ketamine results in decreased expression of VCAN mRNA
CTD
PMID:20080153
NCBI chr13:89,803,429...89,891,146
Ensembl chr13:89,803,431...89,890,628
G
Vcpip1
valosin containing protein (p97)/p47 complex interacting protein 1
decreases expression
ISO
Ketamine results in decreased expression of VCPIP1 mRNA
CTD
PMID:20080153
NCBI chr 1:9,788,847...9,818,607
Ensembl chr 1:9,788,847...9,818,607
G
Vdac2
voltage-dependent anion channel 2
increases expression
ISO
Ketamine results in increased expression of VDAC2 protein
CTD
PMID:18504422
NCBI chr14:21,881,629...21,895,947
Ensembl chr14:21,875,306...21,895,947
G
Vim
vimentin
increases expression multiple interactions
ISO
Ketamine results in increased expression of VIM protein Ketamine results in increased expression of VIM mRNA 2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride inhibits the reaction [Ketamine results in increased expression of VIM protein]
CTD
PMID:28331066
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Vps13a
vacuolar protein sorting 13A
decreases expression
ISO
Ketamine results in decreased expression of VPS13A mRNA
CTD
PMID:20080153
NCBI chr19:16,592,730...16,758,433
Ensembl chr19:16,592,730...16,758,297
G
Vps36
vacuolar protein sorting 36
decreases expression
ISO
Ketamine results in decreased expression of VPS36 mRNA
CTD
PMID:20080153
NCBI chr 8:22,682,849...22,710,969
Ensembl chr 8:22,682,825...22,710,859
G
Washc3
WASH complex subunit 3
decreases expression
ISO
Ketamine results in decreased expression of WASHC3 mRNA
CTD
PMID:20080153
NCBI chr10:88,036,954...88,160,001
Ensembl chr10:88,036,955...88,082,020
G
Wdr36
WD repeat domain 36
decreases expression
ISO
Ketamine results in decreased expression of WDR36 mRNA
CTD
PMID:20080153
NCBI chr18:32,970,241...33,000,008
Ensembl chr18:32,970,278...33,000,647
G
Wdr47
WD repeat domain 47
decreases expression
ISO
Ketamine results in decreased expression of WDR47 mRNA
CTD
PMID:20080153
NCBI chr 3:108,498,302...108,553,035
Ensembl chr 3:108,498,595...108,553,035
G
Wfdc6a
WAP four-disulfide core domain 6A
increases expression
ISO
Ketamine results in increased expression of WFDC6A mRNA
CTD
PMID:20080153
NCBI chr 2:164,421,439...164,427,704
Ensembl chr 2:164,421,439...164,427,367
G
Wfs1
wolframin ER transmembrane glycoprotein
increases expression
ISO
Ketamine results in increased expression of WFS1 mRNA
CTD
PMID:20080153
NCBI chr 5:37,123,448...37,146,326
Ensembl chr 5:37,123,448...37,146,549
G
Wrn
Werner syndrome RecQ like helicase
decreases expression
ISO
Ketamine results in decreased expression of WRN mRNA
CTD
PMID:20080153
NCBI chr 8:33,724,400...33,875,591
Ensembl chr 8:33,724,412...33,875,555
G
Wtap
WT1 associating protein
increases expression
ISO
Ketamine results in increased expression of WTAP mRNA
CTD
PMID:20080153
NCBI chr17:13,185,686...13,211,430
Ensembl chr17:13,185,683...13,213,056
G
Xbp1
X-box binding protein 1
multiple interactions
EXP
Ketamine affects the expression of and affects the splicing of XBP1 mRNA
CTD
PMID:35728656
NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
G
Xylt2
xylosyltransferase II
increases expression
ISO
Ketamine results in increased expression of XYLT2 mRNA
CTD
PMID:20080153
NCBI chr11:94,554,671...94,568,341
Ensembl chr11:94,554,677...94,568,341
G
Yars2
tyrosyl-tRNA synthetase 2 (mitochondrial)
decreases expression
ISO
Ketamine results in decreased expression of YARS2 mRNA
CTD
PMID:20080153
NCBI chr16:16,120,829...16,127,504
Ensembl chr16:16,120,829...16,127,504
G
Ybx3
Y box protein 3
decreases expression
ISO
Ketamine results in decreased expression of YBX3 mRNA
CTD
PMID:20080153
NCBI chr 6:131,341,821...131,365,413
Ensembl chr 6:131,341,818...131,365,439
G
Yjefn3
YjeF N-terminal domain containing 3
increases expression
ISO
Ketamine results in increased expression of YJEFN3 mRNA
CTD
PMID:20080153
NCBI chr 8:70,340,438...70,346,633
Ensembl chr 8:70,340,438...70,355,362
G
Ypel5
yippee like 5
increases expression
ISO
Ketamine results in increased expression of YPEL5 mRNA
CTD
PMID:20080153
NCBI chr17:73,143,623...73,157,439
Ensembl chr17:73,143,448...73,158,190
G
Yy1
YY1 transcription factor
decreases expression
ISO
Ketamine results in decreased expression of YY1 mRNA
CTD
PMID:20080153
NCBI chr12:108,758,841...108,786,074
Ensembl chr12:108,758,899...108,786,074
G
Zbed5
zinc finger BED-type containing 5
decreases expression
ISO
Ketamine results in decreased expression of ZBED5 mRNA
CTD
PMID:20080153
NCBI chr 5:129,924,564...129,937,350
Ensembl chr 5:129,924,564...129,932,464
G
Zbtb8b
zinc finger and BTB domain containing 8b
decreases expression
ISO
Ketamine results in decreased expression of ZBTB8B mRNA
CTD
PMID:20080153
NCBI chr 4:129,320,063...129,340,761
Ensembl chr 4:129,319,558...129,334,646
G
Zcchc9
zinc finger, CCHC domain containing 9
decreases expression
ISO
Ketamine results in decreased expression of ZCCHC9 mRNA
CTD
PMID:20080153
NCBI chr13:91,944,652...91,955,824
Ensembl chr13:91,944,652...91,955,824
G
Zdhhc23
zinc finger, DHHC domain containing 23
decreases expression
ISO
Ketamine results in decreased expression of ZDHHC23 mRNA
CTD
PMID:20080153
NCBI chr16:43,785,396...43,800,295
Ensembl chr16:43,785,396...43,800,154
G
Zfand2a
zinc finger, AN1-type domain 2A
increases expression
ISO
Ketamine results in increased expression of ZFAND2A mRNA
CTD
PMID:20080153
NCBI chr 5:139,456,971...139,470,246
Ensembl chr 5:139,456,966...139,470,304
G
Zfhx4
zinc finger homeodomain 4
decreases expression
ISO
Ketamine results in decreased expression of ZFHX4 mRNA
CTD
PMID:20080153
NCBI chr 3:5,276,268...5,480,921
Ensembl chr 3:5,283,586...5,480,917
G
Zfp36
zinc finger protein 36
increases expression
ISO
Ketamine results in increased expression of ZFP36 mRNA
CTD
PMID:20080153
NCBI chr 7:28,076,208...28,078,680
Ensembl chr 7:28,076,209...28,079,678
G
Zfp524
zinc finger protein 524
decreases expression
ISO
Ketamine results in decreased expression of ZFP524 mRNA
CTD
PMID:20080153
NCBI chr 7:5,018,142...5,021,487
Ensembl chr 7:5,017,414...5,021,487
G
Zfp57
zinc finger protein 57
decreases expression
ISO
Ketamine results in decreased expression of ZFP57 mRNA
CTD
PMID:20080153
NCBI chr17:37,307,060...37,326,196
Ensembl chr17:37,312,055...37,321,527
G
Zfp61
zinc finger protein 61
decreases expression
ISO
Ketamine results in decreased expression of ZFP61 mRNA
CTD
PMID:20080153
NCBI chr 7:23,990,470...24,003,273
Ensembl chr 7:23,990,464...24,000,657
G
Zfp638
zinc finger protein 638
decreases expression
ISO
Ketamine results in decreased expression of ZFP638 mRNA
CTD
PMID:20080153
NCBI chr 6:83,844,050...83,963,855
Ensembl chr 6:83,844,091...83,966,532
G
Zmynd8
zinc finger, MYND-type containing 8
decreases expression
ISO
Ketamine results in decreased expression of ZMYND8 mRNA
CTD
PMID:20080153
NCBI chr 2:165,626,072...165,740,896
Ensembl chr 2:165,626,072...165,740,936
G
Znhit6
zinc finger, HIT type 6
decreases expression
ISO
Ketamine results in decreased expression of ZNHIT6 mRNA
CTD
PMID:20080153
NCBI chr 3:145,281,943...145,313,570
Ensembl chr 3:145,281,960...145,310,550
G
Zswim5
zinc finger SWIM-type containing 5
decreases expression
ISO
Ketamine results in decreased expression of ZSWIM5 mRNA
CTD
PMID:20080153
NCBI chr 4:116,731,326...116,846,461
Ensembl chr 4:116,734,573...116,846,461
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all